Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,29495,0.141986781821964,0.00338864060395109,0.13534504623822,0.148628517405708,0
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29438,0.102581098991584,0.0020202352146588,0.098621437970853,0.106540760012315,0
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29561,0.0777843500642647,0.00212665449647752,0.0736161072511688,0.0819525928773606,1.71127924998323e-286
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,29697,-0.0734615239279538,0.0023365112616934,-0.0780410860008728,-0.0688819618550347,1.79565121596026e-213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,29430,0.0641995985791234,0.00206330915355728,0.0601555126381512,0.0682436845200957,3.74177796036919e-209
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24840,0.0738897580505857,0.00239463706218821,0.0691962694086968,0.0785832466924746,3.44624059707727e-205
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29213,-0.0973998847368137,0.00386352035642421,-0.104972384635405,-0.0898273848382222,9.4776211205288e-139
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,24721,0.0572665788911928,0.00226957997144941,0.0528182021471519,0.0617149556352336,1.01356081561759e-138
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,29448,0.0507272578689418,0.00209173293697084,0.046627461312479,0.0548270544254047,1.17489204427893e-128
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29815,0.0446658948681091,0.00191178117466798,0.0409188037657599,0.0484129859704584,1.19820860823139e-119
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,29561,0.0588656824364238,0.00263795404609105,0.0536952925060853,0.0640360723667622,2.1263574640331e-109
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFP,Properdin,24961,0.0335385595754941,0.00151084246191437,0.0305773083501419,0.0364998108008463,3.95303420638862e-108
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,29438,0.0393749127353377,0.00181096494888057,0.0358254214355318,0.0429244040351436,5.36607779625122e-104
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFH,Complement factor H,23688,0.0322135254479735,0.00153740951327555,0.0292002028019534,0.0352268480939936,1.32449829251556e-96
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29781,0.0349250339835318,0.00171053893310982,0.0315723776746366,0.0382776902924271,4.99212630881005e-92
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,24402,0.0412656918990226,0.00203065371348868,0.0372856106205848,0.0452457731774604,4.72613977277625e-91
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,29473,0.0452974781680334,0.00225519741174312,0.0408772912410169,0.0497176650950499,3.88609512367183e-89
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24961,0.0326565838372189,0.00170254661506006,0.0293195924717012,0.0359935752027366,2.0580622915284e-81
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FST,Follistatin,29531,0.0631192468296855,0.00332737318724146,0.0565975953826923,0.0696408982766788,9.06811045853511e-80
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29720,0.0729178457343064,0.00386415522404617,0.0653441014951759,0.0804915899734369,5.80186671163037e-79
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,24376,0.0530875428667313,0.00282081873320126,0.0475587381496568,0.0586163475838057,1.86995481403384e-78
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,29164,0.0635899988441661,0.00339965011901368,0.0569266846108993,0.0702533130774329,1.28801548812357e-77
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,24376,0.142365270372524,0.00762617548569028,0.127417966420571,0.157312574324477,3.12217203252879e-77
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29589,0.0519375378122045,0.00279949924387808,0.0464505192942035,0.0574245563302056,2.11742895518721e-76
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,24961,-0.0332076673820363,0.00180838131300235,-0.0367520947555209,-0.0296632400085517,8.06299093867805e-75
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,24235,-0.0612183035400234,0.00336030583343798,-0.0678045029735619,-0.054632104106485,1.15245566087862e-73
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,29308,0.0459580219473231,0.00255273658347068,0.0409546582437206,0.0509613856509257,4.48354137603675e-72
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29623,0.0552899092971079,0.00310847615992505,0.0491972960236547,0.061382522570561,2.08028676031457e-70
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29429,0.0386527606124925,0.00218997577821444,0.0343604080871922,0.0429451131377928,2.32609026282965e-69
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2,Complement C2,29540,0.0269483746727829,0.00154007617756372,0.023929825364758,0.0299669239808077,3.27644156870842e-68
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,29473,0.0447087259861945,0.00256328592407513,0.0396846855750073,0.0497327663973818,8.68925607623466e-68
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,29378,0.034283600853147,0.00196837165368847,0.0304255924119176,0.0381416092943764,1.33621680056297e-67
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGRN,Agrin,29576,0.039170561673612,0.00226822231891856,0.0347248459285316,0.0436162774186924,1.70016810686309e-66
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,29576,0.047188005246859,0.00273842465439123,0.0418206929242522,0.0525553175694658,3.2310745022012e-66
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,29438,0.032547738989939,0.00188946581613615,0.0288443859903122,0.0362510919895659,3.58756425398408e-66
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24863,0.102893854493691,0.00602724483248024,0.0910804546220298,0.114707254365352,5.68480873863811e-65
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24235,0.101359754276276,0.00601836175745599,0.0895637652316621,0.11315574332089,2.76548633614463e-63
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,29473,0.0291500330015973,0.00173676096353901,0.0257459815130608,0.0325540844901337,6.25546414513646e-63
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,29576,0.0737293086043516,0.00440329074109959,0.0650988587517965,0.0823597584569068,1.21543942631105e-62
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24800,0.0958467008087638,0.00577565802892761,0.0845264110720657,0.107166990545462,1.62910452170451e-61
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,28949,0.04535150535323,0.0027348546177962,0.0399911903023494,0.0507118204041105,1.78517645410237e-61
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,29540,0.028065625215349,0.00170558515685323,0.0247226783079167,0.0314085721227814,1.43467620366605e-60
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29486,0.0431442572345314,0.00262292412966323,0.0380033259403914,0.0482851885286713,1.5900280552307e-60
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24800,0.111632739600975,0.00680900820759526,0.0982870835140879,0.124978395687861,4.31379675945175e-60
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29815,0.0538605899705887,0.00329224156860363,0.0474077964961255,0.0603133834450518,6.75443886646923e-60
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23400,-0.11933439702783,0.00729170549159791,-0.133626139791362,-0.105042654264298,7.22770988845716e-60
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,29815,0.028357831202037,0.00173771551454597,0.0249519087935269,0.0317637536105471,1.31152183565018e-59
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29369,0.0352612027109463,0.00216461770678563,0.0310185520056465,0.0395038534162461,2.12580191245397e-59
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C3,Complement C3,23774,0.0500356579909297,0.0030714390753347,0.0440156374032737,0.0560556785785858,2.41406732510117e-59
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29438,0.0260271449547224,0.00160258024607651,0.0228860876724124,0.0291682022370324,4.69320183797897e-59
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,29599,0.0637625725389117,0.00393903595200292,0.056042062072986,0.0714830830048374,1.10748886044054e-58
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,29213,0.0386636549432702,0.00238981196435,0.0339796234931442,0.0433476863933962,1.28626282262677e-58
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24510,0.0145198090432741,0.000898182568957662,0.0127593712081171,0.0162802468784311,1.76621625182937e-58
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,29689,0.0240416800548546,0.0014886779113651,0.021123871348579,0.0269594887611302,2.02662788980259e-58
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29554,0.0248984202529586,0.00154309877658341,0.0218739466508551,0.0279228938550621,2.55853798291629e-58
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",29720,0.0777348017143514,0.00483646992644778,0.0682553206585137,0.087214282770189,6.96674888619028e-58
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29720,0.0347761310754824,0.00216410650212649,0.0305344823313144,0.0390177798196503,7.32345747260547e-58
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28911,0.0583009319748982,0.00362788226798534,0.051190282729647,0.0654115812201495,7.35285785991834e-58
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29438,0.037853566135306,0.00237237553885625,0.0332037100791477,0.0425034221914642,4.49570131433627e-57
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFI,Complement factor I,24961,0.0207734718608726,0.00131253109984941,0.0182009109051677,0.0233460328165774,3.80169486968947e-56
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29328,-0.0656913816948212,0.00416007554933933,-0.0738451297715263,-0.0575376336181162,6.11437175282977e-56
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PYY,Peptide YY,24106,-0.101130036325061,0.00641114524246382,-0.11369588100029,-0.088564191649832,8.92388039479134e-56
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,24618,0.0434658260718365,0.00275801774099828,0.0380601112994799,0.0488715408441932,1.10166917558361e-55
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,29385,0.0293491903759605,0.00186503044868044,0.0256937306965468,0.0330046500553742,1.43301475050353e-55
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24840,0.0786125810066573,0.00502174307203811,0.0687699645854626,0.088455197427852,5.67768382169398e-55
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,29438,0.0349070625874955,0.00223760278992327,0.0305213611192459,0.0392927640557451,1.20180663461035e-54
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,24224,-0.125805330455039,0.00811292016406697,-0.14170665397661,-0.109904006933468,5.67610234981014e-54
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29356,0.0275732767331554,0.00178148533692469,0.024081565472783,0.0310649879935278,8.01417246012753e-54
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,29502,0.0201169740107806,0.00130516062245327,0.0175588591907722,0.022675088830789,2.14940184875038e-53
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29756,0.123755101270643,0.0080321344660043,0.108012117717274,0.139498084824011,2.34396312883125e-53
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,29689,0.0303878130667188,0.00197469532137694,0.02651741023682,0.0342582158966176,3.13517455817857e-53
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24800,0.103982077183687,0.00677347026451233,0.090706075465243,0.117258078902131,6.07898646094129e-53
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29428,0.115103920513846,0.00753521094830638,0.100334907055166,0.129872933972527,1.77245801711924e-52
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFB,Complement factor B,24533,0.0329319415711739,0.00216371463394461,0.0286910608886424,0.0371728222537053,4.50201464051161e-52
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,29438,0.0250724875556948,0.00165048173511424,0.0218375433548709,0.0283074317565187,6.3867984794228e-52
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,29438,0.0758828602399034,0.00500337078375653,0.0660762535037406,0.0856894669760662,9.27473590955381e-52
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29344,0.0408717235667044,0.00270090394872887,0.0355779518271958,0.046165495306213,1.54572041698143e-51
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29720,0.06253123407677,0.00413344209600043,0.0544296875686091,0.0706327805849308,1.64450637700063e-51
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28926,0.0719343604787128,0.00475630005725208,0.0626120123664987,0.0812567085909269,1.77086816865852e-51
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,29473,0.0453294558202062,0.00300004824706722,0.0394493612559545,0.051209550384458,2.18287543279564e-51
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29531,0.0449893898744195,0.00298256821937808,0.0391435561644385,0.0508352235844006,3.19927811009905e-51
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29438,0.0285454516386449,0.00189348158638675,0.0248342277293268,0.0322566755479629,3.6385441109193e-51
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29473,0.0318327057781291,0.00211602657288993,0.0276852936952648,0.0359801178609933,5.88069865204019e-51
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29365,0.0200768902825217,0.00133459139451042,0.0174610911492813,0.0226926894157621,5.9033052289397e-51
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29386,0.0285907619178519,0.00190400315555513,0.0248589157329638,0.0323226081027399,8.88885110508883e-51
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24764,0.0862182282445058,0.00576970140574648,0.0749096134892427,0.0975268429997689,2.85536559771879e-50
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,28863,0.0376851005877964,0.00252614031068315,0.0327338655788575,0.0426363355967354,3.86939968471871e-50
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29344,0.0312474204089238,0.00209879944200619,0.0271337735025916,0.0353610673152559,5.98409062966687e-50
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29492,0.0332933638761906,0.00223832655568517,0.0289062438270477,0.0376804839253335,7.35167726297249e-50
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,29525,0.0278057124152983,0.00187210599978822,0.0241363846557134,0.0314750401748832,1.01179326755259e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24878,0.0145135062542525,0.000977043853134201,0.0125985003021094,0.0164285122063955,1.06286457766315e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,29429,0.0332661313910131,0.00224383252414423,0.0288682196436904,0.0376640431383357,1.51181169039364e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24235,0.0254559745684356,0.00171835479702231,0.0220879991662719,0.0288239499705994,1.95389267455854e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29561,0.0327967063461951,0.00221817658307608,0.028449080243366,0.0371443324490242,2.72975888754079e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,29781,0.0408141759464832,0.0027608611819316,0.0354028880298973,0.0462254638630692,2.81561571917969e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,29429,0.0570795182816337,0.00387061956537662,0.0494931039334955,0.0646659326297719,4.82536590575788e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24788,-0.0539359550743489,0.00366251572143967,-0.0611144858883707,-0.0467574242603272,7.01683731634345e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,24376,0.0504672562656583,0.00342731306188791,0.043749722664358,0.0571847898669586,7.22592925558878e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,29161,0.0682401887866921,0.0046378396549512,0.0591500230629877,0.0773303545103964,7.87331112735169e-49
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29364,0.0188797476013554,0.00128693536390341,0.0163573542881048,0.0214021409146061,1.48447740602915e-48
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,29647,0.036004202035876,0.00245753160242939,0.0311874400951144,0.0408209639766376,1.97433324090116e-48
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24946,0.0251929665031427,0.00172158453301561,0.0218186608184321,0.0285672721878533,2.720488415735e-48
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,29619,0.0654083695951619,0.00448234848590242,0.0566229665627931,0.0741937726275306,4.61009273698839e-48
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29815,0.0152622095364231,0.00104667523513427,0.0132107260755599,0.0173136929972863,5.38287364254849e-48
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,29376,0.0394814087602866,0.00270862638788788,0.0341725010400264,0.0447903164805469,5.8587504780307e-48
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29781,0.0274414212675325,0.00188958692434858,0.0237378308958093,0.0311450116392557,1.27119636139779e-47
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24920,0.0186565997943004,0.00128646092191733,0.0161351363873425,0.0211780632012584,1.83040415763609e-47
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,24961,0.0199191304482662,0.00137957537974931,0.0172151627039576,0.0226230981925749,4.58055605134569e-47
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,28979,0.03239681879385,0.00225040626085428,0.0279860225225757,0.0368076150651244,7.95880025752634e-47
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29302,0.099493861136927,0.00691918927252826,0.0859322501627716,0.113055472111082,1.00557727820338e-46
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,29367,-0.0599479606764944,0.00417237023971208,-0.06812580634633,-0.0517701150066587,1.18607052678305e-46
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,29473,0.0439263574998157,0.00305941613362633,0.0379299018779081,0.0499228131217233,1.36870795864532e-46
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,29344,0.0810459606168861,0.00564971789207529,0.0699725135484186,0.0921194076853537,1.64252083813628e-46
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,28272,0.0217897059051095,0.00152086572958931,0.0188088090751145,0.0247706027351046,2.15286096282961e-46
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),24479,0.168538929928268,0.0117867210309624,0.145436956707581,0.191640903148954,3.40634701165286e-46
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24917,0.0258950885706497,0.00181560729651457,0.0223364982694811,0.0294536788718182,5.68866267537871e-46
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28769,0.0497319733337532,0.00348840479480279,0.0428946999359397,0.0565692467315667,5.87114581974186e-46
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",24235,0.0816694629502607,0.00573420099081738,0.0704304290082586,0.0929084968922628,7.64362625720977e-46
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,24917,0.0419978741887421,0.00295680788807667,0.0362025307281118,0.0477932176493723,1.30834707314275e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,24887,0.0686437918605752,0.00483557186031995,0.0591660710143481,0.0781215127068023,1.47007935880395e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29438,0.0474716217285337,0.00334962894386525,0.0409063489985578,0.0540368944585096,1.92180740579907e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,29213,0.0382545101685317,0.0027002439877267,0.0329620319525873,0.043546988384476,2.07236139108777e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24235,0.0492171965379035,0.00348764025345354,0.0423814216411346,0.0560529714346725,4.84058359408439e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24235,0.0717261085500325,0.00508816666519885,0.0617533018862428,0.0816989152138223,5.99716782663742e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,29561,0.027812873231346,0.00197754032470982,0.0239368941949147,0.0316888522677772,8.77112123300989e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,29344,0.0521219429200944,0.00370653990889137,0.0448571246986673,0.0593867611415215,9.07115475532144e-45
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,24909,0.0209125310569006,0.00149102938874151,0.0179901134549672,0.0238349486588339,1.60688373729171e-44
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,24946,0.0261123422389585,0.00187091755218927,0.0224453438366675,0.0297793406412494,4.18199409917946e-44
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29452,-0.0890452103674879,0.0064064479675176,-0.101601848383822,-0.0764885723511534,8.79714513511667e-44
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29344,0.0410796819190749,0.00295562649299984,0.0352866539927952,0.0468727098453545,8.86922435059478e-44
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29429,0.0755531737507005,0.00544294821719986,0.0648849952449888,0.0862213522564123,1.13548659801444e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29689,0.0416499227121432,0.00300561988511986,0.0357589077373082,0.0475409376869781,1.56970333332217e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24800,0.0876031843342785,0.00632062750469817,0.0752147544250701,0.0999916142434869,1.61143878031667e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29815,0.0203266694784778,0.001470158981788,0.0174451578741733,0.0232081810827823,2.41230569861807e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24235,0.0415798865760158,0.00302572299287433,0.0356494695099821,0.0475103036420495,8.22057395159121e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,29461,0.0481609957955216,0.00350642698342663,0.0412883989080054,0.0550335926830378,8.48461425152614e-43
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,29029,0.048469758279059,0.0035385002985625,0.0415342976938765,0.0554052188642415,1.4195327536995e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29344,0.0625929711022177,0.00458475725576503,0.0536068468809182,0.0715790953235172,2.63134396492379e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29689,0.0469732267148622,0.00344212054785239,0.0402266704410715,0.0537197829886529,2.83853906677997e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,29689,0.0335622094801011,0.00246723314903652,0.0287264325079896,0.0383979864522127,5.12594933452432e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29014,0.0200925289033589,0.00147950737739733,0.0171926944436602,0.0229923633630577,7.01629142031244e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24800,0.101960582003771,0.0075058444287912,0.0872491269233401,0.116672037084202,7.02377784030169e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,29689,0.0544591622852022,0.00401044122451511,0.0465986974851526,0.0623196270852518,7.08481361668933e-42
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,29438,0.0209518663275414,0.00155186265309768,0.0179102155274699,0.0239935171276128,2.04677986386024e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29492,0.0272251103298105,0.00201792438109819,0.0232699785428581,0.031180242116763,2.32434912881202e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,29331,0.0409261507429696,0.00303709347519023,0.0349734475315967,0.0468788539543424,2.89606212103337e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C9,Complement component C9,24946,0.0472298218692025,0.00351136875675909,0.0403475391059547,0.0541121046324503,4.25195909731357e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,29656,0.038100273707555,0.00283625905650131,0.0325412059568124,0.0436593414582975,5.08853304355011e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29468,0.034694915765814,0.00258338008079106,0.0296314908074636,0.0397583407241645,5.32386922931304e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,29720,0.0978293258619499,0.00729229601443452,0.0835364256736582,0.112122226050242,6.46153190026655e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,29781,0.0365772814380126,0.00272760565102889,0.031231174361996,0.0419233885140292,6.94296626263405e-41
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRN,Progranulin,29308,0.0217746745643758,0.0016293954061176,0.0185810595683852,0.0249682895603663,1.29700155974021e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29731,0.0180544789005222,0.0013523688364266,0.015403835981126,0.0207051218199183,1.54487346760917e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29689,0.059616404054647,0.00447219183493438,0.0508509080581756,0.0683819000511184,2.01232216406442e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29531,0.0457515767506455,0.00343400912858513,0.0390209188586187,0.0524822346426724,2.22358392851803e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,24224,0.081775930337945,0.00614187995785606,0.0697378456205471,0.0938140150553429,2.64350852445898e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASN,Vasorin,29060,0.0241810367392007,0.00181843747137707,0.0206168992953016,0.0277451741830997,3.13018876913929e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24235,0.0850788264377297,0.00640507273359942,0.0725248838798748,0.0976327689955845,4.01231677931432e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,29637,0.035743841350965,0.00269262411734472,0.0304662980809694,0.0410213846209607,4.22491370888551e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,29344,-0.0792292497160417,0.00596877991305877,-0.0909280583456369,-0.0675304410864465,4.28008824741018e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,24811,0.0564940017925261,0.00426196348137862,0.0481405533690241,0.0648474502160282,5.74414087196903e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24933,-0.0441211256123033,0.00332907126603474,-0.0506461052937314,-0.0375961459308753,5.89777767127785e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,29344,0.0634504353708477,0.00479085932949863,0.0540603510850303,0.072840519656665,6.36007233644047e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24946,0.019435666961154,0.00146741450177842,0.0165595345376683,0.0223117993846397,6.59398144136462e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,29473,0.0212831230630522,0.00160892565570337,0.0181296287778736,0.0244366173482308,7.8406492276217e-40
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29213,0.0364266608086626,0.00275948944662683,0.031018061493274,0.0418352601240512,1.1323891056676e-39
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29689,0.0399920938007481,0.00303076923229925,0.0340517861054416,0.0459324014960546,1.20689957567081e-39
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,24631,0.0863743629532467,0.0065588035881,0.0735191079205706,0.0992296179859227,1.79452008243672e-39
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24225,0.0338413832648494,0.00257209668534235,0.0288000737615784,0.0388826927681204,2.114871443774e-39
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,29344,0.0650479022249356,0.00495224728519728,0.0553414975459489,0.0747543069039222,2.67838553840155e-39
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24917,0.0534279761361255,0.00406759910404902,0.0454554818921895,0.0614004703800616,2.80277211784988e-39
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,29473,0.0348695365917476,0.00265853772483832,0.0296588026510645,0.0400802705324307,3.43165824704957e-39
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,29429,0.0522152209095633,0.0039935203868779,0.0443879209512827,0.060042520867844,5.87825643963081e-39
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29720,0.0283317156448157,0.00217400696000969,0.0240706620031967,0.0325927692864347,1.02740635736877e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,29678,0.029448162358579,0.00227108371563133,0.0249968382759416,0.0338994864412164,2.40708654591612e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,24376,0.0492767708840741,0.00380084101862821,0.0418271224875628,0.0567264192805853,2.5976860002137e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,29815,0.0271419720912843,0.00210021950252832,0.0230255418663288,0.0312584023162398,4.20516192407336e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24204,0.0484566661346149,0.00374910197770556,0.041108426258312,0.0558049060109178,4.35681250740488e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,24376,0.0924351750059294,0.00715856184176925,0.0784043937960617,0.106465956215797,5.0985168461596e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28926,0.0362218236994339,0.00280973769916558,0.0307147378090694,0.0417289095897985,6.39114863069173e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29505,0.0194164403230231,0.00150795005343025,0.0164608582182998,0.0223720224277463,7.76585544557222e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,24189,0.0234435223735913,0.00182029682911736,0.0198757405885213,0.0270113041586614,7.87567765340897e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24841,0.0169868207414002,0.00132062428182876,0.0143983971490158,0.0195752443337846,9.63211546192857e-38
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,29689,0.0667908549028106,0.00519850038872671,0.0566017941409062,0.0769799156647149,1.11108040862946e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,29430,-0.0382598969403044,0.00297849839970753,-0.0440977538037312,-0.0324220400768776,1.15318402366223e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29699,0.0693473360588899,0.00540076030793727,0.0587618458553328,0.0799328262624469,1.22826029502994e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,29429,0.0395812982723829,0.00308625220537281,0.0335322439498522,0.0456303525949136,1.49712173415195e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29561,0.0215040202543828,0.00167740081559428,0.018216314655818,0.0247917258529476,1.59855547671983e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,29115,0.0366358414998975,0.00286065531921982,0.0310289570742266,0.0422427259255683,1.89617941805313e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24933,0.022344555860966,0.00174655449410392,0.0189213090525224,0.0257678026694097,2.33696635913623e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,29429,0.0561721380648246,0.00439785700133289,0.0475523383422122,0.0647919377874371,2.92934998312271e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29781,0.0467790153717783,0.0036700531211662,0.0395857112542926,0.0539723194892641,4.09634066215314e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29815,0.020728917870871,0.00162746120289605,0.0175390939131947,0.0239187418285472,4.60352215501566e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAX,Protein max,28769,0.0882534317729107,0.00695140799015721,0.0746286721122026,0.101878191433619,7.83883700570253e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,24961,-0.0299678617189832,0.00236162556966399,-0.0345966478355246,-0.0253390756024418,8.78561593615362e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,24917,0.0546627454524466,0.00430897780854955,0.0462171489476895,0.0631083419572037,9.21499462764781e-37
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,29720,0.0386425714070001,0.00304897064524082,0.0326665889423281,0.0446185538716721,1.02618440002243e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28926,0.0711868567557574,0.005624704946784,0.0601624350600608,0.082211278451454,1.2946956599569e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,29781,0.028679704030987,0.00227100189784153,0.0242285403112176,0.0331308677507564,1.8205875784188e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,24917,0.0831899922869248,0.0065880836394006,0.0702773483536996,0.0961026362201499,1.93027957293269e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,29116,0.0477010414234203,0.00378121376347072,0.0402898624470177,0.0551122203998229,2.16653446819506e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28926,0.0327390801453234,0.00259884595280805,0.0276453420778196,0.0378328182128272,2.71338684390765e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24946,0.0604012947796292,0.00479594307485481,0.0510012463529138,0.0698013432063446,2.92898758965935e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,29344,0.0246261010031868,0.00196026007277562,0.0207839912605466,0.028468210745827,4.19620338847442e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,29561,-0.0333192124629585,0.00265323522497118,-0.038519553503902,-0.028118871422015,4.44541796679679e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,29731,0.0415562819325576,0.00331630988007177,0.0350563145676169,0.0480562492974982,6.23794264410854e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24800,0.0975488908737181,0.00778373496232984,0.0822927703475516,0.112805011399885,6.37929709918454e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29576,0.107359478066547,0.0085794115704561,0.0905438313884532,0.124175124744641,7.75332066975956e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,29344,0.023508095265766,0.00187897941885856,0.0198252956048032,0.0271908949267288,8.01514900850712e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,23386,0.0202202118529999,0.00161579066138218,0.0170532621566908,0.0233871615493089,8.14100728623587e-36
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,29561,0.0463632812936328,0.00371140850328685,0.0390889206271906,0.053637641960075,1.01508083535775e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,28792,-0.102654902277738,0.00821895435262458,-0.118764052808883,-0.0865457517465943,1.04759449153509e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,24863,0.0639195424911165,0.00512060106659581,0.0538831644005887,0.0739559205816443,1.18529514897859e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29449,0.0229235305171968,0.0018378635361445,0.0193213179863536,0.02652574304804,1.29093284097381e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FN1,Fibronectin,24961,0.0220202189801212,0.00176667272550625,0.018557540438129,0.0254828975221135,1.4931858278848e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24235,0.0572823643518534,0.0046033615174246,0.0482597757777012,0.0663049529260056,1.94488491012854e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,29473,0.0503374861385206,0.00404802936678403,0.0424033485796239,0.0582716236974173,2.06941436884779e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,24840,0.0759734668955168,0.0061231435043992,0.0639721056268944,0.0879748281641393,3.02398513774415e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29561,0.0302907244910085,0.00244318862142308,0.0255020747930193,0.0350793741889977,3.2771889066858e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,29448,0.0770498728842161,0.00621497619876259,0.0648685195346414,0.0892312262337907,3.30328766289454e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,29561,0.0228505714949555,0.00184725053791787,0.0192299604406365,0.0264711825492745,4.63660196760791e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24376,0.0519008589085197,0.00419776027341041,0.0436732487726353,0.0601284690444041,5.21674120756468e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24376,0.0335035802000006,0.00271067516601084,0.0281906568746194,0.0388165035253818,5.48633362130277e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,24917,0.0797716466688671,0.00645800955952924,0.0671139479321898,0.0924293454055444,5.98840325984681e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24376,0.0302007254586238,0.00245096882027706,0.0253968265708808,0.0350046243463668,8.7602687293375e-35
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29218,0.0327435886435411,0.00267261028463802,0.0275052724856506,0.0379819048014317,2.00282501509194e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29095,0.0382903274543921,0.00312743321247419,0.0321605583579427,0.0444200965508415,2.21565242637058e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,28748,0.0374173940897148,0.0030571238070771,0.0314254314278437,0.0434093567515859,2.33135217031135e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24863,0.0679741173115584,0.00555510457351355,0.0570861123474719,0.078862122275645,2.49632619645581e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,24800,0.0555322630088123,0.00454334759418914,0.0466273017242015,0.064437224293423,2.94897084799892e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29781,0.0592337493303084,0.00484766074032931,0.0497323342792629,0.0687351643813538,2.97179651509353e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29429,-0.0281683967350734,0.00230973409107648,-0.0326954755535833,-0.0236413179165635,3.97098760085444e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29438,0.0294544327947703,0.00241549344513313,0.0247200656423094,0.0341887999472312,4.04684538771322e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALB2,Calretinin,28769,0.0246316052367174,0.00202027888390754,0.0206718586242586,0.0285913518491762,4.15401517602145e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,28757,0.0255023363360673,0.00209773604703666,0.0213907736838755,0.0296138989882592,6.37371496704936e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28533,0.0978994030591842,0.00807369149865046,0.0820749677218292,0.113723838396539,9.3450371232053e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29374,0.0431948636362776,0.00356398276553946,0.0362094574158202,0.0501802698567349,9.98447658577461e-34
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,24917,0.0546395941768379,0.0045149409532648,0.0457903099084389,0.0634888784452369,1.28176809701771e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,29781,0.03614136890279,0.00299602990943774,0.030269150280292,0.0420135875252879,1.98035034205116e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29462,0.0752672312690424,0.00625950287077436,0.0629986056423247,0.0875358568957602,3.16174167045382e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24909,0.014928351178662,0.00124141651965342,0.0124951748001413,0.0173615275571827,3.2361670608536e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29815,0.0229318816365364,0.00190855650579172,0.0191911108851846,0.0266726523878881,3.52358839129778e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,29473,-0.0372424792530926,0.00310527278135705,-0.0433288139045524,-0.0311561446016328,4.60022884137006e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28792,0.0872164626287479,0.0072750297643529,0.0729574042906162,0.10147552096688,4.89581157492966e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29599,0.0258885183770343,0.00216364754703101,0.0216477691848535,0.0301292675692151,6.43952061657461e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,24224,0.0697001008030915,0.00582735080333185,0.058278493228561,0.0811217083776219,7.05281592500124e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24933,0.0478732808645335,0.00400848888527172,0.040016642649401,0.0557299190796661,8.68273867073272e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28911,0.0274017212302431,0.00229557488682067,0.0229023944520746,0.0319010480084116,9.09225011585757e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,29438,-0.0295805133480181,0.0024785848378423,-0.034438539630189,-0.0247224870658472,9.31862995401e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29429,0.0267968989828326,0.00224591994314739,0.0223948958942637,0.0311989020714015,9.66732932319901e-33
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24800,0.0713760024207244,0.00598707296096994,0.0596413394172233,0.0831106654242255,1.12095183155907e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24863,0.0897562830809499,0.00752891578486517,0.0749996081426142,0.104512958019286,1.12229803894248e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24917,0.0570312234410285,0.0047847182116949,0.0476531757461065,0.0664092711359505,1.150117618632e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,29025,0.0334607657287696,0.00280822077824085,0.0279566530034176,0.0389648784541217,1.17431021090237e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29344,0.0663525826018722,0.00557682015919602,0.055422015089848,0.0772831501138964,1.44193729236994e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,29296,0.0593509940308815,0.00498891994005134,0.0495727109483809,0.0691292771133821,1.4659621143126e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24224,0.0668712077863772,0.00563591302396305,0.0558248182594096,0.0779175973133448,2.20709729096929e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29344,0.0298268074362793,0.00251918046663277,0.024889213721679,0.0347644011508795,2.87586104637752e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDK,Midkine,29450,0.0397721168774472,0.00336204558368407,0.0331825075334264,0.0463617262214679,3.24174638302498e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29344,0.0689747831968902,0.00583912073562584,0.0575301065550635,0.0804194598387168,3.97731246175997e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,29576,0.0331094038248079,0.00280866080747541,0.0276044286421561,0.0386143790074597,5.28882610278162e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29322,0.0343567165990102,0.00291934236552512,0.028634805562581,0.0400786276354394,6.68127701370333e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOST,Sclerostin,29428,0.0300881783132246,0.00255757493129174,0.0250753314478928,0.0351010251785564,7.02556105090186e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,28867,0.043758184344743,0.00372550793830411,0.0364561887856669,0.051060179903819,8.79324233866351e-32
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,24961,0.0197729248161253,0.00168503778326152,0.0164702507609327,0.0230755988713179,1.02895624680051e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29438,0.0443815129146587,0.00378506851025668,0.0369627786345556,0.0518002471947618,1.11087392122468e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,29429,0.0286912151529915,0.00244722199647985,0.023894660039891,0.033487770266092,1.12969290388559e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29344,0.0257932190136434,0.00220115786081511,0.0214789496064458,0.030107488420841,1.21235846534397e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28792,0.041582760204094,0.00355547452969686,0.0346140301258882,0.0485514902822999,1.58558160726307e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,28769,0.0360950771926546,0.00308667761076197,0.0300451890755611,0.042144965309748,1.61562150298885e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24800,0.0687288908393339,0.00587655233701017,0.057210848258794,0.0802469334198739,1.62745788249569e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,29689,0.0446215355082618,0.00381881988357449,0.0371366485364558,0.0521064224800678,1.79018332646305e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29344,0.0563245753710799,0.00482197580468635,0.0468735027938946,0.0657756479482651,1.87584429836783e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,24840,0.0215921840117262,0.00184928258231318,0.0179675901503923,0.02521677787306,2.043311762595e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,24376,0.0238704383849976,0.00204446530729393,0.0198632863827015,0.0278775903872937,2.05882924455734e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,29324,0.0603353559664924,0.00517749494558849,0.0501874658731389,0.0704832460598458,2.58548938286857e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29383,0.0370384786308589,0.00318177811192008,0.0308021935314955,0.0432747637302222,2.99355215852101e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24847,0.0498186003572488,0.00428235595731401,0.0414251826809133,0.0582120180335842,3.35679744498785e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,24523,0.0215677352706751,0.00185589432823257,0.0179301823873392,0.0252052881540109,3.88102780075806e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29589,0.0329771587102783,0.00283945713601896,0.0274118227236811,0.0385424946968754,4.09255068922098e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29356,0.0259871787004411,0.00224192138583966,0.0215930127841954,0.0303813446166868,5.31871331716787e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,29449,0.0201422642703393,0.00174389674096246,0.0167242266580529,0.0235603018826257,8.58735209052466e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,29689,0.0400191544525317,0.00346783331573128,0.0332222011536984,0.046816107751365,9.63451855925259e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,29187,0.021596328111724,0.00187174285349663,0.0179277121188706,0.0252649441045774,9.88779095531497e-31
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29344,0.0248401160548677,0.00215554417449401,0.0206152494728595,0.029064982636876,1.16507558212886e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28911,0.0555896006611842,0.00482383949215588,0.0461348752565587,0.0650443260658097,1.16629030335924e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,29213,0.026036378103613,0.00226218662217556,0.0216024923241489,0.0304702638830771,1.377470969223e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,29438,0.0920916930821285,0.00801324718059636,0.0763857286081596,0.107797657556097,1.67305726569997e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,29409,0.0689428188354405,0.00600792120703969,0.0571672932696427,0.0807183444012383,2.03783471106924e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,24808,0.0562961999362226,0.00491494527401713,0.046662907199149,0.0659294926732962,2.67373725894897e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,24376,0.027328989437154,0.00239344018847502,0.022637846667743,0.032020132206565,4.04240315443158e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24235,0.0238100855991769,0.00208764856955147,0.0197182944028561,0.0279018767954978,4.69898902258279e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,24909,0.0111354535614468,0.000976797606446142,0.00922093025281239,0.0130499768700813,4.96626682699004e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24376,0.0946852515526733,0.00830697248936619,0.0784035854735156,0.110966917631831,5.08110641326781e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24800,0.105138272876815,0.00923719920291369,0.0870333624391041,0.123243183314526,6.09762158196867e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGMN,Legumain,29576,0.0269651525058697,0.00236977125509504,0.0223204008458834,0.0316099041658559,6.15598841596165e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,29344,0.0584206955588635,0.00513788094815993,0.04835044890047,0.068490942217257,6.76885430935988e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,24883,0.0333333451010726,0.00293535435893808,0.027580050557554,0.0390866396445913,8.21784837584833e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,28911,0.0375737478260791,0.0033120636113204,0.0310821031478912,0.0440653925042671,9.12942342689527e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28926,0.0329011671822819,0.00290123130999135,0.0272147538146989,0.0385875805498649,9.56445705895301e-30
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_E,,29429,0.0217321425405093,0.00191764657698704,0.0179735552496147,0.0254907298314039,1.04141013074096e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29213,0.0430662700119405,0.00380044608006122,0.0356173956950205,0.0505151443288605,1.05222376846863e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,29781,0.0574709713049198,0.0050747571467535,0.0475244472972829,0.0674174953125566,1.13662359472771e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24946,0.0201122454366556,0.00177771778615297,0.0166279185757957,0.0235965722975154,1.32831778984118e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,29678,0.04517424822685,0.00399710662387543,0.0373399192440542,0.0530085772096459,1.47868179073436e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,29077,0.0350902595722463,0.00310855388446322,0.0289974939586984,0.0411830251857942,1.72703159041907e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29720,0.02547780972778,0.00226037815314462,0.0210474685476166,0.0299081509079434,2.08259031432246e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",24961,0.012372390402681,0.00109792368664678,0.0102204599768533,0.0145243208285087,2.20109456621049e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,29213,0.0191690353333837,0.00170137790275955,0.0158343346439749,0.0225037360227924,2.2017506470431e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,29781,0.0312276750399875,0.00277324869435462,0.0257921075990524,0.0366632424809225,2.36193100606779e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,24933,0.0179551286469606,0.00159451483514109,0.0148298795700841,0.0210803777238371,2.41893111563677e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24840,0.0802359470830166,0.00712835156292743,0.0662643780196789,0.0942075161463544,2.55137322806726e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,24933,0.0209049577936179,0.00185920613700551,0.0172609137650872,0.0245490018221487,2.91505084149642e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24235,0.0474334219584415,0.00422259909036049,0.039157127741335,0.0557097161755481,3.3074573078052e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,24224,0.0295840060063189,0.00263581425736506,0.0244178100618833,0.0347502019507544,3.67570126399431e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,28701,0.0560837341069516,0.00500548274108072,0.0462729879344334,0.0658944802794698,4.45579517538426e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24917,0.066977117753471,0.00597721769479483,0.0552617710716732,0.0786924644352689,4.50286759920026e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24840,0.0232505700807591,0.00207509867754213,0.0191833766727766,0.0273177634887417,4.54778230771015e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24376,0.0659083836219898,0.00588644236171136,0.0543709565930355,0.077445810650944,4.98600731629858e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29815,0.0203116401196664,0.00181455458996564,0.0167551131233338,0.0238681671159991,5.00076651976039e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,29539,0.0220308874557822,0.00196868703336098,0.0181722608703947,0.0258895140411698,5.18343830715268e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29127,0.022215287822751,0.00198658608882262,0.0183215790886587,0.0261089965568433,5.68157846378869e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24917,0.0394225277399253,0.00352471969997268,0.0325140771279788,0.0463309783518717,5.68820996078402e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,29781,0.0648705590550766,0.00580136162669868,0.0534998902667472,0.0762412278434061,5.70879562235685e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,29576,0.049142616192459,0.00439594359532096,0.0405265667456299,0.0577586656392881,5.90116415236872e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,24756,0.020977187896773,0.00187696365203232,0.0172983391387896,0.0246560366547563,6.2603500142787e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,29781,0.0242069842131035,0.00216726503120042,0.0199591447519507,0.0284548236742563,6.57427004859588e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24165,0.0626580699046262,0.00560881455890654,0.0516647933691693,0.073651346440083,6.62992651255684e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,29326,0.021146785548622,0.00189429250235933,0.0174339722439977,0.0248595988532462,7.04187210086119e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29755,0.0281007788996736,0.00251814304688165,0.0231652185277855,0.0330363392715616,7.35826946260913e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,29429,0.0411727535500082,0.00368989589550432,0.0339405575948197,0.0484049495051966,7.45896700509506e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,29344,0.066171037837698,0.00594015974587827,0.0545283247357766,0.0778137509396194,9.19210514620367e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,29531,0.023213548290728,0.00208467336805946,0.0191275884893315,0.0272995080921246,9.63288881331414e-29
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29344,0.0266134715339953,0.00239874432201011,0.0219119326628555,0.0313150104051351,1.51630793348039e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,24909,0.0206731154499887,0.00186298536874847,0.0170216641272417,0.0243245667727357,1.51752093583899e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29576,0.0806175250649432,0.00726641075213439,0.0663753599907598,0.0948596901391266,1.51822950818175e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29344,0.0444220005465379,0.00400615333211773,0.0365699400155871,0.0522740610774886,1.6266431840027e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24863,0.035211057760044,0.00317509473582356,0.0289878720778298,0.0414342434422581,1.64093613124547e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,29344,0.0603802739627308,0.00545006208980383,0.0496981522667153,0.0710623956587463,1.81038784775113e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29344,0.0635233915060534,0.00574327860431661,0.0522665654415929,0.074780217570514,2.21981544899948e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29668,0.0252875400754637,0.00228636482604898,0.0208062650164077,0.0297688151345197,2.22469011414826e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24376,0.0870194479203997,0.00786678213226874,0.071600554941153,0.102438340899646,2.24986369424522e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C5,Complement C5,24961,0.0110799472872477,0.00100176485336447,0.00911648817465334,0.013043406399842,2.27185809816622e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,24800,0.0835191965878914,0.00755573938719969,0.06870994738898,0.0983284457868028,2.44911391141622e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24376,0.0523959987472427,0.00474080605147721,0.0431040188863474,0.0616879786081381,2.49992748639127e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,29513,0.0276850395020083,0.00250926299644304,0.0227668840289799,0.0326031949750367,3.00380938228933e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,29815,0.0142434083512447,0.00129393297873847,0.0117072997129173,0.0167795169895721,3.96884738787119e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29370,0.0269531540756471,0.00244879415924559,0.0221535175235257,0.0317527906277685,4.02659006014421e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24917,0.0650679827078711,0.00591492322468787,0.0534747331874829,0.0766612322282593,4.40339049011544e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29158,0.0697517368754934,0.00634295307197195,0.0573195488544283,0.0821839248965584,4.49974827287322e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,28792,0.0539896926453558,0.00491138821439004,0.0443633717451513,0.0636160135455603,4.70906011265394e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29438,0.0255642228038474,0.00232635827691274,0.0210045605810984,0.0301238850265963,4.89752560098764e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29420,0.0161878915726162,0.00147458427964805,0.0132977063845061,0.0190780767607264,5.53013431383933e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,24800,0.0562572663100938,0.00512431261516256,0.0462136135843752,0.0663009190358124,5.62519144735788e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29344,0.0250695261542049,0.00228938871177413,0.0205823242791276,0.0295567280292822,7.49782404473127e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29438,0.0369985368411981,0.00338013589033316,0.0303734704961451,0.043623603186251,7.86990760754787e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,29473,0.0255964963400165,0.00234054116336387,0.0210090356598233,0.0301839570202097,8.75632016074951e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,29589,0.0422037803331147,0.0038613541719924,0.0346355261560096,0.0497720345102198,9.38474657453289e-28
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24376,-0.0220688731981772,0.00202541558561259,-0.0260386877459779,-0.0180990586503765,1.39492699949438e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,29164,0.0369010368544862,0.00338782060368013,0.0302609084712732,0.0435411652376992,1.41821792404447e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,24376,0.0496684238950944,0.00456355989849519,0.0407238464940438,0.0586130012961449,1.5950902003439e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,29531,0.0412470502966025,0.00379083977389736,0.0338170043397637,0.0486770962534413,1.60663239259168e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,29589,0.022194886043881,0.0020432451966171,0.0181901254585115,0.0261996466292506,1.95829097712833e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29438,0.0214406389620789,0.0019742604432243,0.0175710884933593,0.0253101894307985,2.0132138535636e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29344,0.0173674669043031,0.00160064091450348,0.0142302107118763,0.0205047230967299,2.24024120629831e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,29669,0.0202729245795182,0.00187027581922171,0.0166071839738437,0.0239386651851928,2.51614623183349e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29635,0.0207724718028376,0.00191686281472774,0.0170154206859712,0.0245295229197039,2.59535750744212e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24840,0.0646542298474058,0.00596645601159379,0.052959976064682,0.0763484836301297,2.66704801674212e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,29689,0.0209678691119816,0.00193575901035079,0.0171737814516941,0.0247619567722692,2.73522330845422e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,24376,0.0613670480326464,0.00566933435851479,0.0502551526899574,0.0724789433753354,3.04354938367828e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29576,0.0193329669828695,0.00178675325298511,0.0158309306070187,0.0228350033587203,3.10747276751376e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,28911,0.0275617363102284,0.0025535426242213,0.0225567927667546,0.0325666798537021,4.16046722465163e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,24840,0.0586549495671132,0.00543399300142538,0.0480043232843195,0.069305575849907,4.21706648107412e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29286,0.0217718409428397,0.00201738052967741,0.017817775104672,0.0257259067810074,4.21744097524505e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29781,0.0703273895783515,0.00653459504150956,0.0575195832969928,0.0831351958597103,5.81286906398122e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24863,0.070648537644457,0.00656821528825498,0.0577748356794772,0.0835222396094367,6.35681291967936e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24376,0.0205074427922522,0.00190700410153828,0.0167697147532372,0.0242451708312672,6.53969035903893e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28911,0.0660557486951763,0.00614713379324505,0.054007366460416,0.0781041309299366,6.97374131456828e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,29213,0.0210603733884541,0.00196566217988269,0.017207675515884,0.0249130712610242,9.79657181627444e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24800,0.103829259319027,0.00968977588427124,0.0848372985858553,0.122821220052199,9.86893604482096e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,29576,0.0335759835609149,0.00313412128837806,0.0274331058356939,0.0397188612861359,9.89844259421683e-27
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,24840,0.0191357774139611,0.00178673788301657,0.0156337711632486,0.0226377836646736,1.04618870356923e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,29473,0.0186148128442576,0.00174196303697989,0.015200565291777,0.0220290603967381,1.32274288689299e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24862,0.0160113131613348,0.00149855444412709,0.0130741464508457,0.0189484798718239,1.37399641592835e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,29781,0.0244592698887254,0.00229118075095503,0.0199685556168536,0.0289499841605973,1.48218273027609e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,28911,0.0596073552899679,0.00558967919660884,0.0486515840646146,0.0705631265153212,1.68358237076157e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,29118,0.0181362428961316,0.00170229953875847,0.014799735800165,0.0214727499920982,1.86952009997778e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,29473,-0.0477319557346341,0.0044977689300267,-0.0565475828374864,-0.0389163286317818,2.91204184938371e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,24863,0.0530106424632195,0.00499469811746606,0.043221034152986,0.062800250773453,2.9393718480549e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29576,0.0837364452830245,0.00789454514315366,0.0682631368024433,0.0992097537636057,3.08636832284494e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29429,0.0572644651650041,0.00540128194362558,0.046677952555498,0.0678509777745102,3.25219308087695e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,29438,0.0365080316189043,0.00344920017480462,0.0297475992762872,0.0432684639615213,3.91894522266352e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,24224,0.0347255721097056,0.00328319452112234,0.0282905108483059,0.0411606333711054,4.35435757474076e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,29781,0.0528362944980287,0.00499766551729756,0.0430408700841255,0.0626317189119319,4.46072251481689e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,24440,0.0899549615207633,0.00850907273900873,0.0732771789523062,0.10663274408922,4.59188706211225e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29428,-0.0337871659279746,0.00319796638358891,-0.0400551800398088,-0.0275191518161403,4.81070863927775e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29781,0.0177816640210408,0.0016838641652935,0.0144812902570656,0.0210820377850161,5.07560026123991e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLG,Plasminogen,24416,0.0154627353989523,0.0014642312850403,0.0125928420802734,0.0183326287176313,5.17984671814552e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29561,0.0154150452284521,0.0014601004140556,0.0125532484169031,0.018276842040001,5.21675221794509e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,24961,0.021683155238055,0.00205621033758946,0.0176529829763797,0.0257133274997304,6.0621605607323e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,29461,0.0278604772179011,0.00264795291190975,0.022670489510558,0.0330504649252442,7.64207691479904e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,29429,0.0336036399501421,0.00319405169424987,0.0273432986294123,0.0398639812708718,7.70963958658857e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29344,0.0587905523482459,0.00559048395217008,0.0478332038019925,0.0697479008944993,8.0886787081311e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,24961,0.0211247894855968,0.00201020714145436,0.0171847834883462,0.0250647954828473,8.91168662817241e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29755,0.0356469195320141,0.00339594841455483,0.0289908606394866,0.0423029784245416,9.90150448460014e-26
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,29689,0.0301225732413099,0.00286995894683294,0.0244974537055173,0.0357476927771024,1.00168981810842e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29296,0.0179364233185071,0.00170907662662082,0.0145866331303303,0.0212862135066839,1.01390044619272e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24917,0.0236704565891493,0.00225921687356223,0.0192423915169674,0.0280985216613313,1.24207520983263e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29403,0.0244984496556706,0.00234356447507174,0.01990506328453,0.0290918360268112,1.56564775221798e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29449,0.0650059527254447,0.00621930993063894,0.0528161052613923,0.077195800189497,1.58562468363399e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24863,0.0435946342288807,0.0041746312318263,0.0354123570145011,0.0517769114432602,1.78587902018158e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,29561,0.0190143206657046,0.00182133230429058,0.0154445093492951,0.0225841319821142,1.80716327737664e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,29554,-0.0224996997599544,0.00215547997120614,-0.0267244405035185,-0.0182749590163904,1.83425475214733e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,29344,0.0194596552086114,0.00186466091676694,0.0158049198117482,0.0231143906054746,1.88126058597105e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,29781,0.0186628432740649,0.00178897755629143,0.0151564472637337,0.0221692392843961,1.95688795472587e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24518,0.0384722620466465,0.00369023417999709,0.0312394030538522,0.0457051210394408,2.14515971033666e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,24961,0.0127628978625658,0.00122432640317213,0.0103632181123484,0.0151625776127831,2.16308443043176e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29781,0.046723382799234,0.00448687987031764,0.0379290982534114,0.0555176673450566,2.38282252913842e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29531,0.0487859911287439,0.0046870251631927,0.0395994218088862,0.0579725604486016,2.50254105925598e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELL,L-selectin,24961,0.0159651550954699,0.00153381552939453,0.0129588766578566,0.0189714335330832,2.54775551917772e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29627,0.0498968197588726,0.00479818227041232,0.0404923825088645,0.0593012570088808,2.76666939432008e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,29368,0.0457959127366223,0.0044109780441159,0.0371503957701551,0.0544414297030894,3.30211404073329e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,28769,0.0421217331044131,0.00406280345056454,0.0341586383413066,0.0500848278675196,3.85357215856997e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,29344,0.0377734231806856,0.00364812261666793,0.0306231028520165,0.0449237435093548,4.42403753402389e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29589,0.0260747692488422,0.00252067289221179,0.0211342503801071,0.0310152881175773,4.89704915662307e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24840,0.0724967293430437,0.00700836386384042,0.0587603361699165,0.0862331225161709,4.99252093469658e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWC2,Brorin,29109,0.0272440854898044,0.00263475416232956,0.0220799673316385,0.0324082036479704,5.11822912416554e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,24032,0.0376500086241191,0.00364254466936695,0.0305106210721598,0.0447893961760783,5.45405935462223e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29344,0.0266804131279072,0.00258434280795254,0.0216151012243202,0.0317457250314942,6.06468719064477e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,24235,0.052383676193183,0.00507318901189261,0.0424402257298734,0.0623271266564925,6.08177759563522e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29589,0.0297696593044184,0.00289207733010972,0.0241011877374034,0.0354381308714335,8.30005680011622e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,29340,0.029321399515415,0.00284964083467396,0.023736103479454,0.0349066955513759,8.65921238599369e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28581,0.0261801025853662,0.00254446088979564,0.0211929592413667,0.0311672459293656,8.72207087786806e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29561,0.0492398863634,0.00478672674158219,0.039857901949899,0.0586218707769011,8.90284545079996e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28792,0.0529078872954879,0.00514545851802937,0.0428227886001503,0.0629929859908255,9.33273819605459e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29344,0.0460226901983891,0.00447768584636804,0.0372464259395077,0.0547989544572704,9.73012366075754e-25
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNLY,Granulysin,29438,0.0354452621435134,0.00345190532532914,0.0286795277058683,0.0422109965811586,1.0776172601518e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24800,0.0519744031588868,0.00506257239919766,0.0420517612564594,0.0618970450613142,1.11900675768768e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28911,0.0514164577034309,0.00500923964667371,0.0415983479959504,0.0612345674109114,1.12494951927e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24917,0.0662846243734072,0.00647422169332857,0.0535951498544832,0.0789740988923312,1.49499527096695e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,24840,0.0206518213097703,0.00201714159603471,0.0166982237815423,0.0246054188379984,1.49669663644282e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29111,0.019914960738694,0.00194981226309147,0.0160933287030347,0.0237365927743532,1.89178714064959e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,29720,0.024016213855452,0.00235430800875965,0.0194017701582831,0.0286306575526209,2.15371221283182e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,28740,0.038010442094896,0.00372963855472195,0.030700350527641,0.0453205336621511,2.38185581545479e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,28911,0.0317463096664602,0.00311667102141013,0.0256376344644964,0.0378549848684241,2.51821402372506e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29561,0.064087349139303,0.00629206619965572,0.0517548993879778,0.0764197988906282,2.52707177263021e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,24376,0.0308540695555309,0.00303014830022305,0.0249149788870937,0.036793160223968,2.65920619569494e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,28926,0.0621710054950622,0.00610998184956686,0.0501954410699112,0.0741465699202133,2.80824549638821e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,29164,0.0206427549456532,0.00203250185817172,0.0166590513036366,0.0246264585876697,3.40751856652871e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,29473,0.0512381530703173,0.00504726750784633,0.0413455087549385,0.0611307973856961,3.57038842492674e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24759,0.0471215824524843,0.00464195418486792,0.0380233522501431,0.0562198126548254,3.64884893629576e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,28926,0.0326458496667999,0.00321704467141652,0.0263404421108235,0.0389512572227763,3.7213115682399e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,29344,0.0196930398764951,0.00194121653462879,0.0158882554686227,0.0234978242843676,3.83532072713914e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24899,0.0320372550388518,0.00316559252978676,0.0258326936804698,0.0382418163972339,4.99001942933237e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24961,0.0174123949484496,0.00172164865754104,0.0140379635796692,0.02078682631723,5.33890344487051e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29429,0.0483102282249277,0.00478089337689659,0.0389396772062104,0.057680779243645,5.75326788722789e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24604,0.0212589896428152,0.00210632954385322,0.0171305837368629,0.0253873955487675,6.61079642359946e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,24799,0.039192212557947,0.00388593088758956,0.0315757880182715,0.0468086370976226,7.10855071180609e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29164,0.0165918806475201,0.00164580678061784,0.0133660993575091,0.019817661937531,7.3134491036112e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,28769,0.02984370259942,0.00296357034007476,0.0240351047328735,0.0356523004659666,8.19625083912329e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,24417,0.0255499908317706,0.00253789268760691,0.0205757211640611,0.0305242604994802,8.56780618202713e-24
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24800,0.0351706945255875,0.00350223374400434,0.028306316387339,0.042035072663836,1.10185477585915e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23618,0.0718755537224429,0.00716172275852654,0.0578385771157309,0.0859125303291549,1.18021641799038e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,29540,0.0218867983456655,0.00218368786395679,0.0176067701323102,0.0261668265590208,1.31937785664914e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,29379,0.0752703028472841,0.00752038504905019,0.0605303481511458,0.0900102575434225,1.52042293326131e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24376,0.0399907908114891,0.0039965603402878,0.032157532544525,0.0478240490784531,1.58771611555148e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,24917,0.0348307598458157,0.00348250444576773,0.028005051132111,0.0416564685595205,1.66018241610057e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,29781,0.0360018251514694,0.00360122918319971,0.028943415952398,0.0430602343505408,1.70921320749793e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,29323,0.0282782251360338,0.00283317252454995,0.0227252069879159,0.0338312432841517,2.00969406333348e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,29395,-0.0672170681352744,0.00673596329161248,-0.0804195561868349,-0.054014580083714,2.05584152285054e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,24190,0.0277564345294464,0.0027816871108284,0.0223043277922227,0.03320854126667,2.10593574264974e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,29473,0.0435005019085666,0.00436245174476859,0.0349500964888202,0.052050907328313,2.21085296363046e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28769,0.0487159845885147,0.00488805345038866,0.0391353998257529,0.0582965693512765,2.3349551424987e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29213,0.0622874542666461,0.00625280929874302,0.0500319480411097,0.0745429604921824,2.44737629986595e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,24106,0.0389335717834344,0.00390895475524796,0.0312720204631484,0.0465951231037204,2.5278129991366e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24106,0.0372307354844821,0.00373801161669387,0.0299042327157621,0.0445572382532021,2.52934384426332e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,24840,0.0299718179274873,0.00301055915030388,0.0240711219928917,0.0358725138620829,2.63713018764119e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,24933,0.0166435776854044,0.00167279255760044,0.0133649042725075,0.0199222510983012,2.79902311113878e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,29109,0.0686328639676587,0.0069001184413135,0.0551086318226842,0.0821570961126332,2.842083252063e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29391,0.0269788068206377,0.00271326341055123,0.0216608105359573,0.0322968031053181,2.9355862915601e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29368,0.0576468827286014,0.00580220892760237,0.0462745532305008,0.0690192122267021,3.17949919825846e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28857,0.0344879509710655,0.00347184315700451,0.0276831383833367,0.0412927635587944,3.23947121858401e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29344,0.0617785032315746,0.00623046842874735,0.0495667851112298,0.0739902213519194,3.87472840412807e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,29720,0.0186042235248817,0.0018770239097331,0.0149252566618048,0.0222831903879586,4.02798787935621e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24917,0.0463301292471131,0.00468106814554766,0.0371552356818397,0.0555050228123865,4.71518722490456e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,29213,0.0222471472513472,0.00224840292002329,0.0178402775281015,0.0266540169745928,4.77437840305151e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,29158,0.0494701175875882,0.00500046786142101,0.0396692005792031,0.0592710345959734,4.84924992396888e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,29627,0.04027122767052,0.00407106947357891,0.0322919315023054,0.0482505238387347,4.8935834798001e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24917,0.0416045111649696,0.00420598810686936,0.0333607744755057,0.0498482478544336,4.9859163519975e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,23857,0.0528099223349388,0.00534688058051175,0.0423300363971357,0.0632898082727418,5.81070926896707e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,29815,0.0107043197128335,0.00108443759284518,0.00857882203085692,0.01282981739481,6.0395409240061e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29438,0.0502638609632943,0.00509737863679615,0.0402729988351739,0.0602547230914148,6.6851978749599e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29439,0.0369695469176054,0.0037529978108551,0.0296136712083294,0.0443254226268814,7.38666069941237e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29429,0.0730056913384881,0.00741648866867668,0.0584693735478818,0.0875420091290944,7.9154172566181e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,29781,0.0301973438838519,0.0030677444045381,0.0241845648509572,0.0362101229167466,7.92349371883572e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24235,0.0399266413418385,0.00405635114826553,0.0319761930912381,0.047877089592439,8.1106925305215e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24863,0.0554257693618241,0.0056364609246176,0.0443783059495736,0.0664732327740746,8.89360865267885e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,28792,0.0348730571163955,0.00354754228497842,0.0279198742378378,0.0418262399949532,9.06376654535245e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,24800,0.0384298875049835,0.00390984253741602,0.0307665961316481,0.0460931788783189,9.29362806676292e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,29344,0.0198661200572096,0.00202176629218148,0.0159034581245339,0.0238287819898853,9.42265227631602e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29473,0.0197893471457518,0.00201423188908559,0.015841452643144,0.0237372416483595,9.54688802929018e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,24601,0.0201676541872395,0.0020526273630809,0.0161445045556009,0.0241908038188781,9.64968554253774e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,29492,0.015666041292279,0.00159494469235791,0.0125399496952575,0.0187921328893006,9.78065775650009e-23
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29473,0.051816391849557,0.00528134646797514,0.0414649527723257,0.0621678309267883,1.09155500054133e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,29720,0.0391270018464353,0.00399240436807606,0.0313018892850062,0.0469521144078644,1.21415825729059e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24863,0.0462179000293461,0.00471743332838958,0.0369717307057026,0.0554640693529897,1.27135573776672e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,29635,0.0450676328896075,0.00460365683324793,0.0360444654964416,0.0540908002827734,1.35135381975069e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29429,0.0783905799055172,0.0080190601322764,0.0626732220462555,0.094107937764779,1.55199159078587e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,29344,0.0383751567755357,0.00392721231386648,0.0306778206403574,0.046072492910714,1.6135623063472e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELP,P-selectin,29589,0.0366540030823165,0.00375539189314055,0.029293434971761,0.0440145711928719,1.80089658729933e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,29213,0.0335686726586981,0.00344010861970151,0.0268260597640832,0.0403112855533131,1.84464276725772e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,24788,0.0250031984138111,0.00256395042091216,0.0199778555888233,0.0300285412387989,1.98824716343335e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24788,0.0355190299402565,0.00364513911580182,0.0283745572732849,0.0426635026072281,2.14233351665775e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29189,0.0631561664712721,0.0064827204561355,0.0504500343772465,0.0758622985652977,2.15423546572921e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,29561,0.0460239840203713,0.00472440167664178,0.0367641567341534,0.0552838113065891,2.16211128885947e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,29473,0.0184697069095611,0.00189703337733945,0.0147515214899758,0.0221878923291464,2.28604141341873e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,29589,0.0646102096962882,0.0066375341301952,0.0516006428011056,0.0776197765914708,2.33133158110782e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COCH,Cochlin,24917,0.0297457859335269,0.00305543641146189,0.0237571305670616,0.0357344412999922,2.33546635146037e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29448,0.0321195764142087,0.00330124604420049,0.0256491341675758,0.0385900186608417,2.43823819420934e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,29381,0.0437158557949526,0.00449520951789673,0.034905245139875,0.0525264664500302,2.54967432722536e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29473,0.0315427627793829,0.00324403472798232,0.0251844547125375,0.0379010708462282,2.5912195163652e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,24096,0.0304444676431045,0.00313196944465075,0.024305807531589,0.0365831277546199,2.70840811983659e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,24652,0.0192162804233656,0.00197693864122863,0.0153414806865575,0.0230910801601737,2.71139143014126e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24376,0.0548519341814346,0.00564765852600782,0.0437825234704593,0.06592134489241,2.93190713016166e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28926,0.042180176433937,0.0043441251789567,0.0336656910831819,0.0506946617846922,2.96457870176271e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24788,0.0510330203878413,0.00525903823491153,0.0407253054474147,0.0613407353282679,3.1797561755291e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,29344,0.0268833253806992,0.00277207195077725,0.0214500643571758,0.0323165864042226,3.32287271079993e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24788,0.0532301165835273,0.00549172577140557,0.0424663340715724,0.0639938990954822,3.54314576474753e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28821,0.0309191023527402,0.00319052668025495,0.0246656700594405,0.0371725346460399,3.56318584015193e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24800,0.0191664111409106,0.00198065321949883,0.0152843308306929,0.0230484914511283,4.13993679482313e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23716,0.0317138667531992,0.00327950060068614,0.0252860455758544,0.038141687930544,4.42766448593643e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28792,0.0300875816919353,0.00311375998767442,0.0239846121160934,0.0361905512677771,4.68737363860125e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28792,0.0524734717625278,0.00543143225781335,0.0418278645372136,0.0631190789878419,4.76587978465743e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25972,-0.019953302814013,0.00206602104680674,-0.0240027040657542,-0.0159039015622717,4.95942513913467e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28792,0.0526689530594698,0.0054586163668453,0.041970064980453,0.0633678411384866,5.37150339517948e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24863,0.0335640975593156,0.00348259023851066,0.0267382206918347,0.0403899744267964,6.05504851683481e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29561,0.0582018593423548,0.00604220982030896,0.0463591280945492,0.0700445905901604,6.27591477068061e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29429,0.035866079885504,0.00372465071067291,0.028565764492585,0.0431663952784229,6.47373752895089e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24840,0.0421996611562402,0.00438292218221004,0.0336091336791085,0.0507901886333719,6.63868045432479e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,24961,-0.0429396138047924,0.00446278548410204,-0.0516866733536324,-0.0341925542559524,7.0669661946636e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,24376,0.0344171647288434,0.00357958267659949,0.0274011826827084,0.0414331467749784,7.5676800223511e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,29429,0.0566405161004642,0.00589381137881714,0.0450886457979827,0.0681923864029458,7.79863448888384e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,28792,0.0333303079627415,0.00347022769799089,0.0265286616746794,0.0401319542508036,8.24019463248687e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,24863,0.0485597317169468,0.0050552193276569,0.0386515018347392,0.0584679615991543,8.24133988743434e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,29429,-0.0208343036669428,0.00216990697477222,-0.0250873213374963,-0.0165812859963892,8.48321525601129e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24800,0.0299854584274656,0.00312339092756481,0.0238636122094385,0.0361073046454926,8.69933687677565e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,24224,0.0276348827622482,0.00288160506294824,0.0219869368388696,0.0332828286856267,9.61911167730741e-22
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,29815,0.0268413701181392,0.00280159959933887,0.021350234903435,0.0323325053328433,1.03561894040654e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,24898,0.0226851082900203,0.00237801750450307,0.0180241939811943,0.0273460225988464,1.56219855042659e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,24224,0.0527058303634711,0.00552560348263429,0.0418756475375078,0.0635360131894343,1.58144236214661e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,24946,0.0298179693612427,0.00312653061061762,0.0236899693644321,0.0359459693580532,1.59876099179105e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28911,0.0604656237113458,0.0063435400670911,0.0480322851798472,0.0728989622428443,1.66189387378815e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,24728,0.0293296638601054,0.00307735360073721,0.0232980508026605,0.0353612769175503,1.69925584392471e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,29576,0.0664631127007418,0.00697747526387272,0.0527872611835513,0.0801389642179323,1.76537018216782e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,29689,0.0399252328322499,0.00419189795590374,0.0317091128386785,0.0481413528258212,1.78192303692018e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFD,Complement factor D,24961,0.012321697786939,0.00129387901301578,0.00978569492142804,0.0148577006524499,1.82878888385553e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,24376,0.0465872283867549,0.00489298361231863,0.0369969805066103,0.0561774762668994,1.86503466876881e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,29336,0.0453471757881557,0.0047651757196078,0.0360074313777244,0.054686920198587,1.92590218448785e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,29561,0.039445313947015,0.00414684803510715,0.031317491798205,0.047573136095825,2.00492505113382e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,29689,0.037210273460509,0.00391724609980373,0.0295324711048937,0.0448880758161243,2.27076521745888e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24863,0.0423992409412031,0.0044631318261767,0.0336515025618967,0.0511469793205094,2.28430620707859e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29213,0.0461981299765784,0.00486395328589006,0.0366647815362339,0.0557314784169229,2.29583238502965e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,24863,0.0374649872531637,0.00394543935260441,0.0297319261220591,0.0451980483842684,2.376015098917e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,29540,0.0114122970444266,0.00120232332553624,0.0090557433263756,0.0137688507624777,2.43405287847486e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29381,0.0406262391530978,0.00428010451139883,0.0322372343107561,0.0490152439954395,2.43474470668837e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,29781,0.0147867892287427,0.00155805321480322,0.0117330049277284,0.017840573529757,2.46348137167439e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24840,0.0230306058559407,0.00242718254078025,0.0182733280760114,0.02778788363587,2.54439766068247e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24106,0.0427826976675833,0.00451060613262335,0.0339419096476415,0.0516234856875251,2.64278428107912e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29720,-0.0231656042531968,0.00244294083249529,-0.0279537682848876,-0.018377440221506,2.65671989470857e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,28865,0.0313652150919293,0.00330894304150149,0.0248796867305864,0.0378507434532722,2.75924829164305e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29344,0.0778181425807882,0.00821066877242521,0.0617252317868348,0.0939110533747416,2.78878375142542e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24235,0.0642045876122746,0.00677889409603055,0.0509179551840547,0.0774912200404945,3.00958905548458e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24917,0.0178224905826947,0.00188231344491148,0.0141331562306682,0.0215118249347212,3.0854191807186e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,24235,0.056374524101511,0.00595519914282612,0.0447023337815718,0.0680467144214502,3.15086083687327e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,24946,0.0156664897738438,0.00165503360517193,0.0124226239077068,0.0189103556399808,3.15751285285037e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24376,0.0546537519393646,0.00577851573328637,0.0433278611021233,0.0659796427766059,3.40996222393781e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,24788,0.0442254296339399,0.00467673531612409,0.0350590284143367,0.0533918308535431,3.45820106145051e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBIN,Erbin,29344,0.0640321223383149,0.00677479408027857,0.0507535259409689,0.0773107187356609,3.57932225124616e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24917,0.0480728706446438,0.00508592577328013,0.0381044561290148,0.0580412851602729,3.6025010897962e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,24933,0.0296165305191727,0.00313438764002585,0.023473130744722,0.0357599302936233,3.71490309005145e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,29689,0.0168173224562562,0.00178095464072969,0.013326651360426,0.0203079935520864,3.88361944974483e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24376,0.0156840467667162,0.00166083090061845,0.012428818201504,0.0189392753319284,3.91844912942115e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,24933,0.0522744955609534,0.00553622393986008,0.0414234966388276,0.0631254944830791,3.95716547918339e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,28752,0.0685291595974534,0.00726100808444707,0.0542975837519372,0.0827607354429697,4.07809969228366e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28792,0.0476176608393573,0.00504584860323847,0.0377277975770099,0.0575075241017047,4.11550337623054e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28657,0.0358945775649689,0.00380993363267998,0.0284271076449161,0.0433620474850216,4.77860236561226e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,29158,0.0498774873624235,0.00529566292916009,0.0394979880212698,0.0602569867035773,4.89954058581722e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24376,0.017574589067372,0.00186668090261681,0.0139158944982431,0.021233283636501,5.14187776582557e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,29344,0.0459813956692127,0.004886167751164,0.0364045068769313,0.0555582844614941,5.28522424398316e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,29493,0.0405875745719028,0.00431539432031503,0.0321294017040854,0.0490457474397203,5.55175566473441e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29438,0.0262938663178369,0.00279789205350539,0.0208099978929663,0.0317777347427075,5.9647388592785e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,29781,0.0291412754187671,0.00310396597030019,0.0230575021169787,0.0352250487205555,6.51130558320773e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,29618,0.0366888345663885,0.00391017630928308,0.0290248890001936,0.0443527801325833,6.86097544296629e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29512,0.0166951762532712,0.00177942082444807,0.013207511437353,0.0201828410691894,6.89810203697365e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,29168,0.0176103113697672,0.00187913080484827,0.0139272149922646,0.0212934077472698,7.64886156269848e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,29689,0.0402192513585082,0.0042926745793911,0.0318056091829017,0.0486328935341148,7.80350770224709e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24224,0.0560935466070488,0.00599569869600208,0.0443419771628848,0.0678451160512129,9.00877038504422e-21
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,29576,-0.0398673880877265,0.00426939004370379,-0.0482353925733859,-0.0314993836020671,1.04871817514921e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24863,0.0477813703248562,0.00511849786557706,0.0377491145083251,0.0578136261413872,1.0914112665666e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28926,0.0340651646728437,0.00365103553406255,0.0269091350260811,0.0412211943196063,1.12902225429506e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,29669,0.0354238597824312,0.00379740204354028,0.0279809517770922,0.0428667677877701,1.14669272052622e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29429,0.0232956014175438,0.00249946448306291,0.0183966510307405,0.0281945518043471,1.23935194820198e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28926,0.0233140912861279,0.00250471077727824,0.0184048581626626,0.0282233244095933,1.39059383168868e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,24376,0.0184910981775751,0.00198627988123856,0.0145979896103475,0.0223842067448027,1.39061023388257e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,24376,0.0344005416147037,0.00369623039773632,0.0271559300351405,0.0416451531942669,1.4234251056729e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,24961,0.0328070592436266,0.00352688671092768,0.0258943612902084,0.0397197571970449,1.48813667509151e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29492,0.0147195644810666,0.00158298015526421,0.0116169233767487,0.0178222055853845,1.51765592940283e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24235,0.0518652130071995,0.00557901426494919,0.0409303450478991,0.0628000809664999,1.57051333975227e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28962,0.0269816711407885,0.0029028087124864,0.0212921660643152,0.0326711762172618,1.57188484177172e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24788,0.0530548328000724,0.00571334921540527,0.0418566683378781,0.0642529972622667,1.72756668240222e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,29689,0.0212293145568005,0.00228667316223073,0.0167474351588283,0.0257111939547727,1.74118769518447e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29576,0.0767912739044515,0.00827267400248896,0.0605768328595731,0.0930057149493298,1.76473602649851e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,29531,0.0507952082723419,0.00548039719055005,0.0400536297788638,0.06153678676582,2.01174054541843e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,29490,0.0285739094890052,0.00308549705289009,0.0225263352653406,0.0346214837126698,2.164246746531e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24917,0.0450186500457587,0.00486068168588604,0.035491713941422,0.0545455861500953,2.16764233164628e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29473,0.0171977182687903,0.00185756423423463,0.0135568923696905,0.0208385441678902,2.21557063795564e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,24376,0.0581860413429781,0.00628725482930853,0.0458630218775334,0.0705090608084228,2.32205531489236e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24933,0.0139168049760389,0.00150604703905742,0.0109649527794863,0.0168686571725914,2.64082556375447e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24235,-0.0225033030863397,0.00243747179226626,-0.0272807477991816,-0.0177258583734979,2.86140667630124e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,24917,0.0437357859974086,0.00474069943541628,0.0344440151039927,0.0530275568908245,3.03718971108339e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,24376,0.0388764063081166,0.00421706495020264,0.0306109590057194,0.0471418536105137,3.23971708171539e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,29576,0.020374112903587,0.00221196680851773,0.0160386579588922,0.0247095678482817,3.44282743718957e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,24190,0.0737421297834552,0.00801372024813587,0.0580352380971089,0.0894490214698015,3.79036730184628e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPSE,Heparanase,24683,0.0569703642593448,0.00620238844855681,0.0448136829001735,0.0691270456185162,4.42043299741507e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,24224,0.0470715598581416,0.00512610628069624,0.037024391547977,0.0571187281683062,4.53098298138968e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,29561,0.0253033642587933,0.00275680782445601,0.0199000209228595,0.0307067075947271,4.6479135486675e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29429,0.0729879357091224,0.00795276798439075,0.0574005104597165,0.0885753609585283,4.68480817877718e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29815,0.0249798816008831,0.00272190806231296,0.0196449417987497,0.0303148214030165,4.69561147754955e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,29781,0.0320339436143322,0.0034947332651566,0.0251842664146252,0.0388836208140391,5.19871956750002e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24840,0.0591088631466986,0.00645016679871259,0.0464665362212219,0.0717511900721752,5.38066670739642e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,24840,0.027991169951944,0.00305512706068797,0.0220031209129956,0.0339792189908924,5.4757692539909e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,24800,-0.0435803277334261,0.00476212796887504,-0.0529140985524211,-0.034246556914431,6.03896586456615e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29127,0.0247119163418692,0.00270514132241107,0.0194098393499435,0.0300139933337948,6.9421662363933e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,29415,0.0574639349806229,0.0062972891166478,0.0451212483119933,0.0698066216492526,7.60607176264128e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29589,0.0166734352706447,0.00182879604727936,0.0130889950179772,0.0202578755233123,8.18584647051805e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29389,0.0181174123647551,0.00198857347754742,0.0142198083487621,0.022015016380748,8.68608731172452e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,24292,0.0395936698748428,0.00434593759988676,0.0310756321790647,0.0481117075706208,8.81661493419273e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24863,0.0365390770318504,0.00401133168525123,0.028676866928758,0.0444012871349428,8.92713246623278e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29689,0.0401205135580682,0.00440731607792632,0.0314821740453327,0.0487588530708038,9.30837480161795e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29164,0.053715016617437,0.00590371718355333,0.0421437309376724,0.0652863022972015,9.72515627952722e-20
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,28985,0.0180497829994488,0.00198455081797572,0.0141600633962164,0.0219395026026812,1.0033447507262e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28792,0.0342353343104408,0.00376586876466855,0.0268542315316905,0.0416164370891912,1.0431352367433e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29815,0.0156926007535828,0.00172650853247414,0.0123086440299334,0.0190765574772321,1.05772930280871e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,29213,0.0400935839975613,0.00441481024316264,0.0314405559209625,0.0487466120741601,1.13542998067962e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,29429,0.033570579825194,0.00370186857493389,0.0263149174183236,0.0408262422320645,1.27911201880996e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28792,0.0406191014328681,0.00448378594335549,0.0318308809838913,0.0494073218818448,1.39628406914479e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29473,0.0498503462410347,0.00550769079400604,0.0390552722847828,0.0606454201972865,1.50099628929392e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29438,-0.0313846052514277,0.00346969398914992,-0.0381852054701615,-0.0245840050326939,1.58115675355752e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,29344,0.0195642814529137,0.00216330703623214,0.0153241996618987,0.0238043632439287,1.60560871718023e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29673,0.0162578849849461,0.0017986457216479,0.0127325393705162,0.0197832305993759,1.67537589374797e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29438,0.0228706387384195,0.00253118887643745,0.0179095085406021,0.0278317689362369,1.72935488311759e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29568,0.0666766800280567,0.00738861789743803,0.0521949889490782,0.0811583711070353,1.91626187780975e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,24376,0.0401067731293559,0.00444880656538045,0.0313871122612102,0.0488264339975016,2.10657040958422e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29344,0.0336607341038572,0.00373493981996163,0.0263402520567324,0.040981216150982,2.135474198348e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28792,0.0217523373987422,0.00241665949188287,0.0170156847946518,0.0264889900028327,2.37114742811712e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,24788,0.036754090484412,0.00408637335275638,0.0287447987130095,0.0447633822558145,2.54335862407376e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,24823,0.0182844205495349,0.0020344625229294,0.0142968740045933,0.0222719670944765,2.70879566138866e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,29387,0.0468795025425086,0.00522000233251609,0.0366482979707771,0.0571107071142401,2.84612038136032e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,29678,0.0119405991726635,0.00132986748037591,0.00933405891112674,0.0145471394342003,2.89539285581063e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24106,0.0367186503103841,0.0040926734656085,0.0286970103177914,0.0447402903029767,3.12463975751574e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,29034,0.0407926160688564,0.00455093569114037,0.0318727821142213,0.0497124500234916,3.32741348283375e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,29561,0.0329867335935871,0.00368192054381065,0.0257701693277183,0.040203297859456,3.46077132885799e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24185,0.0212578373699335,0.0023727244906111,0.0166072973683358,0.0259083773715313,3.49938149413336e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,24449,0.0149016636484542,0.00166353232512575,0.0116411402912077,0.0181621870057007,3.5415925974756e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,29213,0.0360956435155385,0.00403101719767965,0.0281948498080864,0.0439964372229906,3.61128598394641e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,29438,0.0190925319910836,0.00213232530827438,0.0149131743868658,0.0232718895953014,3.63002039125215e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,29429,0.0495190416242283,0.00553803452797458,0.0386644939493982,0.0603735892990585,4.05398118439593e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29429,0.0567491501646776,0.00634757769266521,0.0443078978870538,0.0691904024423015,4.10342054138957e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,24324,0.0608988279588489,0.00681643573963565,0.047538613909163,0.0742590420085348,4.38890495809443e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24933,0.0368041833639175,0.00412415341187741,0.0287208426766378,0.0448875240511972,4.7973640959806e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,29781,0.0555752999900787,0.006230934476459,0.0433626684162191,0.0677879315639384,4.95667571957152e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24863,0.0745722428616121,0.00836322423825342,0.0581803233546354,0.0909641623685888,5.12743050256379e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,24961,0.0100771760097644,0.00113017135145025,0.00786204016092192,0.0122923118586069,5.13457110315309e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,24863,0.0616903761836151,0.00692058862386214,0.0481260224808453,0.0752547298863848,5.25112570239641e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28792,0.029872816715071,0.00335261147591123,0.0233016982222849,0.036443935207857,5.38213789000719e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29438,0.0221559056709504,0.00248997149887498,0.0172755615331554,0.0270362498087454,6.00169176197311e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,24863,0.0322919305715032,0.00362942938511154,0.0251782489766846,0.0394056121663218,6.10626897978867e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24863,0.0210181363637773,0.00236349770761046,0.0163856808568608,0.0256505918706938,6.35437921626613e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29344,0.0684278399679326,0.00769818847104031,0.0533393905646936,0.0835162893711716,6.5215495951091e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,29296,0.0391388814098148,0.00440319321300152,0.0305086227123319,0.0477691401072978,6.52647482188545e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,29429,0.0490874600659078,0.00553378492757574,0.0382412416078593,0.0599336785239562,7.68448225555633e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,29438,0.0228334306260729,0.00257438478426471,0.0177876364489141,0.0278792248032318,7.75577773968169e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,28760,0.0231791280075459,0.00261470478109331,0.018054306636603,0.0283039493784888,8.08910454689356e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24788,0.0553323419103903,0.00624285092630503,0.0430963540948324,0.0675683297259481,8.2781360717401e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24788,0.0246455040945279,0.00278256005390193,0.0191916863888801,0.0300993218001757,8.748489351634e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29781,0.026245864395335,0.00296368855207441,0.0204370348332692,0.0320546939574008,8.75886513120768e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,29213,0.0472761592940213,0.00533924718338257,0.0368112348145914,0.0577410837734511,8.87425490352767e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29213,0.033825691479188,0.00382152598666891,0.026335500545317,0.0413158824130591,9.1239743107444e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,29473,0.0399954108600116,0.00452000387219193,0.0311362032705154,0.0488546184495078,9.35260595697568e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANG,Angiogenin,29430,0.0197202872140695,0.00223049826185754,0.0153485106208288,0.0240920638073103,9.98633609681255e-19
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,24946,0.0351167907379645,0.0039745716885508,0.0273266302284049,0.042906951247524,1.06210329236708e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,24863,0.0401892049427092,0.00455349863268675,0.0312643476226432,0.0491140622627752,1.15474441922097e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,28792,0.0470724329625379,0.00533509151699524,0.0366156535892273,0.0575292123358486,1.17422780114358e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28792,0.0440942526308794,0.00499834741639733,0.0342974916947407,0.0538910135670182,1.18903157016661e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,29781,0.0369009404393699,0.00418737213514008,0.0286936910544954,0.0451081898242445,1.28975496625721e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,29599,0.0347100692007273,0.00394406485554523,0.0269797020838586,0.0424404363175959,1.4335804076867e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,29213,0.0327032559595498,0.00371611343805208,0.0254196736209677,0.0399868382981318,1.43699356625746e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,24917,0.0530517842832878,0.00603111251642594,0.041230803751093,0.0648727648154827,1.50304914028816e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,28792,0.0254945630577141,0.00289925688272056,0.0198120195675818,0.0311771065478464,1.52914983710989e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,24235,0.0375652157436026,0.00427414253515517,0.0291878963746984,0.0459425351125067,1.60790498942417e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29158,0.0422144572561314,0.00480484184466912,0.0327969672405799,0.0516319472716829,1.63573947084333e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,29518,0.03212206862235,0.00366142129596278,0.0249456828822629,0.039298454362437,1.82958239069184e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,29344,0.0303507806833682,0.0034598566789826,0.0235694615925623,0.0371320997741741,1.84396381656324e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29647,0.0163127228715391,0.00186035704045272,0.0126664230722517,0.0199590226708264,1.90384964439243e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24800,0.0338575996033387,0.00386242417764198,0.0262872482151605,0.041427950991517,1.9695033238888e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,24840,0.0575805638645743,0.00658520868140952,0.0446735548490116,0.0704875728801369,2.39138884804751e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24840,0.0231017679667141,0.00264643924293646,0.0179147470505587,0.0282887888828696,2.71879353060855e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24847,0.02313799828859,0.00265071206773838,0.0179426026358228,0.0283333939413572,2.72842677955897e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29438,0.0265663753089415,0.00304463123480771,0.0205988980887183,0.0325338525291646,2.78360154526946e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24917,0.0618193446767947,0.00708769872090063,0.0479274551838295,0.0757112341697599,2.89928271279801e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29344,0.0309171269309739,0.00354555831792969,0.0239678326278317,0.0378664212341161,2.92710191428112e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24235,0.0284957525390223,0.00327355400384697,0.0220795866914822,0.0349119183865624,3.37932929664408e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24376,0.0284951084987151,0.00327486038966859,0.0220763821349646,0.0349138348624655,3.48884270529097e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24800,0.0564273612868533,0.0064953077968255,0.0436965580050753,0.0691581645686312,3.93291912091466e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,24840,0.0432399759211348,0.00498137602223163,0.0334764789175608,0.0530034729247088,4.18430806556945e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29344,0.060619385104244,0.00699767728231828,0.0469039376309001,0.0743348325775878,4.83581522688471e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,29473,0.0387098342872236,0.00447201966611081,0.0299446757416464,0.0474749928328008,5.13024216439053e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28590,0.0112331576825471,0.00129816175313511,0.00868876064640224,0.0137775547186919,5.26904722603143e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24863,0.0270164016941631,0.00312681185359919,0.0208878504611087,0.0331449529272175,5.94125672280458e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24840,0.0304166639740851,0.00352076540007797,0.0235159637899323,0.0373173641582379,5.99468345213574e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28911,0.023646941590053,0.00273826276217673,0.0182799465761866,0.0290139366039194,6.12943904728352e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,28792,0.0165238259308568,0.00191351415117239,0.0127733381945589,0.0202743136671547,6.15298559384341e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,24917,0.0161581172675627,0.00187358911728881,0.0124858825976766,0.0198303519374487,6.83502083984197e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,24376,0.0639930123131657,0.00742381811993647,0.0494423287980902,0.0785436958282412,7.09811968184872e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,29720,0.0192720157093767,0.00223632095894063,0.0148888266298531,0.0236552047889003,7.16209229572932e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29576,0.0150904072821245,0.0017511670375748,0.0116581198884779,0.0185226946757711,7.18807842484413e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24376,-0.0145627559074931,0.00169218295500882,-0.0178794344993104,-0.0112460773156758,8.02169652747948e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24235,0.0411970339948644,0.00478809856619802,0.0318123608051162,0.0505817071846125,8.15447977813553e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,24800,0.0584077179842019,0.00680134208903843,0.0450770874896866,0.0717383484787173,9.38793440340817e-18
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29492,0.0192995276521149,0.00225036085616144,0.0148888203740385,0.0237102349301913,1.02788868352617e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24235,0.0271807568301748,0.00317067707181134,0.0209662297694246,0.033395283890925,1.07179013308461e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,29213,0.0448929253900706,0.00524108768706088,0.0346203935234313,0.05516545725671,1.127427816093e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29213,0.0443295051935946,0.00517856974280653,0.0341795084976938,0.0544795018894954,1.18127958431744e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OCLN,Occludin,24863,0.0248535959626131,0.00290437568739566,0.0191610196153176,0.0305461723099086,1.2211817287613e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLPS,Colipase,29395,0.0401098928733777,0.00469359036491946,0.0309104557581356,0.0493093299886199,1.33875889554886e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29473,0.0381936220193444,0.00447179694208046,0.0294289000128667,0.0469583440258221,1.3937188978088e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,29378,0.0267507124439578,0.00313349660095478,0.0206090591060865,0.0328923657818292,1.44270111910448e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,29438,0.0259186155405146,0.00303774919168756,0.019964627124807,0.0318726039562222,1.50406385127947e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24840,0.0355709037921632,0.00417069503044155,0.0273963415324977,0.0437454660518286,1.56215765104754e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28792,0.0447704144181821,0.0052525416681411,0.0344754327486255,0.0550653960877386,1.62156681095457e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28792,0.0380346751917114,0.00446588211651253,0.0292815462433469,0.046787804140076,1.7201100631137e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29561,0.0154188149149728,0.00181238559374057,0.0118665391512413,0.0189710906787043,1.86039822026363e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,29127,0.0382408007473792,0.00449766081967729,0.0294253855408118,0.0470562159539467,1.94500685183547e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,29213,0.0564728158113787,0.00664247429732473,0.0434535661886222,0.0694920654341352,1.95482126182433e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,29689,0.0340619633185045,0.00400684592385796,0.0262085453077429,0.0419153813292661,1.9674117110018e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,24961,0.0109064173980827,0.00128359082888445,0.0083905793734692,0.0134222554226962,2.05609401749221e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,29395,0.0494006039525245,0.00581610960499444,0.0380010291267354,0.0608001787783136,2.09366898509431e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,24933,0.0229041368628928,0.00269722059241093,0.0176175845017674,0.0281906892240182,2.14725988682029e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,29576,0.0519092275413396,0.00611434048111594,0.0399251201983524,0.0638933348843269,2.16627394750009e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24800,0.042880176616392,0.00505100434435943,0.0329802081014475,0.0527801451313365,2.19104977818887e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24376,0.0463684892272028,0.00546976968794381,0.035647740638833,0.0570892378155727,2.43503560908427e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29473,-0.0190296294219328,0.00224508527451357,-0.0234299965599794,-0.0146292622838862,2.43515278517677e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29404,0.0259138541751255,0.00305798223002998,0.0199202090042668,0.0319074993459843,2.47665844556437e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,29561,0.0300612998808125,0.00355021126114639,0.0231028858089656,0.0370197139526594,2.62230836744026e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24863,0.0404829313042176,0.00478224320065371,0.0311097346309363,0.0498561279774988,2.69492470105818e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,29561,0.012251758302438,0.00144772066579942,0.00941422579747117,0.0150892908074049,2.72939846131373e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MLN,Promotilin,29429,0.0497761509301702,0.00588324004409289,0.0382450004437482,0.0613073014165923,2.77995726556167e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28911,0.0622196118219666,0.00735503642542781,0.0478037404281281,0.0766354832158051,2.81120128324936e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,24917,0.0174913972849554,0.00206858514835676,0.0134369703941762,0.0215458241757347,2.92339669862674e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,29689,0.0366029662834054,0.00432958121649655,0.0281169870990722,0.0450889454677386,2.93799497873338e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29531,-0.045729171198096,0.00542266749017521,-0.0563575994788394,-0.0351007429173526,3.52158170099834e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,28769,0.0345482448027305,0.00409726398731883,0.0265176073875856,0.0425788822178754,3.55399450470322e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29449,0.0217342268736356,0.00257823011791274,0.0166808958425266,0.0267875579047446,3.61524376912939e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,24840,0.0211029331240205,0.00250315664255448,0.0161967461046138,0.0260091201434273,3.6254465993709e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,29344,0.0499641594981532,0.00594225540008048,0.0383173389139954,0.0616109800823109,4.34658649874744e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29561,0.0340602640463631,0.00405089921527155,0.0261205015844308,0.0420000265082953,4.35285400075998e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,24224,0.0442550024476934,0.00526321133188905,0.0339391082371909,0.054570896658196,4.38380006291323e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,24701,0.0400872193680337,0.00477269769627832,0.0307327318833282,0.0494417068527392,4.73075275737839e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLU,Clusterin,24961,0.0176142606380479,0.00210073430517482,0.0134968213999053,0.0217316998761906,5.34569477729821e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,29473,0.0708532409694235,0.00845929924816784,0.0542730144430146,0.0874334674958325,5.72622639017174e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEXN,Nexilin,24946,0.0381860270990931,0.00455908167134976,0.0292502270232476,0.0471218271749386,5.76923230401065e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29576,0.047408602935655,0.00566256428443789,0.0363099769381568,0.0585072289331533,5.89745530447411e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28792,0.0469558136607314,0.00561078514107721,0.0359586747842201,0.0579529525372427,6.07858886139835e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,29486,0.0586625605352259,0.00701485446820802,0.0449134457775382,0.0724116752929136,6.40100963151767e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24096,0.0548696275510029,0.00656797413850446,0.0419963982395342,0.0677428568624717,6.94358510855413e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,24800,0.0197882786705289,0.00236965735242744,0.0151437502597711,0.0244328070812867,7.13687816767771e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,29640,0.0272360826639754,0.00326420780848712,0.0208382353593407,0.0336339299686102,7.49906335911878e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RETN,Resistin,29357,0.0232626754236419,0.00279110068144904,0.0177921180880018,0.028733232759282,8.11220893447239e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,24917,0.0411217162497223,0.00493579044118925,0.0314475669849914,0.0507958655144533,8.40066550814646e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29349,0.0491179054084395,0.00589678876693886,0.0375601994252393,0.0606756113916396,8.46050751024585e-17
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,29438,0.0159935999416022,0.0019256452399416,0.0122193352713166,0.0197678646118877,1.03545626340179e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24917,0.0485755885151852,0.0058493154257529,0.0371109302807095,0.0600402467496609,1.05285973754797e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29429,0.0235559891031529,0.00283750372678847,0.0179944817986475,0.0291174964076583,1.07014102786816e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,29752,0.0164889341491743,0.00198627984453889,0.0125958256538781,0.0203820426444705,1.07185283594615e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,29473,0.0666813409948671,0.00804831863775637,0.0509066364648647,0.0824560455248696,1.22931061597772e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24639,0.0174226958955648,0.00210460437585828,0.0132976713188826,0.021547720472247,1.31139193124658e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPART,Spartin,24376,0.0424150891660233,0.00512544948856797,0.0323692081684301,0.0524609701636166,1.34524692525066e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23901,0.0292603127798106,0.00353644046969774,0.0223288894592031,0.0361917361004182,1.36294324718538e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29429,0.0275505409427192,0.00333180258096637,0.0210202078840251,0.0340808740014132,1.40764288522717e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24800,0.0417120320384848,0.00504674292922498,0.0318204158972038,0.0516036481797658,1.46444100605344e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28548,-0.0551723443303132,0.00667957628612136,-0.068264313851111,-0.0420803748095153,1.52088525678327e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F2,Prothrombin,24961,0.00809160990945602,0.000979605435507979,0.00617158325586038,0.0100116365630517,1.52733232515267e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29689,0.0250219736002274,0.00302976637682685,0.0190836315016468,0.030960315698808,1.53301618225303e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29537,0.0280619887230774,0.00339788661030142,0.0214021309668866,0.0347218464792682,1.53402975466459e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,29429,0.035172366649741,0.00425989692119754,0.0268229686841938,0.0435217646152882,1.56057865733239e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29213,0.0240467894480601,0.00291280501022249,0.018337691628024,0.0297558872680962,1.57519578471807e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,29438,0.0132167745718266,0.00160121876243583,0.0100783857974523,0.0163551633462008,1.59252517231708e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,24224,0.0270296877246942,0.00327453378881616,0.0206116014986145,0.0334477739507739,1.60219857628088e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,24946,0.028817413224175,0.0034940747036891,0.0219690268049444,0.0356657996434056,1.69625506348727e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,29344,-0.073748435800467,0.00894692782054686,-0.0912844143287389,-0.0562124572721952,1.75054494266261e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,29688,0.01756289326769,0.00213145296799197,0.0133852454504257,0.0217405410849542,1.79419426936752e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,29187,0.0201817833392453,0.0024505174278142,0.0153787691807295,0.0249847974977611,1.85855897875561e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,29203,0.0248009659985252,0.00301346293743505,0.0188945786411526,0.0307073533558979,1.94839182881696e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24106,0.0220310851142069,0.00268413445228434,0.0167701815877296,0.0272919886406842,2.36268196867957e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24863,0.0412316391086936,0.00502580892015564,0.0313810536251886,0.0510822245921987,2.43706787969483e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24235,0.0245907197222475,0.00299977699546613,0.0187111568111339,0.0304702826333611,2.57446230662339e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29473,0.0425910552455966,0.00519676492800191,0.0324053959867129,0.0527767145044803,2.59170413201096e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,24224,0.0143256109930259,0.00174887309997564,0.0108978197170737,0.0177534022689782,2.70980438518268e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24863,0.0428693521396937,0.00523586136712801,0.0326070638601229,0.0531316404192646,2.79068152911837e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,29169,0.0315805313481911,0.00385993087742576,0.0240150668284366,0.0391459958679456,2.9130996717871e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,29781,0.0141850704763907,0.00173525920496314,0.0107839624346629,0.0175861785181184,3.08489148267854e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24133,0.0270407846734914,0.00331228999820987,0.0205486962770001,0.0335328730699827,3.40455377418057e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29344,0.0740773187606975,0.0090920849675598,0.0562568322242803,0.0918978052971147,3.86311626562377e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPTC,Opticin,29344,0.024385476020422,0.00299351445516976,0.0185181876882893,0.0302527643525547,3.90632263407359e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24800,0.0345649957267303,0.00424786557783006,0.0262391791941834,0.0428908122592773,4.2394604103226e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29576,0.0110225652935127,0.00135565109473136,0.0083654891478392,0.0136796414391861,4.42890160494958e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,29531,0.0161163541208703,0.00198457838042897,0.0122265804952296,0.0200061277465111,4.81024305538573e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,28700,0.0374382565675511,0.00461055271857886,0.0284015732391365,0.0464749398959657,4.84218191249641e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,24376,-0.028060154055166,0.003462075468145,-0.0348458219727302,-0.0212744861376017,5.5198903688714e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,24190,0.0703063851652077,0.0086749011619269,0.053303578887831,0.0873091914425844,5.54153922982432e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,24800,0.0181544027399258,0.00224008016991729,0.0137638456068879,0.0225449598729637,5.545328547351e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28792,0.025183180913498,0.00310766467427667,0.0190921581519157,0.0312742036750803,5.54659183235061e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24376,0.031171597622453,0.00384676156868917,0.0236319449478222,0.0387112502970837,5.59621812236133e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,24224,0.0155087675845307,0.00191471405203479,0.0117559280425425,0.0192616071265189,5.76325874449978e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,29731,0.0148155433373582,0.00182995645201823,0.0112288286914025,0.0184022579833139,5.88904558943447e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29781,0.0207979354927423,0.00256911767285058,0.0157624648539552,0.0258334061315295,5.92532507983729e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,29213,0.0516302637223201,0.00638066517493631,0.0391241599794449,0.0641363674651953,6.11149793486027e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,29344,0.041174613196771,0.00509198763170662,0.031194317438626,0.051154908954916,6.39291631664193e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29815,-0.018231728226956,0.00225523736350268,-0.0226519934594213,-0.0138114629944908,6.49380215362175e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24917,0.0214057708475883,0.00264767379909856,0.0162163302013551,0.0265952114938214,6.51034632111221e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,24235,0.0284835871485157,0.00352529983890155,0.0215739994642687,0.0353931748327628,6.78963891225131e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29589,0.0159201061188971,0.0019714193993759,0.0120561240961203,0.0197840881416738,6.97594418269707e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28930,-0.0420503224140538,0.00521548353740848,-0.0522726701473744,-0.0318279746807332,7.75542265172563e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29213,0.050156818797191,0.00622460380141268,0.0379565953464222,0.0623570422479599,8.05975529632535e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29390,0.0583590685406731,0.00724595369886884,0.0441569992908901,0.072561137790456,8.31245498735763e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29344,-0.0368126304936411,0.00457688761274309,-0.0457833302146175,-0.0278419307726646,9.08264308668674e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29561,0.0132026503592074,0.0016419249308393,0.00998447749476234,0.0164208232236524,9.24433326729984e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29576,0.0465270018936857,0.00579076373677264,0.0351771049696114,0.0578768988177601,9.72800912065065e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24376,0.0441645248784313,0.00549609372763085,0.0333921811722748,0.0549368685845878,9.72968997370439e-16
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28926,0.0290780544535974,0.0036206948430564,0.0219814925612069,0.0361746163459879,1.00270609940193e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,29473,0.0460006063019942,0.00572944132124696,0.0347709013123501,0.0572303112916382,1.02059254174306e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,24840,-0.0223168007849933,0.00277971140806686,-0.0277650351448043,-0.0168685664251822,1.03046340790611e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,24840,0.0209858145822539,0.0026152753016457,0.0158598749910283,0.0261117541734794,1.06568881784648e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,24324,0.016253521084395,0.00202835546357661,0.0122779443757848,0.0202290977930052,1.16791800907015e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24917,0.0251897629481443,0.00314364903420334,0.0190282108411057,0.0313513150551828,1.1690439581605e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,28926,0.0212600933548792,0.0026540518612743,0.0160581517067816,0.0264620350029769,1.18576493747465e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24800,0.0342456127187197,0.00427544398489398,0.0258657425083275,0.0426254829291119,1.19874104847873e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,29561,0.0302011430572071,0.00377149491994301,0.0228090130141188,0.0375932731002954,1.21098143612854e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29429,0.0337648864532107,0.00421730826863827,0.0254989622466797,0.0420308106597417,1.22573470211809e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29211,0.0309446681423294,0.00386614321078249,0.0233670274491957,0.0385223088354631,1.24863497282872e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,29187,0.025216310944392,0.00315858827882295,0.019025477917899,0.031407143970885,1.4753766682572e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29428,0.0169636937960015,0.0021251337902771,0.0127984315670583,0.0211289560249446,1.48691606621114e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,24750,0.0465179005485848,0.00583257842303298,0.0350860468394402,0.0579497542577295,1.58252929339287e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29344,0.023244210233596,0.0029173788374159,0.0175261477122609,0.0289622727549312,1.67749081908642e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24424,0.0231148495086187,0.00291022072557124,0.0174108168864991,0.0288188821307383,2.06398630061521e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,29526,0.0147504392782056,0.00185902986611727,0.0111067407406157,0.0183941378157954,2.18813792112919e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28769,0.0352014047575723,0.00443740047895762,0.0265040998188154,0.0438987096963293,2.21835888324804e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27934,0.0210069223766575,0.00264818743850893,0.01581647499718,0.026197369756135,2.22647412966435e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,29429,0.0284861841765532,0.00359165426322617,0.0214465418206299,0.0355258265324765,2.24660807531004e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORT1,Sortilin,29428,0.0195276142892906,0.00246324228855708,0.0146996594037187,0.0243555691748625,2.31272004712422e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28769,0.0445321374782301,0.00562466544670135,0.0335077932026955,0.0555564817537648,2.51427256643607e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29344,0.0401129589545832,0.0050787487009524,0.0301586115007165,0.0500673064084498,2.92804340402655e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,29539,0.015974242223744,0.0020258988148605,0.0120034805466174,0.0199450039008706,3.2528691965572e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,28769,0.0372468967545527,0.00472506992790587,0.0279857596958572,0.0465080338132482,3.31328425400388e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,28926,-0.0230385170921369,0.00292297451712884,-0.0287675471457094,-0.0173094870385644,3.33790745836184e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29438,0.0122226978627008,0.00155110874343166,0.00918252472557475,0.0152628709998268,3.38690365470131e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29815,0.0182470352952886,0.00231607461875772,0.0137075290425235,0.0227865415480538,3.42744124282911e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28769,0.0411325510309784,0.00522631561127249,0.0308889724328843,0.0513761296290725,3.66233347550096e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29561,0.0435627509576685,0.00553712425205771,0.0327099874236354,0.0544155144917016,3.74399818111876e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,29678,0.0299990425392785,0.00381593985604687,0.0225198004214266,0.0374782846571303,3.92339560454867e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,24376,0.0149507380731277,0.00190271194902618,0.0112214226530364,0.018680053493219,4.07688845634044e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24840,0.0160128465520266,0.00203839102585348,0.0120176001413538,0.0200080929626994,4.13800117118344e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29473,-0.0205894869211638,0.00262371325543967,-0.0257319649018256,-0.0154470089405021,4.388658863191e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29213,0.0291573522433674,0.00371594615956608,0.0218740977706179,0.0364406067161169,4.42191970640352e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24735,0.0565720077169062,0.00721223027907636,0.0424360363699166,0.0707079790638959,4.54343860823158e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,24840,0.0344352457789438,0.00439483166019427,0.025821375724963,0.0430491158329246,4.86013311460277e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,29278,0.0199159847047281,0.00254392349718836,0.0149298946502389,0.0249020747592173,5.08932145515278e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,29473,0.0418539801455029,0.0053466717482835,0.0313745035188673,0.0523334567721386,5.12069813028848e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,29594,0.0578437289670589,0.00743278298228882,0.0432754743217728,0.072411983612345,7.35642770543981e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24788,0.0250818157534543,0.00322337520566973,0.0187640003503416,0.0313996311565669,7.46169298851773e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29531,0.0458902747194469,0.00590019324291962,0.0343258959633244,0.0574546534755693,7.62192352522405e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,24900,0.0177208727674817,0.00227993988070281,0.0132521906013042,0.0221895549336592,7.99059835087456e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29473,-0.0219085579049589,0.00282073733380719,-0.027437203079221,-0.0163799127306968,8.29935859354464e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MENT,Protein MENT,24376,-0.0116629960459378,0.00150267856707833,-0.0146082460374113,-0.00871774605446423,8.72366671276011e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24863,0.0500765995681911,0.00645248510195489,0.0374297287683595,0.0627234703680227,8.76161070537276e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28782,0.0403721922688702,0.00520423668339419,0.0301718883694176,0.0505724961683228,8.94340205996521e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,29158,0.0327184872573683,0.00422077760519359,0.0244457631511889,0.0409912113635478,9.35645591853305e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,29395,0.0470673938158613,0.00607486966196661,0.0351606492784068,0.0589741383533159,9.64383796349037e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29438,0.0609207916945049,0.00786485706901957,0.0455056718392265,0.0763359115497832,9.79111366548661e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28792,0.0324636590735449,0.00419236157746367,0.0242466303817161,0.0406806877653737,9.9864076363689e-15
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29599,0.0296593958338571,0.00383108820644691,0.0221504629492211,0.037168328718493,1.0116298953924e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29650,0.0160503601046288,0.00207567101431899,0.0119820449165636,0.020118675292694,1.08691787502224e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29576,0.0141075863845859,0.00182635443721809,0.0105279316876385,0.0176872410815333,1.15880770603812e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29321,0.0145757874247749,0.00188703860904389,0.0108771917510488,0.0182743830985009,1.16177453569117e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPL,Periplakin,24224,0.0167001408715791,0.00216467245896699,0.0124573828520038,0.0209428988911544,1.25775188983344e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29781,0.0140509629557601,0.00182257583176114,0.0104787143255083,0.017623211586012,1.30342755639303e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29473,-0.0533044953251884,0.00691486420343521,-0.0668576291639214,-0.0397513614864554,1.3111578484389e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,29438,0.0136567896340037,0.00177179978801969,0.0101840620494851,0.0171295172185223,1.31964012962337e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,29344,0.0278710386154099,0.00361989235450468,0.0207760496005807,0.034966027630239,1.4098701961447e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,28926,0.0242845196027402,0.00315766769406012,0.0180954909223824,0.030473548283098,1.51031141246232e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,24376,0.0225578746117641,0.00293388210927682,0.0168074656775816,0.0283082835459467,1.54185823199885e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28792,0.0339195211102921,0.00441221427219151,0.0252715811367967,0.0425674610837874,1.54640319291574e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,29429,0.0345023699616512,0.00448842438174705,0.025705058173427,0.0432996817498754,1.55350453219413e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29781,0.0342439894445681,0.00445509192087102,0.0255120092796609,0.0429759696094753,1.55881087200452e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,29076,0.0183847390363923,0.00239233555042856,0.0136957613575524,0.0230737167152323,1.57994757849198e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,24106,0.0306181873208304,0.0039860146924558,0.0228055985236171,0.0384307761180438,1.63332168640966e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29273,0.0139822249578671,0.00182103081501933,0.0104130045604292,0.017551445355305,1.66372017444266e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24800,0.0432924902333329,0.00564194865351969,0.0322342708724343,0.0543507095942315,1.73756763796718e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,24235,0.0286326335294529,0.00373156946009196,0.0213187573876727,0.0359465096712332,1.74230058171421e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,24917,0.0139469916373156,0.00181858510769777,0.010382564826228,0.0175114184484033,1.7946637282849e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24800,0.0278182262535008,0.00362905757172841,0.0207052734129131,0.0349311790940884,1.84779979445041e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,29627,0.0301322605549462,0.00393255522888048,0.0224244523063405,0.037840068803552,1.88261335609885e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29561,-0.0177024832982597,0.00231137106082015,-0.0222327705774672,-0.0131721960190522,1.93304688507715e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,28769,0.0342290115537607,0.00447096495533931,0.0254659202412957,0.0429921028662258,1.98060774179557e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,29473,0.0288702452982109,0.00377564158533561,0.0214699877909531,0.0362705028054687,2.12890574459541e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FURIN,Furin,29561,0.0169510473174395,0.00221764329436169,0.0126044664604905,0.0212976281743884,2.1742084771269e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24224,0.0204877337852202,0.00268086031555546,0.0152332475667315,0.0257422200037089,2.21408315937829e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29689,0.0236001506946026,0.00309208511197034,0.0175396638751407,0.0296606375140644,2.37256238413333e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29689,0.0286125199437169,0.0037504384452945,0.0212616605909397,0.0359633792964941,2.43444463979983e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,29213,-0.0262428050369467,0.00344548517736349,-0.0329959559845792,-0.0194896540893143,2.6835916307857e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28792,0.0329134094482208,0.00432474873932471,0.0244369019191443,0.0413899169772972,2.81426997026106e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29668,0.0213326954009608,0.00280514880294689,0.0158346037471849,0.0268307870547367,2.93697795106024e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,28792,0.0192501397139186,0.00253262652303819,0.0142861917287637,0.0242140876990734,3.03113342171057e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24800,0.0107904052672483,0.00141988589089526,0.00800742892109358,0.013573381613403,3.07816552078153e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,28926,0.0301877723649725,0.00397274640466377,0.0224011894118316,0.0379743553181135,3.08123616151463e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTG,Protogenin,29720,-0.0125406742850554,0.00165061502864427,-0.0157758797411982,-0.00930546882891263,3.10595700075151e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24376,0.0211952554261773,0.00279217206684854,0.0157225981751541,0.0266679126772004,3.28927926126528e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24800,0.0439886688546626,0.00579918753846993,0.0326222612792615,0.0553550764300637,3.43317295579688e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24235,0.0460624989592391,0.00607996766065225,0.0341457623443607,0.0579792355741175,3.68801406503537e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,29473,-0.0267956848374878,0.00353794293181839,-0.0337300529838518,-0.0198613166911237,3.73062493692699e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,29429,0.0156492610004106,0.00206769564428805,0.011596577537606,0.0197019444632152,3.88731560601647e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,28911,0.024511090681127,0.00324300958293977,0.018154791898565,0.0308673894636889,4.21008122150489e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,24828,0.0236612450524648,0.00313049486055406,0.0175254751257788,0.0297970149791507,4.2245585620728e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29429,0.0498637097919433,0.00660941921589046,0.036909248128798,0.0628181714550886,4.67703386768611e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,24376,0.0136036869926981,0.00180546960294604,0.0100649665709238,0.0171424074144723,5.06444050605543e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,29781,0.0387359556756784,0.00514169732779137,0.0286582289132073,0.0488136824381495,5.07248815074648e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,29213,0.0304190197362268,0.00403913641948109,0.0225023123540439,0.0383357271184098,5.17794818176436e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24106,0.0332301785840953,0.00441838734775601,0.0245701393824936,0.0418902177856971,5.63063276864754e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,29158,0.0117187854010042,0.00156018117731296,0.00866083029347077,0.0147767405085376,6.02791872951313e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29531,0.0253569181077874,0.00337946234853535,0.0187331719046581,0.0319806643109167,6.4011551791223e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29815,0.0158113508278614,0.00210740095826494,0.0116808449496621,0.0199418567060606,6.42228943808228e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,29572,-0.032345241642731,0.00431491924022995,-0.0408024833535817,-0.0238879999318803,6.75645101430207e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,24840,0.0416022286802479,0.00555468175795102,0.0307150524346639,0.0524894049258319,7.13956714662852e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,24376,-0.0163829692578126,0.00219088209102046,-0.0206770981562127,-0.0120888403594125,7.81288011172415e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,24190,0.0241762991557407,0.00323626997649708,0.0178332100018064,0.0305193883096749,8.26454557233933e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,28926,0.0393191850938076,0.0052659169530499,0.0289979878658298,0.0496403823217854,8.4529030996658e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24783,0.0212951788971408,0.0028549548465939,0.0156994673978168,0.0268908903964648,9.00275115658979e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,29429,0.0321827321136452,0.00431632953211969,0.0237227262306906,0.0406427379965998,9.16163999099316e-14
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,28911,0.0376882695335422,0.00506903643194454,0.0277529581269309,0.0476235809401535,1.074701191003e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28769,0.0550811660618426,0.00740918211224067,0.0405591691218508,0.0696031630018343,1.08152516551772e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28792,0.0250350776746134,0.00337383542535186,0.0184223602409238,0.0316477951083031,1.20028196560435e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,23783,-0.021323952576651,0.00287665227175736,-0.0269621910292955,-0.0156857141240066,1.27822526439507e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24224,0.0441900033102367,0.0059643104518142,0.0324999548246809,0.0558800517957926,1.31347833067145e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29429,0.0494711255391809,0.00667894972977006,0.0363803840688316,0.0625618670095302,1.32632740829663e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NADK,NAD kinase,29473,0.0264786539891472,0.00358014860832744,0.0194615627168255,0.033495745261469,1.44123296579541e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24376,0.026224055191801,0.00354936981747368,0.0192672903495526,0.0331808200340495,1.53419067524032e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24917,0.016473330585647,0.00223165314862468,0.0120992904143426,0.0208473707569513,1.61211374775365e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28792,0.0308991310540972,0.00418660630218508,0.0226933827018145,0.03910487940638,1.61994312073044e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,29429,-0.037073062560765,0.00502355592660109,-0.0469192321769031,-0.0272268929446269,1.62664204222152e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24917,0.0355422678588642,0.00481905241210136,0.0260969251311455,0.0449876105865828,1.69013074240167e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29689,0.0318863518572712,0.00432462667009946,0.0234100835838763,0.0403626201306661,1.70925583013551e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29689,0.0347126260877093,0.00470929789480866,0.0254824022138843,0.0439428499615342,1.73661484143812e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,24933,0.0153044270665357,0.00207709694021352,0.0112333170637172,0.0193755370693542,1.78347201232676e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,29514,0.0149446743826744,0.00202904294602783,0.0109677502084598,0.0189215985568889,1.81262056787635e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASPN,Asporin,24917,0.0134130512409182,0.00182141908815624,0.00984306982813195,0.0169830326537044,1.8392638738364e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29815,0.0192160462328401,0.00261164823641856,0.0140972156894598,0.0243348767762205,1.91753213615956e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24800,0.0395697273419548,0.00537852456242077,0.0290278191996101,0.0501116354842995,1.93952405556856e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24440,0.0548519073109897,0.00746285765597516,0.0402247063052784,0.069479108316701,2.04451249289118e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28714,0.0228516716175298,0.00311044713189199,0.0167551952390215,0.0289481479960381,2.08494303192316e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,29781,0.0273697086293211,0.00372708808588767,0.0200646159809813,0.0346748012776609,2.1347885014833e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24224,0.0157520824550062,0.00214527832960707,0.0115473369289763,0.019956827981036,2.1597412647783e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,24800,0.0518307337434505,0.00706896928103609,0.0379755539526198,0.0656859135342813,2.33432223646177e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29438,-0.0195166444388067,0.00266298159790885,-0.0247360883707081,-0.0142972005069054,2.38070217344597e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29556,0.0151893379755286,0.00207255817024274,0.0111271239618528,0.0192515519892044,2.38191773109592e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29531,0.0417448460169251,0.0057053130444478,0.0305624324498074,0.0529272595840428,2.60348492051535e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28769,0.0296298051440609,0.00405190738555736,0.0216880666683685,0.0375715436197534,2.68942410131083e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29213,0.0258478408031166,0.00353477940455068,0.0189196731701973,0.032776008436036,2.69083953280366e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29503,0.0238483951566182,0.00326258669948156,0.0174537252256343,0.0302430650876021,2.74621411220433e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,29782,0.0208598550039935,0.00285384129650748,0.0152663260628389,0.0264533839451482,2.7509402710236e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,24800,0.0326565675919681,0.00446823898749124,0.0238988191764852,0.0414143160074509,2.78108459975689e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29269,0.0126340800790501,0.00173215898880447,0.00923904846099332,0.0160291116971068,3.08900810953679e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24800,0.0193230366267173,0.00265013006877878,0.0141287816919109,0.0245172915615237,3.16051672472269e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29429,0.050257192148824,0.0069006855738432,0.0367318484240913,0.0637825358735566,3.34847099979269e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29576,0.0186466048808576,0.00256128253766223,0.0136264911070396,0.0236667186546755,3.41676377567124e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29623,0.00975288793314695,0.00134105379565595,0.0071244224936613,0.0123813533726326,3.61490481700158e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28926,0.0232759202155267,0.00320897043210015,0.0169863381686104,0.029565502262443,4.16670997099376e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28792,0.0213704682435932,0.00294825544370005,0.0155918875739411,0.0271490489132453,4.31976846913418e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24360,0.0226867574813613,0.00312972629049682,0.0165524939519875,0.028821021010735,4.33019658420934e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24933,0.0103209325353412,0.00142534163312101,0.00752726293442403,0.0131146021362584,4.58223283283695e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29689,0.0458813434566967,0.00633762747468697,0.0334595936063102,0.0583030933070831,4.61227825934563e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLC,Galectin-10,29421,0.031807413101865,0.00439431142269582,0.0231945627133812,0.0404202634903488,4.65415272331106e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,24840,0.0339606495323338,0.00469146891546158,0.0247653704580291,0.0431559286066385,4.6579943947047e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29627,0.0165028289120677,0.00228108589887426,0.0120319005502741,0.0209737572738612,4.78101732602971e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24204,0.0381135462016644,0.00527210792581317,0.0277802146670705,0.0484468777362582,4.99976463355157e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,24642,0.0209912493341372,0.00290447931947306,0.01529846986797,0.0266840288003044,5.07416939214894e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29731,0.0155962001108276,0.00215853527854598,0.0113654709648775,0.0198269292567777,5.11789210560796e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24917,0.0154292750690881,0.00213747607721267,0.0112398219577513,0.0196187281804249,5.40883545813846e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29561,0.0171405066594833,0.00237647475020655,0.0124826161490785,0.0217983971698881,5.62219945963001e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EZR,Ezrin,29689,0.0114536587621789,0.00158802024144548,0.00834113908894575,0.014566178435412,5.62316134883601e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,24751,0.0280281805689469,0.00389463545196839,0.0203946950830889,0.035661666054805,6.34866679938599e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,24552,0.0113552632824679,0.00157807012185389,0.00826224584363427,0.0144482807213015,6.39427611932305e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24190,0.0382764984909043,0.00532218177176337,0.0278450222182481,0.0487079747635605,6.57643157990776e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29344,0.0109408371251619,0.00152148486888503,0.00795872678214726,0.0139229474681766,6.59078442813844e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,29438,-0.0178091185884586,0.00247734805649173,-0.0226647207791823,-0.0129535163977348,6.69279287972148e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,24840,0.0276484837634955,0.00385412375749592,0.0200944011988035,0.0352025663281875,7.50225144570333e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,24106,0.0584107353479095,0.00814923214612938,0.0424382403414959,0.0743832303543231,7.85020162137282e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24190,0.0290496581995767,0.0040572643392903,0.0210974200945677,0.0370018963045857,8.3036433095623e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28769,0.0244684583369781,0.00341937031327334,0.0177664925229623,0.0311704241509938,8.51540022972869e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29689,0.0164108244139021,0.0022935395974864,0.0119154868028287,0.0209061620249754,8.54629858246591e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29576,0.0492905187989674,0.00689115128928095,0.0357838622719767,0.062797175325958,8.70476210616641e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29328,0.0123559681283213,0.0017280690797063,0.00896895273209699,0.0157429835245457,8.87057692157051e-13
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29473,0.0297034443726797,0.00416435449777899,0.0215413095570329,0.0378655791883265,1.00626276945247e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24376,0.0326972273190001,0.00458417406890205,0.0237122461439521,0.0416822084940482,1.01218682334541e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,29429,0.0189375200649464,0.00265657694874991,0.0137306292453966,0.0241444108844962,1.03774729737853e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,29338,0.0512830888674685,0.00719497931075783,0.0371809294183832,0.0653852483165538,1.04477003224194e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24800,0.0483344100585243,0.00678219198493475,0.0350413137680522,0.0616275063489964,1.05643951850428e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,29781,0.023376653483274,0.00328235531785457,0.0169432370602791,0.029810069906269,1.08852175902693e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,28842,0.0420489440947273,0.00590502809466647,0.030475089029181,0.0536227991602736,1.09757960266516e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,29634,-0.0119854904070139,0.00168510162820413,-0.015288289598294,-0.00868269121573385,1.16440888009718e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29429,0.0360365500129011,0.00508093772932846,0.0260779120634173,0.0459951879623849,1.34684842018282e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,29429,-0.0249834151178078,0.00352707331890549,-0.0318964788228626,-0.018070351412753,1.43895151738064e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,29429,0.0244112883036585,0.00344740377626053,0.0176543769021878,0.0311681997051291,1.46260864078216e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24376,0.031530803146507,0.00445566517627111,0.0227976994010156,0.0402639068919984,1.51772987515425e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,29815,0.0411727712432921,0.00581893563260582,0.0297676574033847,0.0525778850831995,1.52029957813134e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,29634,-0.0270492121903849,0.00382337269154222,-0.0345430226658077,-0.0195554017149622,1.53098101186489e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24376,0.0173077310194761,0.00244654047602801,0.0125125116864612,0.022102950352491,1.54190016480694e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,24235,0.0286089422840352,0.00404752749090651,0.0206757884018584,0.0365420961662119,1.61151494502277e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,24235,0.0548322247972792,0.00775853649394755,0.039625493269142,0.0700389563254163,1.62209572592532e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24946,0.0187433548443782,0.00265447438704508,0.0135405850457699,0.0239461246429866,1.69592055429658e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,24917,-0.0123392397715984,0.00174756996713032,-0.0157644769071738,-0.00891400263602297,1.69893663386936e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24190,0.0252168965613001,0.0035713857289884,0.0182169805324829,0.0322168125901174,1.70005114567152e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24106,0.0319447913335562,0.00453100945436172,0.0230640128030072,0.0408255698641051,1.83403349460416e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24788,0.0323453956433574,0.00458838408981559,0.0233521628273188,0.041338628459396,1.8439028824351e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24190,0.0322636513685082,0.00457865718240597,0.0232894832909925,0.0412378194460239,1.88354477577478e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,24788,0.0386099225976501,0.00548535175735361,0.027858633153237,0.0493612120420632,1.99052376147094e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,29344,-0.0166254340003852,0.00236265321859312,-0.0212562343088277,-0.0119946336919426,2.01073675703043e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29576,0.0135053609651041,0.00192280681539071,0.00973665960693834,0.0172740623232699,2.20621697920402e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,29344,-0.0212459128309447,0.00302837447619419,-0.0271815268042853,-0.0153102988576041,2.3390311639987e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24800,0.012751672377989,0.00182111789587953,0.00918228130206517,0.0163210634539129,2.58564397154435e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,29430,0.0183578664461925,0.0026228136789681,0.013217151635415,0.02349858125697,2.62751423369907e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24440,0.0326944897992224,0.00467990689161724,0.0235218722916526,0.0418671073067922,2.89800396168217e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,24224,0.0188186366944747,0.00269375083499964,0.0135388850578754,0.024098388331074,2.90085231288073e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,28717,0.0418135935381803,0.00598602679562661,0.0300809810187522,0.0535462060576085,2.9064848333214e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29109,0.0153700976219204,0.00220235229547598,0.0110534871227875,0.0196867081210533,3.03772024618304e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,24863,-0.0244258741148777,0.00350144893235318,-0.03128871402229,-0.0175630342074655,3.11465313002505e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,29815,0.0240965282380676,0.00345699198013207,0.0173208239570088,0.0308722325191265,3.22674320184874e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29344,0.026249005143693,0.00376775014997651,0.0188642148497391,0.033633795437647,3.31168886045829e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,28769,0.0329313405963029,0.0047349756807007,0.0236507882621296,0.0422118929304763,3.60322986294129e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,29315,0.0192897974967954,0.00277676221212056,0.0138473435610391,0.0247322514325517,3.81285975826853e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,24946,0.0419933940869854,0.00604495690372871,0.0301452785556771,0.0538415096182936,3.8271975986366e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,24863,0.0213235403098873,0.00307602293107104,0.0152945353649881,0.0273525452547865,4.24542657159809e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,28792,0.0200166118738712,0.00289056418657534,0.0143511060681835,0.0256821176795589,4.45722791632989e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24376,0.0477744622804041,0.00690020226080822,0.03425006584922,0.0612988587115882,4.51137309948799e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29473,0.026364619961131,0.00380974550244645,0.0188975187763359,0.033831721145926,4.59873982646371e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,29438,0.0256766762487838,0.00371319155820817,0.0183988207946958,0.0329545317028718,4.77454679660713e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24440,0.0336976241437983,0.00487715820941543,0.0241383940533441,0.0432568542342526,4.99102505347391e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24440,0.0174489301866594,0.00252544410416669,0.0124990597424927,0.0223988006308261,4.9918036430775e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,29689,0.0137164859214571,0.00199016704737576,0.0098157585086006,0.0176172133343136,5.60619909744218e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29213,0.0231390784257647,0.00336015147146453,0.0165531815416942,0.0297249753098352,5.84128906137693e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,28911,0.03019180510032,0.0043850834086009,0.0215970416194623,0.0387865685811778,5.89208671954988e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,28911,-0.061131484150465,0.00888388206916535,-0.0785438930060291,-0.0437190752949009,6.05743938099709e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,24909,-0.017053123271872,0.00247869767631745,-0.0219113707174542,-0.0121948758262898,6.13252824894229e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,29689,0.055890404546016,0.00813111210975357,0.039953424810899,0.071827384281133,6.38174479104267e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29344,0.00925159842352211,0.00134641490838501,0.00661262520308748,0.0118905716439567,6.48977609846909e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28792,0.0291159756974388,0.00423750332543025,0.0208104691795955,0.037421482215282,6.50415694601765e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29473,0.0159921819955658,0.00233307877847256,0.0114193475897595,0.020565016401372,7.29513615346516e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24724,0.0201130727921808,0.00293429922037993,0.0143618463202361,0.0258642992641255,7.32596313145413e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28926,0.0159630140775574,0.00233194491180625,0.0113924020504172,0.0205336261046977,7.78040932655454e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29473,0.0143690016651224,0.00210578070711279,0.0102416714791814,0.0184963318510635,9.05056263989199e-12
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,29390,0.0299694498277014,0.00440143734327855,0.0213426326348754,0.0385962670205274,1.00160193642626e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29344,0.00890995150737662,0.00130960558142674,0.00634312456778022,0.011476778446973,1.04041108880715e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24863,0.0531753332439238,0.00783149122917708,0.0378256104347367,0.0685250560531109,1.14709431146359e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24324,0.0385414711627369,0.00567979252143635,0.0274090778207216,0.0496738645047521,1.18164200936795e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29561,0.0109246196516172,0.0016110733538172,0.00776691587813546,0.0140823234250989,1.21628412532025e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24106,0.0299374933866705,0.00441521323609976,0.021283675443915,0.038591311329426,1.22501910015974e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29669,0.0299946064951891,0.00442410627384599,0.021323358198451,0.0386658547919272,1.2258713407465e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,24788,0.0364909466556793,0.00538574532972775,0.0259348858094129,0.0470470075019457,1.26782241129555e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,24224,0.0245296101623428,0.00362136980150804,0.017431725351387,0.0316274949732986,1.2851876239502e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24917,0.0226783616279328,0.00335160873061599,0.0161092085159255,0.0292475147399401,1.34943134698242e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGN,Mimecan,29438,0.0188511735271862,0.00278884488620112,0.013385037550232,0.0243173095041404,1.41060755079071e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24440,0.0156590870505155,0.00231863202065208,0.0111145682900375,0.0202036058109936,1.47468542827448e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24800,0.0133892925655728,0.00198308512691699,0.0095024457168155,0.0172761394143301,1.49299726081605e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28926,0.0310173564259085,0.0045948755533692,0.0220114003413049,0.0400233125105121,1.50199139924479e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,29429,0.0179067080304939,0.00265392087116923,0.0127050231230023,0.0231083929379856,1.53449786743795e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29815,0.0276410933073182,0.00410098301601653,0.0196031665959258,0.0356790200187106,1.61144935681002e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24961,0.00751297354874839,0.00111469690149182,0.00532816762182442,0.00969777947567237,1.61921343910783e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,29669,0.0231178354005024,0.00343448951584291,0.0163862359494503,0.0298494348515545,1.7147065290293e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29213,0.0173095359480943,0.00257503450650388,0.0122624683153467,0.0223566035808419,1.82469573433176e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29720,0.0115213976477966,0.00171492794922883,0.00816013886730814,0.0148826564282851,1.87175785905071e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,28792,0.0299228666096356,0.00445514704859208,0.0211907783943952,0.0386549548248761,1.89642325774654e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,29438,-0.0194611902267989,0.00289938080891277,-0.025143976612268,-0.0137784038413299,1.95206612466715e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24235,0.0453211957639034,0.00675416908338134,0.0320830243604759,0.0585593671673308,1.9877207338617e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,29213,-0.0584523312409954,0.00871868288009383,-0.0755409496859794,-0.0413637127960115,2.0611246522959e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,29158,0.0141097970547497,0.00211037950132515,0.00997345323215241,0.018246140877347,2.33642680986037e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,24747,0.0192273652346282,0.00287625798719754,0.013589899579721,0.0248648308895354,2.36073214835371e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24440,0.0385399115411799,0.00577022569767613,0.0272302691737347,0.0498495539086251,2.45577758681584e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,29720,0.0245280979244152,0.00367270905439359,0.0173295881778037,0.0317266076710266,2.45694943043899e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,24784,0.0251678732554058,0.00377525729984413,0.0177683689477113,0.0325673775631003,2.67423415189962e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,23902,0.0312293320266776,0.00468924806791115,0.0220384058135718,0.0404202582397835,2.8020381554628e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,24235,0.0265023899512366,0.00398149364560088,0.0186986624058589,0.0343061174966143,2.86624171185947e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24224,0.0254134249014857,0.00382670306978005,0.0179130868847168,0.0329137629182546,3.17998853310388e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,24917,0.0360174912008059,0.00542971718530265,0.0253752455176127,0.0466597368839991,3.34762509782841e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24933,0.0183371220946951,0.00276605220341113,0.0129156597760092,0.0237585844133809,3.44062756978609e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29367,0.026126072656796,0.00394301144880433,0.0183977702171396,0.0338543750964525,3.51061339095091e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24440,0.015989527648433,0.00241653044244063,0.0112531279812494,0.0207259273156166,3.7483229579812e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24840,0.0177922299869613,0.00269055987333541,0.0125187326352239,0.0230657273386987,3.84684317809646e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,29473,0.0148987104288064,0.00225669511669755,0.0104755880000791,0.0193218328575336,4.12524375608549e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29520,0.0522067206835822,0.00791236117609069,0.0366984927784445,0.06771494858872,4.23443030861272e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,28769,0.01522119853242,0.00230830941892928,0.0106969120713186,0.0197454849935214,4.35283820550868e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,24224,0.00740271599905012,0.00112423137757611,0.00519922249900094,0.00960620949909929,4.65169631217248e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24788,0.0236253541811277,0.00359287440239264,0.0165833203524382,0.0306673880098173,4.94172727573951e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29473,0.0335568456432263,0.00510560331407356,0.0235498631476421,0.0435638281388104,5.02851489124679e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBN1,Drebrin,24224,0.0223238819274925,0.00339736134709143,0.0156650536871933,0.0289827101677917,5.10118263727187e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29755,0.0166537695409198,0.00253468918719448,0.0116857787340186,0.0216217603478209,5.10289829332152e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29344,0.0258774471518424,0.00394124545322,0.0181526060635312,0.0336022882401536,5.26164468379429e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,29429,0.0185700913913158,0.00283012816202384,0.0130230401937491,0.0241171425888825,5.41270535420872e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24224,0.0227565556032625,0.00346880006846527,0.0159577074690706,0.0295554037374545,5.47638129669445e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29576,0.012415587328651,0.00189282958521066,0.00870564134163815,0.016125533315664,5.49622922074723e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24863,0.0346835551151453,0.00529250407242442,0.0243102471331935,0.0450568630970972,5.73674960006151e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29344,0.0352225719630798,0.00538143891116683,0.0246749516971928,0.0457701922289667,6.03969220680777e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29438,0.011984175614301,0.00183316979654462,0.00839116281307359,0.0155771884155285,6.36185940549461e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29589,0.0130867450761427,0.00200199742779655,0.0091628301176615,0.017010660034624,6.38524252894195e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24224,0.039139830948385,0.00598928097110967,0.02740084024501,0.0508788216517599,6.48827047045612e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28769,0.0119549844037144,0.00183246931243033,0.00836334455135092,0.0155466242560778,6.96047857842425e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29815,0.0288736871365295,0.00443066651146951,0.0201895807740492,0.0375577934990097,7.29772373237359e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,29438,0.034522454508099,0.00530992155965566,0.0241150082511739,0.0449299007650241,8.07957384414656e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29457,0.0249961278863193,0.00384999430912889,0.0174501390404267,0.032542116732212,8.57604829688238e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,24172,0.0187758609771845,0.00289174397692168,0.013108042782418,0.0244436791719509,8.58236283132183e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,24840,0.0163950652537281,0.00252587938256398,0.0114443416639027,0.0213457888435535,8.69729080003604e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,28769,0.0194910905104852,0.00300578502330176,0.0135997518648138,0.0253824291561567,9.04542302228481e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,28792,0.0207650334720616,0.00320296729845547,0.0144872175670888,0.0270428493770343,9.13344795242714e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29540,0.0126292021328438,0.00194866750477909,0.00880981382347679,0.0164485904422108,9.25870267907815e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24863,0.0208997023654304,0.0032255907898507,0.0145775444173231,0.0272218603135378,9.38487604982221e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,29689,0.00991611722853036,0.00153207349032867,0.00691325318748617,0.0129189812695745,9.79938809209567e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24190,0.0292572727385634,0.00452020417787324,0.0203976725499318,0.0381168729271949,9.82059476903015e-11
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24863,0.0287212529906773,0.00443951382487918,0.0200198058939141,0.0374227000874405,1.00184563378407e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24800,0.0205020841434182,0.00317173423942762,0.0142854850341401,0.0267186832526964,1.03868198147765e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24863,0.0456992235308091,0.00708292326822442,0.0318166939250893,0.059581753136529,1.1239465790259e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24224,0.0254311122393403,0.00394668483695335,0.0176956099589117,0.0331666145197688,1.18815944652387e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,28792,0.0173081572476057,0.00268666737796325,0.0120422891867977,0.0225740253084136,1.19580888856251e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,29344,0.0484987198049415,0.00753090560432057,0.0337381448204732,0.0632592947894098,1.2135428804205e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24840,0.0177630694266669,0.00275941563311438,0.0123546147857628,0.0231715240675711,1.23873004938586e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29531,-0.0275984681496639,0.00428909302309948,-0.0360050904749388,-0.0191918458243889,1.25720016045371e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29815,0.0304373369884824,0.00474899880868507,0.0211292993234597,0.0397453746535051,1.48458884768998e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,24933,0.0477319062449235,0.00745949473595907,0.0331112965624437,0.0623525159274033,1.59372764635215e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24224,0.0130528088326957,0.00204054625423092,0.00905333817440304,0.0170522794909883,1.61647463755366e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29429,0.0198537888494366,0.0031048743358368,0.0137682351511965,0.0259393425476767,1.63602590786221e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29429,0.0241371633704599,0.00377808214084941,0.0167321223743951,0.0315422043665248,1.69763638422696e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29720,0.0136359172951227,0.00213491120394022,0.00945149133539988,0.0178203432548455,1.71546271557124e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28792,0.0209044328795052,0.00327322496538771,0.0144889119473453,0.0273199538116652,1.72320826939311e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29344,0.00921164985269562,0.00144250490705442,0.00638434023486895,0.0120389594705223,1.72974452161367e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24759,0.0172981210357501,0.0027135422471155,0.0119795782314038,0.0226166638400965,1.86507349308866e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,29213,0.0147843415444224,0.00232079784153467,0.0102355777750144,0.0193331053138303,1.91379172236808e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,24376,0.0218925357259508,0.0034365385197361,0.015156920227268,0.0286281512246335,1.91754372181292e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29397,0.0234797091643823,0.00368803489322886,0.0162511607736537,0.0307082575551108,1.96300944692231e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,29590,0.0286542571747364,0.00450369169263265,0.0198270214571764,0.0374814928922964,2.01538466724474e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,24840,0.031787442532862,0.00499648138228617,0.0219943390235812,0.0415805460421429,2.02660980826782e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24235,0.0321788822338312,0.00506040666251771,0.0222604851752964,0.0420972792923659,2.06759166169352e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,29627,0.0203630709528266,0.00320458828877235,0.0140820779068328,0.0266440639988204,2.12353091973712e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,29815,0.00999316636811416,0.00157443061926439,0.00690728235435594,0.0130790503818724,2.22475509137132e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29781,0.0247471606376909,0.00390189609082304,0.0170994442996778,0.0323948769757041,2.29544601553469e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,29374,0.0432664574201308,0.00683146059810243,0.02987679464785,0.0566561201924116,2.43266639953416e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,24840,0.0233215292201898,0.00368403886816952,0.0161008130385775,0.0305422454018021,2.48667990817139e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEP,Leptin,29473,0.0281040778557668,0.00444740816072725,0.0193871578607414,0.0368209978507923,2.66672062760628e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,24788,0.0185922359539605,0.00294536972350975,0.0128193112958814,0.0243651606120397,2.79466633191619e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,24224,0.040618301259893,0.00643913221944521,0.0279976021097804,0.0532390004100057,2.87478618285483e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29283,0.00937208813413534,0.00149132090395763,0.00644909916237838,0.0122950771058923,3.33710320762901e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28792,0.0241069612278741,0.00383602307467603,0.0165883560015091,0.0316255664542391,3.33914049361662e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24863,0.0275342364890549,0.00438367505107631,0.0189422333889454,0.0361262395891645,3.41786645981178e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,24224,0.0178653978653856,0.00284459824415957,0.0122899853068329,0.0234408104239384,3.43300828759699e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24376,0.0285098795830465,0.00454387850383941,0.0196038777155212,0.0374158814505717,3.57007595826995e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24190,0.0257790792487594,0.0041132944462522,0.0177170221341051,0.0338411363634137,3.73663015564878e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28911,0.0224369295328781,0.00358674966434813,0.0154069001907557,0.0294669588750004,4.01780431487191e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,24788,0.0218730037857441,0.00349756745300419,0.0150177715778559,0.0287282359936324,4.07188305717495e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',24106,0.0178375697365113,0.00285436059729006,0.0122430229658228,0.0234321165071998,4.19376731804647e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24235,0.0307220104819461,0.00492026752305974,0.021078286136749,0.0403657348271431,4.33680824429735e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,24800,-0.0413989667327684,0.00663166898897135,-0.0543970379511522,-0.0284008955143845,4.37285766705647e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24788,0.0298108387343794,0.0047756943317478,0.0204504778441537,0.0391711996246051,4.38454113277334e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,29561,0.0132183685453763,0.00212012584600847,0.00906292188719969,0.0173738152035529,4.58734356643564e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,24863,0.0198520680205933,0.00318521378351957,0.0136090490048949,0.0260950870362916,4.6621583656862e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28769,0.0277386802280463,0.0044544360935228,0.0190079854847416,0.036469374971351,4.813978258154e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29158,0.045918545173563,0.00737705194615382,0.0314595233591015,0.0603775669880244,4.89635121600317e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,28792,0.0228292355889361,0.00366765577522113,0.0156406302695027,0.0300178409083696,4.8983001048197e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24863,0.0158034569198296,0.00253884117925066,0.0108273282084983,0.0207795856311609,4.90274498737147e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28792,0.0189862202101477,0.00305749356191239,0.0129935328287994,0.0249789075914959,5.37995585692596e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24788,0.0144789267209741,0.00233198251637494,0.00990824098887926,0.019049612453069,5.42214605692013e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29429,0.0251021169772688,0.00404342793944642,0.0171769982159538,0.0330272357385838,5.43353667314721e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24840,0.0283991244919419,0.00458200383001715,0.0194183969851082,0.0373798519987755,5.80956884033434e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24440,0.0202963380134272,0.0032814610055774,0.0138646744424955,0.0267280015843589,6.30264332477777e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24235,0.0223061285493394,0.00360839265046748,0.0152336789544231,0.0293785781442556,6.44127739673691e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24376,0.0319119484085054,0.00517117421705868,0.0217764469430704,0.0420474498739405,6.88757789010818e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28792,0.0244386598073037,0.00396876710285082,0.0166598762857161,0.0322174433288913,7.47628125614442e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,29589,0.0190002230175413,0.00308625954666294,0.0129511543060819,0.0250492917290007,7.537710763041e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,24190,0.0329767985439133,0.00536641263605692,0.0224586297772417,0.0434949673105849,8.11943611627354e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,24235,0.0388202453209304,0.00632554673681533,0.0264221737167724,0.0512183169250885,8.53680211244554e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,24235,0.0154327778880808,0.00251579924487333,0.0105018113681291,0.0203637444080325,8.68356462554138e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24106,0.0253028144019464,0.00412541805398372,0.0172169950161383,0.0333886337877545,8.73623530006251e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29344,0.0276257283365398,0.00450573491941202,0.0187944878944923,0.0364569687785874,8.83101308203074e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,29755,0.0213565752237396,0.00348326828566685,0.0145293693838325,0.0281837810636466,8.83214148308691e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29429,0.0193789771047701,0.00316094596160014,0.0131835230200338,0.0255744311895063,8.85759330415406e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,29438,0.0233517859136483,0.00380902292921571,0.0158861009723855,0.030817470854911,8.86326380120168e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29429,0.0249461449892656,0.00406999673033045,0.0169689513978179,0.0329233385807133,8.93990644576136e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24800,0.0205700565537528,0.00335624224345273,0.0139918217565854,0.0271482913509201,8.98258163914458e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,29213,0.0358862615183717,0.00585632136398536,0.0244078716449604,0.047364651391783,9.02511900888382e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,24815,0.0442166947276953,0.00721562998003441,0.0300740599668279,0.0583593294885628,9.03847639152569e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24800,0.0207109384765894,0.00338279645096329,0.0140806574327014,0.0273412195204775,9.35421255846027e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,29281,0.0186217394192472,0.00304185653270269,0.0126597006151499,0.0245837782233444,9.36794291976561e-10
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24800,0.0190539420008727,0.00311998225426743,0.0129387767825085,0.0251691072192368,1.0298727061657e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,29781,-0.0114573242607824,0.00187620287437546,-0.0151346818945583,-0.00777996662700653,1.02998599121773e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,24917,0.0216028412815705,0.00353961705024487,0.0146651918630906,0.0285404907000505,1.05528212574757e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28911,0.0377680930919181,0.00619112883164502,0.0256334805818938,0.0499027056019423,1.07174876635992e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,24946,0.00985654327202948,0.00161584564523895,0.00668948580736114,0.0130236007366978,1.07677132836284e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,28926,0.0116701620196051,0.00191365360139625,0.00791940096086846,0.0154209230783417,1.08514580646943e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,29720,0.0261817706218291,0.00429343324779923,0.0177666414561426,0.0345968997875156,1.08661524518458e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24800,0.0240312751426447,0.00394275239669581,0.0163034804451209,0.0317590698401685,1.11017070736696e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,24235,0.0310616340092653,0.00509871372433069,0.0210681551095771,0.0410551129089534,1.13151879921291e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24933,-0.00938132167484178,0.00154172012122042,-0.0124030931124338,-0.00635955023724977,1.18211444290126e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29429,0.0369177312544908,0.00606828748802067,0.0250238877779703,0.0488115747310113,1.18877201466342e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRELP,Prolargin,29449,0.00937774810563566,0.0015416744779958,0.00635606612876388,0.0123994300825074,1.19531516025452e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,29429,0.0192416621775018,0.00316494698106245,0.0130383660946194,0.0254449582603842,1.21952204440776e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,29429,0.0156135910555058,0.00257209733376672,0.010572280281323,0.0206549018296885,1.29173210002147e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24376,0.0087889807617218,0.00144888573808339,0.00594916471507836,0.0116287968083652,1.33044525954988e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,29130,0.0138029898624444,0.00227620269735578,0.00934163257562703,0.0182643471492617,1.34374790106036e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,24800,0.028357741221405,0.00467788087707993,0.0191890947023284,0.0375263877404817,1.36303570582966e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28792,0.0203104898965784,0.00335090295101072,0.0137427201125974,0.0268782596805594,1.36788861029969e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29720,0.0157062513585102,0.00259187470428078,0.0106261769381199,0.0207863257789005,1.37926329779141e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24106,0.0278206109355268,0.00459097166738817,0.0188223064674459,0.0368189154036076,1.38268503723218e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,28769,0.0148655941119021,0.00245497124795497,0.0100538504659103,0.0196773377578938,1.41889633795974e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,24811,0.0339183733278825,0.00560151659634872,0.022939400799039,0.0448973458567259,1.42248005481981e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,29531,0.0347272098208973,0.00574101459152501,0.0234748212215083,0.0459795984202863,1.47528591660979e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,24376,0.0337026515028346,0.0055779324415117,0.0227699039174716,0.0446353990881975,1.54289339810778e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28769,0.0111857345172291,0.00185165928643008,0.00755648231582613,0.0148149867186321,1.55113568802649e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,29421,0.0336130704720367,0.00557033082400233,0.0226952220569921,0.0445309188870812,1.61556149320749e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,24096,0.0218336331797464,0.00361839783989224,0.0147415734135577,0.0289256929459352,1.62224201208952e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,28769,0.0244724886987754,0.00406704125252915,0.0165010878438183,0.0324438895537325,1.79525452233454e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,29213,0.0151999248486446,0.00252736023572558,0.0102462987866224,0.0201535509106667,1.82979648068717e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,24106,0.0146869288666059,0.00244447104873831,0.00989576561107879,0.019478092122133,1.90258709270285e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24440,0.0223491489970099,0.00372386979054606,0.0150503642075397,0.0296479337864802,1.98145112982077e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,28792,0.0294964806249176,0.00492622280444126,0.0198410839282127,0.0391518773216225,2.15420311431618e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,29338,0.0122336099851241,0.00204348101983316,0.00822838718625115,0.0162388327839971,2.16691745313257e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,29213,0.0268792957626893,0.00449102979966295,0.01807687735535,0.0356817141700287,2.18766578999304e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24788,0.0203264747783163,0.00339657464580778,0.013669188472533,0.0269837610840995,2.20167324404348e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24106,0.0198135059258812,0.00331187662779796,0.0133222277353972,0.0263047841163652,2.2275519190703e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,24863,0.0308519339435557,0.0051588822043146,0.0207405248230991,0.0409633430640123,2.25696736064519e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,29428,0.0118055167710376,0.00197528139645314,0.00793396523398947,0.0156770683080858,2.30427422641337e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,24863,0.0263328936931537,0.00441102703085322,0.0176872807126814,0.034978506673626,2.40785560410847e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24440,0.0210478702131513,0.00352910041146137,0.014130833406687,0.0279649070196155,2.49384671729599e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,29781,0.0137413249813444,0.00230423593578159,0.00922502254721244,0.0182576274154763,2.49663865184122e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24788,-0.0149747179685193,0.002512441915833,-0.019899104123552,-0.0100503318134866,2.55297531803897e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28911,0.036211974812167,0.00608230628952998,0.0242906544846883,0.0481332951396458,2.65237660552711e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,29429,0.0320652916411179,0.00539579210516271,0.021489539114999,0.0426410441672368,2.83608988521652e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,29727,0.02705266856208,0.00456496967330537,0.0181053280024015,0.0360000091217585,3.13545761636945e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,29429,0.0240766911274401,0.00406577442520826,0.0161077732540319,0.0320456090008483,3.21974968838451e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24224,0.0313509869833742,0.00529985657014353,0.0209632681058929,0.0417387058608555,3.35435183912296e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,28926,0.0258568104559573,0.00437548852813012,0.0172808529408222,0.0344327679710923,3.47056301592285e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28911,0.0203664313875777,0.00344904943938732,0.0136062944863785,0.0271265682887768,3.56713956557471e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29421,0.0239277586473679,0.00405367528930169,0.0159825550803366,0.0318729622143992,3.61448436865011e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGRN,Neugrin,24840,0.00865399160342744,0.00146682896595031,0.00577900683016483,0.0115289763766901,3.68669973727473e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BGN,Biglycan,28745,-0.0467829067992799,0.00793302669167415,-0.0623316391149612,-0.0312341744835985,3.73778655780937e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,24961,0.0118488658089877,0.0020096454856794,0.00790996065705605,0.0157877709609193,3.77216214100937e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,29018,0.0293246976157138,0.00497394115014154,0.0195757729614363,0.0390736222699912,3.77298866856713e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24376,0.00892631739826262,0.0015140622603703,0.00595875536793683,0.0118938794285884,3.78223363994878e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,24817,0.0379158169700727,0.00643919114051897,0.0252950023346555,0.0505366316054899,3.9524007648141e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24840,0.01493364403122,0.00254036129521238,0.00995453589260377,0.0199127521698363,4.19163255090374e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28911,0.0325475997099062,0.00554049787645695,0.0216882238720505,0.0434069755477618,4.28788832277714e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,24796,0.0125040411603987,0.00212862772863376,0.00833193081227653,0.0166761515085209,4.30247065909924e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,24840,0.041683772864847,0.00710850395260881,0.0277511051177338,0.0556164406119603,4.57759181823099e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,24235,0.0183087869994999,0.00312655124439581,0.0121807465604841,0.0244368274385157,4.8054301420491e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,29689,-0.0121935876515647,0.00208350206026588,-0.0162772516896859,-0.0081099236134436,4.89475716829227e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24440,0.0409578109152405,0.00700983823882558,0.0272185279671423,0.0546970938633386,5.1949489554415e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,24376,0.00827036183140821,0.00141570241842426,0.00549558509129666,0.0110451385715198,5.22715409483758e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28926,0.0230796110145034,0.00396249698426567,0.0153131169253426,0.0308461051036641,5.78856991693685e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,24376,0.0195477917319691,0.00335861701041493,0.0129649023915558,0.0261306810723823,5.95169469011367e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24235,0.0108228545712788,0.00185970964022145,0.00717782367644472,0.0144678854661128,5.97147603996709e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,29576,0.00811207487001481,0.00139407032952044,0.00537969702415473,0.0108444527158749,5.9816144290684e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24235,0.0281327263565883,0.00485276777580051,0.0186213015160193,0.0376441511971573,6.82461231143677e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,29576,0.0155852322615483,0.00268976164736943,0.0103132994327042,0.0208571650903923,6.93104276680201e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,29429,0.0349761892694355,0.00605562894033626,0.0231071565463764,0.0468452219924945,7.73522542381101e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29344,0.0106803696283064,0.00185131401758435,0.00705179415384107,0.0143089451027717,8.05084317605279e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24106,0.0284256444624615,0.00492788023644561,0.0187669991990281,0.0380842897258949,8.10398905543521e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24800,0.0317071735233217,0.00550786555594242,0.0209117570336745,0.0425025900129688,8.67818733297666e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,28485,0.0100344441697041,0.00174433837804136,0.00661554094874308,0.0134533473906652,8.87917231998551e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,29074,0.0144841584246224,0.00252432226835641,0.00953648677864384,0.0194318300706009,9.68431935899011e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,24106,-0.0290921173112346,0.00507231292693363,-0.0390338506480245,-0.0191503839744447,9.84035511048309e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24391,0.0247223824083709,0.00431127280984777,0.0162722877010693,0.0331724771156725,9.90387025966693e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,29720,0.0485634104845473,0.00847177170788685,0.0319587379370891,0.0651680830320056,9.99893301686916e-09
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29213,0.0220729924516781,0.00385370042252585,0.0145197396235274,0.0296262452798287,1.0277615445969e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28792,0.0219186081797149,0.00382829573900417,0.0144151485312667,0.029422067828163,1.04202506540896e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29720,0.0127518372721316,0.00222787029883429,0.00838521148641645,0.0171184630578468,1.05182101924408e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTD,Biotinidase,24961,0.00784136678952243,0.00136992527911685,0.00515631324245339,0.0105264203365915,1.05275921070859e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,29438,0.0277573168494187,0.0048521479102878,0.0182471069452546,0.0372675267535828,1.07161387340486e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24917,0.00956999615382635,0.00167341302453121,0.00629010662574518,0.0128498856819075,1.08475245471699e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29473,0.0328537842856176,0.00575245524932383,0.0215789719969429,0.0441285965742923,1.13219084137821e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,29492,0.0125869425861716,0.00220534856549806,0.00826445939779539,0.0169094257745478,1.15772391557754e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BSG,Basigin,29755,0.00775526876750407,0.00136033994439108,0.00508900247649756,0.0104215350585106,1.20248164848171e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29429,0.0229837338849147,0.00404045653684188,0.0150644390727046,0.0309030286971248,1.29450647485257e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,29288,0.0211040766861184,0.00371274057737689,0.0138271051544597,0.0283810482177771,1.32650359985552e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,29339,0.0329942844868197,0.00580924565769812,0.0216081629977314,0.044380405975908,1.36273465394493e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29449,0.0195649611443934,0.00344511807094475,0.0128125297253417,0.0263173925634452,1.3672828689625e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,28769,0.0255602826625173,0.00450304803632778,0.0167343085113149,0.0343862568137198,1.39029589907569e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,29752,0.0172977257623833,0.00305413254405717,0.0113116259760312,0.0232838255487353,1.49498936636862e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,24376,-0.0350489220669697,0.00619391341297984,-0.0471889923564102,-0.0229088517775292,1.54319230841597e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,24917,0.0211304320153109,0.00373597229467246,0.0138079263177529,0.0284529377128689,1.56694801693486e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,24190,0.018420264639984,0.00326019568328541,0.0120302811007446,0.0248102481792234,1.62205741596251e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24676,0.0225806279000976,0.0040045085322702,0.014731791176848,0.0304294646233472,1.73110509106408e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29344,0.0202049792896785,0.003584195902792,0.0131799553202062,0.0272300032591508,1.74381257304159e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,29781,-0.0147821621249943,0.00262267797406927,-0.01992261095417,-0.00964171329581849,1.75327342408997e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24440,0.0248479724155775,0.00440994373568739,0.0162044826936302,0.0334914621375248,1.77465999153152e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28714,0.0178563110807547,0.00317643764202403,0.0116304933023876,0.0240821288591218,1.91074532534189e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24840,0.0328531755977509,0.0058475855004866,0.0213919080167971,0.0443144431787046,1.94971180152927e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KAZN,Kazrin,24800,0.0386957858790551,0.00689455389149623,0.0251824602517225,0.0522091115063877,2.01537511525872e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,24788,0.0133738113565387,0.00238511818852605,0.00869897970702766,0.0180486430060498,2.0782751994822e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29815,0.0118145932657222,0.00210742559416958,0.00768403910114983,0.0159451474302946,2.08677297963102e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24224,0.0207764690481863,0.00370808990797455,0.0135086128285562,0.0280443252678164,2.12948887651713e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28926,0.0248550277994941,0.0044365716704906,0.0161593473253326,0.0335507082736557,2.13442258389147e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,24946,0.0269554016966375,0.00481811596221831,0.0175118944106896,0.0363989089825854,2.23458422818453e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,24828,0.0115923183812814,0.00207852106914575,0.00751841708575569,0.015666219676807,2.46972045956729e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,29635,0.0266615989285997,0.00479327063540697,0.0172667884832021,0.0360564093739974,2.68541908127819e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,24224,0.0163155044026075,0.00293566852506499,0.0105615940934802,0.0220694147117349,2.76263143399852e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24840,0.0880480433978555,0.0158488217346801,0.0569843527978824,0.119111733997829,2.79664207640989e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24863,0.0249950821528311,0.00450533725361106,0.0161646211357534,0.0338255431699088,2.92095103857744e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28911,0.011687552294936,0.0021099857794007,0.00755198016731067,0.0158231244225614,3.0656719421663e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24840,0.0146990782893753,0.00265934717626617,0.00948675782389359,0.019911398754857,3.2841610390266e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28792,0.0173557053104614,0.00314345041480614,0.0111945424974413,0.0235168681234814,3.39543349706703e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,29406,0.0221223071942636,0.00400725627132222,0.014268084902472,0.0299765294860551,3.40769502824718e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,24840,0.0353140285343347,0.00640495379037148,0.0227603191052066,0.0478677379634628,3.55168053016995e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,29288,0.0259185654071915,0.00470374985528807,0.0166992156908268,0.0351379151235561,3.61458199155031e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,24106,0.0144707146013094,0.00262971849598091,0.0093164663491868,0.019624962853432,3.77692726117253e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24863,0.0172887730497237,0.00314461752181122,0.0111253227069737,0.0234522233924737,3.88133576254842e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,29429,-0.0124720369905034,0.0022690299753472,-0.0169193357421839,-0.0080247382388229,3.90310081291402e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24440,0.0273267629580718,0.00497386120268992,0.0175779950007995,0.037075530915344,3.96683582018648e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23845,0.0120544113313869,0.00219530655766163,0.00775161047837007,0.0163572121844037,4.03760358414859e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24800,-0.0109782975413773,0.00199988072726346,-0.0148980637668136,-0.00705853131594086,4.07077825036266e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,29689,0.0103503144382777,0.001890693435116,0.00664455530545037,0.0140560735711051,4.42677852785976e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,29561,0.0248607806963524,0.00454985551775682,0.0159430638815491,0.0337784975111558,4.69064131594992e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,28586,0.0305169760910948,0.00558567294731577,0.0195690571143559,0.0414648950678337,4.70896131607841e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29689,0.00998016618959048,0.00182745304009147,0.0063983582310112,0.0135619741481698,4.76601133180056e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,24190,0.019550869253336,0.00358361777627501,0.012526978411837,0.026574760094835,4.92799560836623e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24917,0.0108584691305708,0.00199237276628537,0.0069534185086515,0.0147635197524901,5.08420701092339e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,29344,0.0251049375023174,0.00462113673388164,0.0160475095039094,0.0341623655007255,5.59699952418144e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,29429,0.030703441383123,0.00565284985998568,0.0196238556575511,0.041783027108695,5.63254797242546e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,24235,0.010720402264866,0.00197380017171549,0.00685175392830367,0.0145890506014284,5.64669983174515e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24788,0.0188267498839004,0.00347008615403353,0.0120253810219947,0.0256281187458061,5.83528794228925e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,28769,0.0261271723685145,0.0048231457692808,0.0166738066607242,0.0355805380763049,6.10796213854232e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29429,-0.00871423904152066,0.00160983695414698,-0.0118695194716487,-0.00555895861139258,6.24202598413592e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24796,0.0137367312959992,0.00254317738576141,0.00875210361990682,0.0187213589720915,6.67293972553332e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,24190,0.0213424081181738,0.00395801479793142,0.0135846991142282,0.0291001171221194,7.02524391974403e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28792,0.0326689939307043,0.00607139499564441,0.0207690597392413,0.0445689281221674,7.4732063946755e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,24917,0.0229042041141251,0.00425925016359168,0.0145560737934854,0.0312523344347647,7.61984641961557e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,28792,0.0309790244612936,0.00576265791636349,0.0196842149452212,0.0422738339773661,7.68267543554266e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,29025,-0.0103955124369385,0.00193402587609505,-0.0141862031540848,-0.00660482171979222,7.71457280327928e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,29720,-0.0162592112441691,0.00303036618768111,-0.0221987289720241,-0.0103196935163142,8.13612489352489e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,24788,0.0115306435675889,0.00214934271029977,0.00731793185540133,0.0157433552797764,8.17971203680772e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,29720,0.0101529676058301,0.00189304546837898,0.00644259848780727,0.0138633367238529,8.23258041824398e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29449,0.0105023037935776,0.00195847233408657,0.00666369801876792,0.0143409095683873,8.26968580463507e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24863,0.0136705864003817,0.00254958449948386,0.00867340078139333,0.0186677720193701,8.30911789601079e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24235,0.0117030189141782,0.0021830215299282,0.00742429671551894,0.0159817411128375,8.35531699341218e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,24800,0.024341501455415,0.00454971482559971,0.0154240603972396,0.0332589425135904,8.86772305833291e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,24961,0.00916399424825206,0.00171342296960707,0.0058056852278222,0.0125223032686819,8.95380720170393e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28638,0.0194757553343021,0.00364423737515675,0.0123330500789948,0.0266184605896093,9.14804017209573e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTR,Transthyretin,24702,0.00896671302903413,0.00167912918496382,0.00567561982650503,0.0122578062315632,9.37176575470292e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,29260,0.00813521792884859,0.00152356427069958,0.00514903195827741,0.0111214038994198,9.38480723595825e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,29213,0.015158499250449,0.00284103925962048,0.00959006230159282,0.0207269361993051,9.59657588309241e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24788,0.038061866472417,0.00713708887898429,0.0240731722696078,0.0520505606752262,9.74667632371149e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,29344,-0.030374243932513,0.00569818189453953,-0.0415426804458105,-0.0192058074192155,9.86576131478257e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28792,0.0159887558810123,0.00299973418090446,0.0101092768864396,0.021868234875585,9.89201177720873e-08
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24863,0.0219205009404805,0.00411461658329887,0.0138558524372147,0.0299851494437463,1.00455916729124e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24933,0.012766635175816,0.00239807768228208,0.00806640291854312,0.0174668674330889,1.02559668886008e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,29473,-0.0131319401213218,0.00247170149934649,-0.017976475060041,-0.00828740518260271,1.08668128434533e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,29429,0.0285019771965246,0.00537031771153604,0.0179761544819139,0.0390277999111352,1.12055873885459e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,29308,0.0243960343874982,0.00460926827409735,0.0153618685702674,0.0334302002047291,1.21309461401594e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,24190,0.0284072469653519,0.0053753454952525,0.017871569794657,0.0389429241360468,1.26981618910494e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24863,0.0230041269305322,0.00435537335011271,0.0144675951643113,0.0315406586967531,1.29010509631368e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29385,0.0175545759851598,0.00332693018147761,0.0110337928294637,0.0240753591408559,1.32601266652829e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24917,0.0114260786455223,0.0021658829080117,0.00718094814581935,0.0156712091452252,1.33513120748314e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24933,-0.0098013213130471,0.00185801257856045,-0.0134430259670256,-0.00615961665906861,1.3374457025136e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,24863,0.0231247059682617,0.00438502813200572,0.0145300508295305,0.031719361106993,1.34921791930397e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29473,0.00989094117259649,0.00187822042213054,0.00620962914522062,0.0135722531999724,1.40311232818397e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24235,0.0146999025501498,0.00279151590407288,0.00922853137816696,0.0201712737221327,1.40678154074095e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,24224,0.0116119905844705,0.00220916217715331,0.00728203271725,0.015941948451691,1.48238471012143e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,29344,0.00732341263439607,0.00139616912495098,0.00458692114949215,0.0100599041193,1.57057312512386e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,24106,0.0177200029628276,0.00337857890058512,0.0110979883176808,0.0243420176079744,1.57764855590958e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,28792,0.0193944540415765,0.00370036053042741,0.0121417474019388,0.0266471606812142,1.60630574486347e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,29473,0.0147844969036879,0.00282112013972811,0.00925510142982078,0.020313892377555,1.61114833736495e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,24235,-0.0253070981859129,0.00483623372390661,-0.0347861162847699,-0.015828080087056,1.68341021371396e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24840,0.0165354308798944,0.00316012920917657,0.0103415776299083,0.0227292841298804,1.68574656166789e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,24840,0.0472638304733525,0.00903600194804269,0.0295532666551888,0.0649743942915161,1.70318560932699e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,24961,0.014355403599291,0.00275088783656812,0.00896366343961752,0.0197471437589645,1.81857585835468e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPARC,SPARC,29561,0.0242964849976823,0.00465929567192429,0.0151642654807107,0.0334287045146539,1.85427635622992e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PI3,Elafin,29009,0.0190115990109745,0.00364621662760392,0.0118650144208709,0.0261581836010782,1.86016104636488e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29213,0.0359892602963209,0.00692458859838357,0.0224170666434891,0.0495614539491527,2.03547867790529e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28714,0.0228111324104835,0.00439195286203393,0.014202904800897,0.03141936002007,2.07397248428006e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,24706,0.0166301190886567,0.00320280401873451,0.0103526232119371,0.0229076149653764,2.09287531563121e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,28348,0.0108303278787161,0.0020876657345423,0.0067385030390132,0.014922152718419,2.14292084655365e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,24946,0.00945975302916791,0.00182369884637707,0.00588530329026886,0.013034202768067,2.15235151277422e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24574,0.00896187224098471,0.00173143946761986,0.00556825088444978,0.0123554935975196,2.28518567228896e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,29492,0.0101928846156106,0.00197121224937261,0.00632930860684026,0.0140564606243809,2.34526091759406e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29540,0.00936580859293786,0.00181129220249083,0.00581567587605585,0.0129159413098199,2.3462752694019e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24440,0.0231933731479604,0.00448679404170893,0.0143992568262109,0.0319874894697099,2.36881904933534e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,29451,0.0218522578455764,0.00423414224727096,0.0135533390409254,0.0301511766502275,2.47274791947843e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29576,0.01394383367883,0.00270207150125922,0.00864777353636194,0.0192398938212981,2.47982849635213e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24235,0.0148368864419283,0.00288022621695796,0.00919164305669071,0.0204821298271659,2.60724269814155e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,24605,0.0366805576747923,0.0071609927984782,0.022645011789775,0.0507161035598096,3.04153324628171e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,24788,0.0336104826827704,0.00656862574444772,0.0207359762236528,0.0464849891418879,3.13046362954466e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,24224,0.0119057048769534,0.00232915957104523,0.00734055211770478,0.0164708576362021,3.2189084102414e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29373,0.0137698660884467,0.00269945103409182,0.00847894206162675,0.0190607901152667,3.39986620030297e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24235,-0.0118342874210663,0.0023219984521623,-0.0163854043873044,-0.00728317045482817,3.48414633018786e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24800,0.0365412444209104,0.00718044886705668,0.0224675646414793,0.0506149242003415,3.62600660782259e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,29720,0.012948878457712,0.0025460886094249,0.00795854478323919,0.0179392121321848,3.6831777045452e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,24840,0.0207662725883058,0.00408564416973328,0.0127584100156286,0.028774135160983,3.74725095638449e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24863,0.0156771143845194,0.00308840210696021,0.00962384625487741,0.0217303825141614,3.87988398333567e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24096,0.020772327807464,0.00409494333325703,0.0127462388742803,0.0287984167406478,3.95167992413187e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,28792,0.0328972438100191,0.00648744124740369,0.0201818589651078,0.0456126286549303,3.98368368072217e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24376,0.025386833069828,0.00501058445863892,0.0155660875308957,0.0352075786087603,4.07853681500732e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,28669,0.0150605819624215,0.00297357217527682,0.00923238049887893,0.0208887834259641,4.11338674604253e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,24224,0.0145607303419869,0.00287804975332512,0.0089197528254697,0.0202017078585042,4.24017665513649e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,28926,0.0168135749249298,0.00332597237642865,0.0102946690671297,0.02333248078273,4.32480196147529e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24863,0.0141367884552037,0.00279915427596719,0.00865044607430803,0.0196231308360994,4.44053449635139e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,24235,0.0106675415060621,0.00211240851992765,0.00652722080700392,0.0148078622051203,4.45148302257005e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28792,0.0158494187602018,0.00314057936257586,0.00969388320955312,0.0220049543108505,4.52349769058836e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29158,0.0244139755812348,0.0048391171615702,0.0149293059445572,0.0338986452179124,4.55933192375285e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,29613,-0.0138494358171951,0.00274530839483779,-0.0192302402710771,-0.00846863136331298,4.56761736034559e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,24933,0.0276792535550221,0.0054960443216157,0.0169070066846553,0.0384515004253889,4.78142378215424e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,29815,0.0185570758908698,0.00368678442451387,0.0113309784188226,0.025783173362917,4.84648767127207e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29213,0.0118445900977594,0.00235400614227887,0.00723073805889281,0.016458442136626,4.89099980824177e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24863,0.0207975151915499,0.00413958805794815,0.0126839225979715,0.0289111077851283,5.09424961499342e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,29473,0.0255967530168354,0.00509915586420543,0.0156024075229927,0.035591098510678,5.20259703065248e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,24933,0.0293893087911644,0.00586048153039081,0.0179027649915984,0.0408758525907304,5.34450238730144e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,29438,-0.00895469475643091,0.00178621104814791,-0.0124556684108008,-0.00545372110206101,5.38330967454746e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24235,0.0229416365015986,0.00458355859425749,0.0139578616568539,0.0319254113463432,5.61945031817095e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,24235,0.0189743614345979,0.00379125271209618,0.0115435061188894,0.0264052167503064,5.63194819776097e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,24933,0.0171534627380419,0.00342862674213025,0.0104333543234666,0.0238735711526172,5.68249790887839e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,28926,0.0179551895907775,0.00358962539969256,0.01091952380738,0.0249908553741749,5.70802915767301e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29473,0.0241965012334391,0.00485053577532816,0.0146894511137959,0.0337035513530823,6.12216711148147e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,24224,0.0176996029857542,0.00355359656670052,0.0107345537150212,0.0246646522564872,6.37715113227316e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,24235,0.0210810875990532,0.00423557501746653,0.0127793605648188,0.0293828146332876,6.49701002435933e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24106,0.0222673575119814,0.00447663818591362,0.0134931466675907,0.0310415683563721,6.59937749524805e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,28792,0.0239799325892572,0.00482193107524249,0.014528947681782,0.0334309174967325,6.62704306552492e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,29692,0.0087323246345289,0.00175776452029971,0.00528710617474146,0.0121775430943163,6.80723729007012e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29336,0.0114654835922749,0.00230987135061274,0.00693813574507397,0.0159928314394759,6.95540453973667e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,24863,0.0181314306668582,0.00365744170318796,0.0109628449286098,0.0253000164051066,7.19099859059518e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,24828,0.00847112278001321,0.00171106194092307,0.005117441375804,0.0118248041842224,7.43941834381317e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,29561,0.027120000766114,0.00548408124905818,0.01637120151796,0.0378688000142681,7.64738008385964e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28926,0.0119229598704433,0.00241525967119728,0.00718905091489658,0.0166568688259899,7.99742724074635e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24917,0.0096298634664842,0.00195343344537979,0.00580113391353981,0.0134585930194286,8.28802769480625e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28769,0.01251327803905,0.00253879813504395,0.00753723369436384,0.0174893223837361,8.31878126403148e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29537,0.0100876336047818,0.0020491501253385,0.00607129935911839,0.0141039678504453,8.57578350665962e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29377,0.00831287713407567,0.00169029871539727,0.00499989165189702,0.0116258626162543,8.79080322354638e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29720,0.0125008481028946,0.00254430622421249,0.00751400790343818,0.0174876883023511,9.00486782922532e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28911,0.0186900436537601,0.00381632021391809,0.0112100560344806,0.0261700312730396,9.76375232815542e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,28792,0.018831141193967,0.00384743709963256,0.0112901644786872,0.0263721179092468,9.91071390404266e-07
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,24106,0.0216117829537692,0.00442146568193471,0.0129457102171771,0.0302778556903612,1.02560499901247e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24840,0.0152819079741016,0.00312916154932977,0.00914875133741525,0.0214150646107879,1.04756982156545e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,29429,0.0307055955331387,0.00629010078380729,0.0183769979968764,0.043034193069401,1.05793188627156e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24543,0.00262790381927398,0.000538676917325385,0.00157209706131623,0.00368371057723174,1.07597371727734e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,29213,0.0153019425379573,0.00313859008743305,0.00915030596658855,0.0214535791093261,1.09147536511161e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,28911,0.0106042544086017,0.0021754633396698,0.00634034626284888,0.0148681625543545,1.09673178046449e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24840,0.00718608603782645,0.00147665161858458,0.00429184886540068,0.0100803232102522,1.14303799432978e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,28790,0.0159706317192408,0.00329011203242743,0.00952201213568307,0.0224192513027986,1.21549631302461e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24224,0.0143347498381122,0.00295558156693741,0.00854180996691484,0.0201276897093095,1.24189862630192e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24235,0.0163758408627402,0.00338781612715095,0.00973572125352436,0.0230159604719561,1.34808470421853e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,29421,0.0148358569412044,0.0030707491321751,0.00881718864214124,0.0208545252402676,1.36294364266566e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24917,0.0210166640579056,0.00435977873870877,0.0124714977300364,0.0295618303857748,1.43984795612713e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,24106,0.0212658719915502,0.00441216594372955,0.0126180267418403,0.0299137172412601,1.44558415024759e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,24324,0.0119808905611646,0.00249253432242936,0.00709552328920303,0.0168662578331261,1.54350230992702e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24946,0.00825120756451007,0.00171979912213572,0.00488040128512405,0.0116220138438961,1.61366032407306e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29344,0.00994295481546407,0.00207562583417961,0.00587472818047204,0.0140111814504561,1.67311365496156e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29344,0.00761837395025648,0.00159072824056433,0.0045005465987504,0.0107362013017626,1.68233695763172e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28911,0.0106114793625708,0.00222265085718797,0.00625508368248238,0.0149678750426592,1.81265298411408e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,28792,0.0124888374471272,0.00261600486514,0.00736146791145282,0.0176162069828016,1.81478998589999e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,24961,-0.0229706449340908,0.0048133818912556,-0.0324048734409517,-0.0135364164272298,1.83213368682016e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,28926,0.0107964740588433,0.00226448501506383,0.00635808342931822,0.0152348646883684,1.87210893422806e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,28926,0.0149582583102355,0.00314266296064388,0.00879863890737349,0.0211178777130975,1.94779371474382e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,29213,0.0112114485247945,0.00235569222966312,0.00659429175465477,0.0158286052949342,1.95193736029356e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,29696,0.00751430721218629,0.00158025229772037,0.00441701270865437,0.0106116017157182,1.99247475107039e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,29429,-0.0136924919807888,0.00288343242203822,-0.0193440195279837,-0.00804096443359387,2.05714548432817e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29473,0.00892409750608719,0.00188037005888103,0.00523857219068038,0.012609622821494,2.08527827521467e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,29815,0.013953617744481,0.00294231058874234,0.00818668899054606,0.019720546498416,2.12176012953973e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,29689,0.00943016374823048,0.00198984692932673,0.00553006376675008,0.0133302637297109,2.15620652490913e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,28911,0.0191392449226528,0.00404193483282692,0.011217052650312,0.0270614371949935,2.19909949136298e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,24106,0.0114116176067488,0.00241013811412615,0.00668774690306159,0.0161354883104361,2.20474779790564e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24910,0.00776729961596393,0.00164617283372559,0.00454080086186178,0.0109937983700661,2.38998792576353e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,29449,-0.0112216289205101,0.00238334288982429,-0.0158929809845657,-0.00655027685645446,2.50858443049353e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28769,0.026590485123832,0.00564932094696272,0.0155178160677851,0.037663154179879,2.52749492618077e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24106,0.0101995264452441,0.00216764920427551,0.00595093400486411,0.0144481188856241,2.5485000155924e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,28911,0.0167085827253674,0.00355244645473437,0.00974578767408805,0.0236713777766468,2.57044034349154e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24440,0.0225598406164204,0.00480133271089686,0.0131492285030626,0.0319704527297783,2.63296948816952e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28911,-0.0160877326080448,0.0034253974655076,-0.0228015116404397,-0.00937395357564987,2.6573860772954e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,24235,0.0162611233511197,0.00346433283020907,0.00947103100390996,0.0230512156983295,2.69552425299725e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,29158,0.0192700172508158,0.00410831619478687,0.0112177175090335,0.027322316992598,2.73786153662105e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29492,0.0104509144139518,0.00223575828881195,0.00606882816788037,0.0148330006600232,2.96062257741312e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29473,0.0196191191631309,0.00419905033441036,0.0113889805076866,0.0278492578185752,2.99196811956176e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,29561,0.00819932041039496,0.00175938300515344,0.00475092972029422,0.0116477111004957,3.17066107116201e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28792,0.012223915445924,0.00262401233340442,0.00708085127245133,0.0173669796193966,3.19972771049941e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,24224,0.0137756984935744,0.0029579082191014,0.00797819838413567,0.0195731986030132,3.22173021024968e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,28926,0.035118756137816,0.00754235068704518,0.0203357487912075,0.0499017634844246,3.23516296739288e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29576,0.00830823302067439,0.00178492812689793,0.00480977389195444,0.0118066921493943,3.2592375719703e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24224,0.0150581314471078,0.00323620939654376,0.00871516102988204,0.0214011018643336,3.2884690475872e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,24933,0.0133869654373638,0.00287785768770103,0.00774636436946973,0.0190275665052578,3.30880695997871e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,24096,0.0341826723259038,0.0073526919804503,0.0197713960442212,0.0485939486075864,3.35314899463134e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,24096,0.0122409857967402,0.00263380947434359,0.00707871922702679,0.0174032523664537,3.37539945298311e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29429,0.0143775459912633,0.00310160318621164,0.0082984037462885,0.0204566882362381,3.5756758172271e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24788,0.00890495204983726,0.00192130152145895,0.00513920106777772,0.0126707030318968,3.59008684280271e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,29213,0.0101760403546782,0.00219574921226978,0.00587237189862947,0.014479708810727,3.59472470546467e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,24788,0.0106995248855936,0.00231414028404295,0.00616380992886945,0.0152352398423178,3.79145622182548e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24863,0.0179820134860416,0.0038924679970227,0.0103527762118771,0.0256112507602061,3.86232219331832e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,24788,0.0112785658126351,0.00244171070024827,0.00649281284014845,0.0160643187851217,3.87299738165848e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24883,0.0149542446923624,0.00323949737051817,0.00860482984614682,0.0213036595385781,3.92737863878568e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24788,0.01333324196026,0.00288908205728966,0.00767064112797224,0.0189958427925477,3.94980268260562e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,24106,0.0203356227172235,0.00440873129468411,0.0116945093796427,0.0289767360548044,3.99747527172408e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,28769,0.0116858416886907,0.00253392955636674,0.00671933975821185,0.0166523436191695,4.01017405730893e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24376,0.0114562834477157,0.00248657790634569,0.00658259075127813,0.0163299761441532,4.10096787974744e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29815,0.00694033435907514,0.00150654041624992,0.0039875151432253,0.00989315357492498,4.10598616699895e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,28599,0.0213043512300852,0.00462785673420771,0.0122337520310381,0.0303749504291323,4.17229843007547e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,24224,0.0191705414182377,0.00417105291170521,0.0109952777112955,0.0273458051251799,4.32661895053086e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,29110,0.0110104339230816,0.00239571131960902,0.00631483973664792,0.0157060281095153,4.32707379390057e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,24946,0.00685074463649433,0.00149214004053042,0.0039261501570547,0.00977533911593396,4.42811000334071e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29781,0.0115328943148261,0.00251507302977985,0.00660335117645765,0.0164624374531947,4.54719814861325e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNC,Tenascin,29589,0.014496573184369,0.0031623965174872,0.00829827601009414,0.020694870358644,4.57926883628823e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28733,0.017694632924693,0.00386261827879186,0.0101239010982609,0.025265364751125,4.64713520915678e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,28666,0.014406999907883,0.00314546611741172,0.008241886317756,0.0205721134980099,4.66389218735143e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,24106,0.0189253046001715,0.00413463063437984,0.010821428556787,0.027029180643556,4.73443762921237e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28792,-0.0156783912703642,0.00342731447226047,-0.0223959276359948,-0.00896085490473369,4.79254052829421e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,28714,0.0139145992292175,0.00304648948775711,0.0079434798332136,0.0198857186252214,4.95813763611927e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29589,-0.0139042832393709,0.00304426539742861,-0.0198710434183309,-0.00793752306041078,4.95875329507667e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24800,0.0162293348703403,0.00355591259207485,0.00925974618987356,0.023198923550807,5.04187755932037e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,24560,0.0331245114348008,0.00725929830910568,0.0188962867489537,0.047352736120648,5.06608686357327e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,29429,-0.013988538782629,0.00306640259779691,-0.019998687874311,-0.00797838969094709,5.09039033796527e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24863,-0.013565934996849,0.00297370271520145,-0.0193943923186438,-0.00773747767505414,5.09186284761102e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,24863,0.00915407129801476,0.00201023168351975,0.00521401719831606,0.0130941253977135,5.2950681733713e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24863,0.0281521188254122,0.00618381821367152,0.016031835126616,0.0402724025242084,5.32517144986835e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24800,0.0078545567842476,0.0017253661917191,0.00447283904847817,0.011236274520017,5.32894227616083e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,24224,0.00891619983462205,0.00195974852750159,0.00507509272071893,0.0127573069485252,5.39921077570833e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,24800,0.0181326670073625,0.00398814425022978,0.0103159042769121,0.0259494297378129,5.47661589795657e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,29438,0.0269299547959701,0.00595526224538891,0.0152576407950079,0.0386022687969324,6.14843382779061e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28714,0.012691733838688,0.00280932224372986,0.00718546224097749,0.0181980054363986,6.27578345017084e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,24440,0.0222062084702957,0.00491566578319935,0.012571503535225,0.0318409134053664,6.28857743650895e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28493,-0.02565283436901,0.00568134189043518,-0.036788264474263,-0.0145174042637571,6.34873074705054e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,29561,0.00981261382747737,0.00217329143608562,0.00555296261274956,0.0140722650422052,6.35332234176386e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24917,-0.00822266825160779,0.00182184191290134,-0.0117934784008944,-0.00465185810232118,6.40939283453012e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,24106,0.0202359026734112,0.00448447589361391,0.011446329921928,0.0290254754248945,6.43906878997562e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28792,0.0089731131120194,0.00198874509487559,0.00507517272606324,0.0128710534979756,6.44891124869815e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,24224,0.0358470900486099,0.00794867179805807,0.020267693324416,0.0514264867728037,6.51866987202934e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,24096,0.022805057922233,0.00505691982453065,0.0128934950661529,0.032716620778313,6.52337023439483e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24106,0.0144617022473272,0.0032070955273931,0.0081757950136367,0.0207476094810176,6.53536017506561e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24235,0.00918686335099605,0.00204051834923052,0.00518744738650423,0.0131862793154879,6.75605777723087e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,24190,0.0204399367356459,0.00454086408032636,0.0115398431382062,0.0293400303330856,6.78439829921192e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DMD,Dystrophin,24235,0.0153766454472816,0.00341715918867227,0.00867901343748397,0.0220742774570793,6.83231752988544e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,28769,0.0146490990823935,0.00325735221290048,0.00826468874510855,0.0210335094196784,6.91098379333824e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,24106,0.0142043478612592,0.00316706988572076,0.00799689088524648,0.0204118048372719,7.32463004707266e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,29579,0.0101456070620232,0.00226581815707011,0.00570460347416581,0.0145866106498807,7.57408763788642e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,29429,0.0231158836284182,0.00516853624042247,0.0129855525971902,0.0332462146596463,7.76272518027263e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,29720,0.0194557640900773,0.00435646461784022,0.0109170934391105,0.0279944347410442,8.0006847754101e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24788,0.033710803459073,0.00754875064135358,0.0189152522020199,0.048506354716126,8.01425775692803e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28792,0.0105555018322778,0.00237190762245953,0.00590656289225714,0.0152044407722985,8.6105603608503e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24440,-0.0130178954197261,0.00293835646043997,-0.0187770740821884,-0.00725871675726375,9.44967982377036e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,29689,0.00783139669055112,0.00176839375132107,0.00436534493796182,0.0112974484431404,9.52132312649907e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24917,0.0219471818978641,0.00496464271623779,0.0122164821740381,0.0316778816216902,9.87987497652714e-06
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRL,Prolactin,29689,-0.0221683427787914,0.00501797965817416,-0.0320035829088128,-0.0123331026487701,1.00071351916565e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29438,0.0155216623533743,0.00352142285604898,0.00861967355551831,0.0224236511512303,1.04804129196847e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24840,0.00969696004366207,0.00220141994885873,0.00538217694389896,0.0140117431434252,1.06291848386531e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29473,0.0105304419125319,0.00239113342236279,0.00584382040470086,0.015217063420363,1.06669599556461e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,29344,-0.00949967657691647,0.00216267635151975,-0.0137385222258952,-0.00526083092793775,1.12418033745655e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,29589,0.015566947263917,0.00354482236175945,0.00861909543486847,0.0225147990929655,1.12982323558912e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,24788,0.0100222743542974,0.00228241007817765,0.00554875060106925,0.0144957981075256,1.13249364027817e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24190,0.0158435266739423,0.00361991048960367,0.00874850211431908,0.0229385512335655,1.20953979428922e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,29484,0.0233493112297515,0.00534093073132388,0.0128810869963567,0.0338175354631463,1.23666003662636e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,28911,0.0167861190298639,0.00384000339543343,0.00925971237481434,0.0243125256849134,1.2389363503547e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,29448,0.0222895174727607,0.00510435914865557,0.0122849735413958,0.0322940614041256,1.2653256581497e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,24235,0.0204023919399333,0.00467349545130308,0.0112423408553792,0.0295624430244873,1.27326724284838e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,29781,0.00256901991229952,0.000589046037969337,0.00141448967787961,0.00372355014671942,1.29712398014487e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,29429,0.0194760975333074,0.00446595400331633,0.0107228276868074,0.0282293673798074,1.29899428619899e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,29164,0.0132425239647822,0.00303730194620055,0.00728941215022912,0.0191956357793353,1.30529814986416e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_A,,24863,0.00938967282628815,0.00216683188832137,0.00514268232517826,0.013636663327398,1.47423795706322e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,24788,0.0120225197234839,0.00277729210757988,0.0065790271926273,0.0174660122543405,1.50468077064239e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24863,0.0139978765725784,0.00323376358953251,0.00765969993709473,0.0203360532080622,1.50602743178125e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24788,0.016332518548427,0.00377410012556067,0.00893528230232809,0.0237297547945259,1.51383648055032e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,29683,0.0267962095438684,0.00619264697511531,0.0146586214726424,0.0389337976150944,1.51578334819036e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,24224,0.0120286341155737,0.00278991342410763,0.00656040380432275,0.0174968644268247,1.6281187727863e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,29342,-0.0116925867213817,0.00271570909772516,-0.017015376552923,-0.00636979688984034,1.67121228096189e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24190,0.0123827265021407,0.00287654202565073,0.0067447041318653,0.0180207488724162,1.67849728722119e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29429,0.0117781519294167,0.00274179197120354,0.00640423966585776,0.0171520641929756,1.7463341488838e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,24190,0.00910193436562045,0.00211883730079037,0.00494901325607133,0.0132548554751696,1.74805631086793e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARTN,Artemin,28926,0.0127544961619528,0.00296968393524033,0.00693391564888172,0.0185750766750238,1.75341545410148e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,29286,0.0159456581147085,0.00371731613851619,0.00865971848321681,0.0232315977462003,1.79599384175937e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,29438,0.0127013016607622,0.00296466270061644,0.00689056276755397,0.0185120405539704,1.83953498907999e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28792,0.0107181345096511,0.0025029251527641,0.00581240121023351,0.0156238678090688,1.85617541894506e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29641,-0.00643136611612807,0.00150334014222535,-0.00937791279488976,-0.00348481943736639,1.89127356868489e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29429,0.0293594270214043,0.0068646891591624,0.015904636269446,0.0428142177733626,1.9013145746945e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24011,0.016246130380139,0.0038045608422247,0.0087891911293786,0.0237030696308994,1.96072449976825e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,24190,0.0185313326371302,0.00433989277163124,0.010025142804733,0.0270375224695275,1.96220236992236e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,24224,0.00576963180897085,0.00135155849114526,0.00312057716632614,0.00841868645161557,1.97210227651044e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,24224,0.0180141154015837,0.00423182441469587,0.00971973954877974,0.0263084912543876,2.08135322744343e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MB,Myoglobin,29815,0.0147647125364838,0.00347667229789825,0.00795043483260319,0.0215789902403644,2.17507578671504e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,24863,0.0125192120568087,0.00294888371269835,0.00673939997991998,0.0182990241336975,2.18988626269939e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,24338,-0.0162368654611735,0.00382688746207066,-0.023737564886832,-0.00873616603551504,2.21526611783523e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,24771,0.0265281638665009,0.00625336816947445,0.014271562254331,0.0387847654786709,2.22123332406779e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,24788,-0.0112543812703652,0.00265317073099709,-0.0164545959031195,-0.00605416663761087,2.22478326425479e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28792,0.0114761902236465,0.00270746550989827,0.00616955782424589,0.0167828226230471,2.25497102964782e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,29790,0.00950238741130579,0.00224224627196817,0.00510758471824818,0.0138971901043634,2.26311334482655e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29689,0.0138480983899842,0.0032720322486584,0.00743491518261375,0.0202612815973547,2.32047068122792e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSN,Gelsolin,24840,0.0053453383408013,0.00126409028045026,0.00286772139111879,0.00782295529048381,2.35986160280722e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,24933,-0.0130876966509973,0.0030958235382771,-0.0191555107860204,-0.00701988251597419,2.37108688398633e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24946,-0.00739823400123643,0.00175308955280319,-0.0108342895247307,-0.00396217847774218,2.45044383174452e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24788,0.0103613886420075,0.00245744162025371,0.00554480306631019,0.0151779742177048,2.49189042625215e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28769,0.0204130227394161,0.00485601424500321,0.0108952348192098,0.0299308106596224,2.63428785496214e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,28847,0.0204362030250029,0.00486356953404228,0.0109036067382801,0.0299687993117258,2.65487013476814e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24106,0.0107078039583249,0.00254947714368147,0.00571082875670922,0.0157047791599406,2.67873953778992e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,28911,0.0101309118317885,0.00241334344639694,0.00540075867685047,0.0148610649867265,2.70237706437887e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PXN,Paxillin,28769,0.0143168780930601,0.00341096290205692,0.00763139080502857,0.0210023653810917,2.70911694769889e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,24011,0.0156113643624143,0.003720811942704,0.00831857295471447,0.0229041557701142,2.73022484284028e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,24235,0.0190299330914376,0.00453673778977487,0.0101379270234788,0.0279219391593963,2.74290225479388e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28792,0.016822406196925,0.00402699333498184,0.00892949926036056,0.0247153131334894,2.95714599388448e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,29720,-0.00459162895685223,0.00110029420220911,-0.00674820559318208,-0.00243505232052238,3.01347694795363e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24917,-0.0108808278382201,0.00260953454434999,-0.0159955155451461,-0.00576614013129412,3.06108383105393e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29084,0.0321706100548138,0.00771721440325591,0.0170448698244322,0.0472963502851954,3.07252935481552e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24800,0.00707577052358537,0.00169784601767049,0.00374799232895122,0.0104035487182195,3.0900476685222e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,24610,0.0177257363083376,0.00425560570270803,0.00938474913102988,0.0260667234856453,3.12047968514905e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,28769,0.0143744873241726,0.00345117932883697,0.00761017583965214,0.021138798808693,3.12131248378581e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,29492,0.00902570010473054,0.00217729719455264,0.00475819760340737,0.0132932026060537,3.40214595393692e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,24096,0.0175556000237719,0.00423993208448048,0.00924533313819019,0.0258658669093537,3.47671752616145e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29784,0.0157309230495757,0.0038131033451676,0.00825724049304725,0.0232046056061042,3.70949413709539e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,29363,0.0187377726726065,0.00454460469418573,0.00983034747200249,0.0276451978732106,3.74865801231193e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,29493,0.0253581657899633,0.00616255591824492,0.0132795561902033,0.0374367753897233,3.88436207616764e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,29560,0.0104938143876076,0.00255723693245724,0.00548162999999137,0.0155059987752237,4.07904668517413e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29678,0.00813368235032243,0.00198548728722225,0.00424212726736682,0.012025237433278,4.20434144806769e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,24800,-0.0307439281610333,0.00750625057332942,-0.045456179284759,-0.0160316770373077,4.22090226099576e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,28792,0.0207584923893914,0.00506917421189865,0.01082291093407,0.0306940738447127,4.23240673604018e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28769,0.00818290976699759,0.00200367255309122,0.0042557115629388,0.0121101079710564,4.43952730897965e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,24106,0.0162565726094979,0.00399341872798189,0.00842947190265336,0.0240836733163424,4.69931690499789e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,24917,0.00932823886242038,0.00229445492899913,0.00483110720158209,0.0138253705232587,4.80649053445715e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,28342,0.00849359871482163,0.00209006417922598,0.00439707292353872,0.0125901245061045,4.84107248899108e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24840,-0.00727352016821442,0.00179211917643309,-0.0107860737540233,-0.00376096658240556,4.95159073159746e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29344,0.0212937350788141,0.00526769478201141,0.0109690533060718,0.0316184168515565,5.30587910800728e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28792,0.0157745213420057,0.0039181747051213,0.00809489891996796,0.0234541437640435,5.68820406186869e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29589,0.00917405060278839,0.00228229040370046,0.00470076141153549,0.0136473397940413,5.84244515001822e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAT,Catalase,24582,0.014267611909562,0.00354940057085891,0.0073107867906785,0.0212244370284454,5.8440026809219e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28792,0.0152135809564952,0.00378978263130215,0.00778560699914301,0.0226415549138475,5.9756322483323e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TREH,Trehalase,24933,-0.0198862146516549,0.00495557357018402,-0.0295991388492155,-0.0101732904540942,6.01528636520628e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,29531,0.00880468597825907,0.00220343503096979,0.00448595331755829,0.0131234186389598,6.46077944123799e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,24840,0.0166583439901729,0.00417688800489812,0.0084716435005726,0.0248450444797732,6.67618849979892e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,24011,0.0134703717262334,0.003380281615328,0.00684501976019049,0.0200957236922763,6.7683741344734e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,28717,-0.0162529518224713,0.00408278896038995,-0.0242552181848356,-0.00825068546010698,6.88395068947799e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,29585,0.0108285575230591,0.00272487632821303,0.00548779991976152,0.0161693151263566,7.08542336761332e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24840,0.00836231028303413,0.00210514199720463,0.00423623196851305,0.0124883885975552,7.13750308772921e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28769,0.0220565335408803,0.00558545035062894,0.0111090508536476,0.033004016228113,7.86893773581923e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,24224,0.00790082045967769,0.00200506260101355,0.00397089776169113,0.0118307431576643,8.15619593754022e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,28911,-0.00612386465506137,0.00155511428460021,-0.00917188865287778,-0.00307584065724496,8.23949769900204e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,29463,0.0100464329510794,0.00255770541384306,0.00503333033994703,0.0150595355622118,8.58830648526162e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,24224,0.0117538020825277,0.00299953388982918,0.00587471565846246,0.0176328885065929,8.93306787786336e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,24106,0.0111341592044527,0.00284647337693917,0.00555507138565193,0.0167132470232535,9.19523314855436e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,29317,0.0217991005261656,0.00557494924858812,0.0108721999989328,0.0327260010533983,9.2431902151101e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,24224,0.00880234347483954,0.00225805000244486,0.00437656547004762,0.0132281214796315,9.71691603461676e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29429,0.0219484782269675,0.00563060113392811,0.0109125000044684,0.0329844564494666,9.71772777267217e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24933,0.0355454383551522,0.00912893544723313,0.0176527248785753,0.0534381518317292,9.89794474900821e-05
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24376,0.00971008528587312,0.00249800308037163,0.00481399924834473,0.0146061713234015,0.000101701335661968
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNST,Consortin,29473,0.0277980600516376,0.0071711023889809,0.013742699369235,0.0418534207340402,0.00010624319893678
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,29720,0.00874276129652126,0.00225757827238013,0.00431790788265621,0.0131676147103863,0.000107898574214191
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29344,0.0153409312358086,0.00396401221740417,0.00757146728969645,0.0231103951819208,0.000109047801625759
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,28769,0.0142163436516428,0.00368963600317577,0.00698465708541833,0.0214480302178674,0.000116909829367382
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,24863,0.00954076391354354,0.00247663676060473,0.00468655586275826,0.0143949719643288,0.000117304131433778
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28792,-0.00845065529298401,0.00219969216206861,-0.0127620519306385,-0.00413925865532953,0.00012242497013717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24106,0.00930756199319229,0.00242336228268096,0.00455777191913761,0.014057352067247,0.000122966085932591
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,29576,0.0109795796695971,0.00285881671824523,0.00537629890183649,0.0165828604373578,0.000122988491813388
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29213,0.00756736307132874,0.00197063443505522,0.00370491957862051,0.011429806564037,0.00012326163368384
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24863,0.00666402059673191,0.00173639224773552,0.00326069179117029,0.0100673494022935,0.000124421188875697
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSPN,Claspin,28714,0.00883743527094885,0.00230328844121801,0.00432298992616155,0.0133518806157361,0.000124875366978363
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,29469,0.00552080994583997,0.00144025700150867,0.00269790622288298,0.00834371366879695,0.000126743850693724
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,24788,0.0159079326728077,0.00416071380105808,0.00775293362273387,0.0240629317228816,0.000131964155278141
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29449,0.00638015209840711,0.00167079944538132,0.00310538518545973,0.0096549190113545,0.000134474087526623
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,24235,0.0228152889875693,0.00598203534481913,0.0110904997117238,0.0345400782634148,0.000137092532004911
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29815,0.00765499472189305,0.00201141031810894,0.00371263049839952,0.0115973589453866,0.000141637839718709
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28792,0.0179825004132794,0.00473019753048236,0.00871131325353395,0.0272536875730248,0.000144038762933925
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,29237,0.0125083674037929,0.00329113645880586,0.00605773994453337,0.0189589948630523,0.000144625744413351
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,29346,0.00803216511886609,0.00211491363566253,0.00388693439296754,0.0121773958447646,0.000146239453707392
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,28792,0.00783194714529207,0.0020638589528687,0.00378678359766942,0.0118771106929147,0.000148060691971393
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28792,0.0160550545294026,0.00423235579197526,0.00775963717713108,0.0243504718816741,0.000148897233226885
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,24788,-0.0199315720560741,0.00525457828334395,-0.0302305454914283,-0.00963259862071997,0.000149082264820841
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,24440,0.0132563027166635,0.00350103025806023,0.00639428341086544,0.0201183220224615,0.000153210971576534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,24190,0.0113792461610481,0.00301169932492108,0.00547631548420278,0.0172821768378934,0.000158251180992308
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,28926,0.00726166795809621,0.00192418537625626,0.00349026462063394,0.0110330712955585,0.000161041130511701
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,24096,0.0183383513609894,0.0048595592869406,0.00881361515858586,0.027863087563393,0.000161251886051594
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,24106,0.0107568996907978,0.00285568298857015,0.00515976103320028,0.0163540383483953,0.000165720482409695
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NBN,Nibrin,28926,0.0130788292782382,0.00347758595389522,0.00626276080860359,0.0198948977478728,0.000169641333564164
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28769,0.0124898760509549,0.00332322920083837,0.00597634681731165,0.0190034052845981,0.000171371896086574
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,24224,0.0139532220437964,0.00371938118468328,0.00666323492181712,0.0212432091657756,0.000176196446428177
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,24235,-0.00566942820534564,0.00151132319253708,-0.00863162166271831,-0.00270723474797296,0.000176329212539365
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,24840,0.0235253678880058,0.00627682732606044,0.0112227863289274,0.0358279494470843,0.00017867459514278
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29344,0.0241220624107031,0.00644875353515264,0.011482505481804,0.0367616193396023,0.000183947329137823
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29344,0.00887291892857035,0.00237882420832173,0.00421042348025976,0.0135354143768809,0.000191870833591688
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,29213,0.00834218905936396,0.00223715572026318,0.00395736384764813,0.0127270142710798,0.000192660612806456
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24788,0.0121989979935465,0.00327223744031423,0.0057854126105306,0.0186125833765624,0.000193412129292538
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,28792,0.0145183625816881,0.0038992524551786,0.006875827769538,0.0221608973938381,0.000196955255471818
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24840,0.0114426795863182,0.00307725500010674,0.005411259786109,0.0174740993865274,0.000200874071279455
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,29438,0.00592686501749732,0.00159502586339531,0.0028006143252425,0.00905311570975213,0.000202902392496754
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,24788,0.0100284478855105,0.00269981477870966,0.0047368109192396,0.0153200848517815,0.000204056975091179
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29473,0.0110648105594198,0.00298265630031388,0.00521880421080463,0.0169108169080351,0.000207872207643724
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24224,0.00947006265055751,0.00255616971254059,0.00445997001397795,0.0144801552871371,0.000212039527079298
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24376,0.0129991521384967,0.00351329844266412,0.00611308719087505,0.0198852170861184,0.000216086288972144
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28769,0.014155323618926,0.00383234802896383,0.00664392148215688,0.0216667257556951,0.000221473764435194
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,24224,0.00739062781124273,0.00200197892674459,0.00346674911482334,0.0113145065076621,0.00022328311436026
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29031,0.0359840979347306,0.00975612098311512,0.0168621008078249,0.0551060950616362,0.000226114945035053
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,F3,Tissue factor,29536,-0.00665869562595479,0.00181153024811542,-0.010209294912261,-0.00310809633964856,0.000237590398477803
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,29429,0.00644104435164319,0.00175758916022457,0.00299616959760303,0.00988591910568335,0.000248059703767628
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29689,0.00565461425119833,0.00154374543110375,0.00262887320623498,0.00868035529616168,0.000249791038223566
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,24224,0.00771368829108179,0.00210863775343177,0.00358075829435552,0.0118466182878081,0.000254592843214017
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,24106,0.0287350285112991,0.00785656759635267,0.0133361560224478,0.0441339010001503,0.000255276210126838
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,24946,0.0349837368141297,0.00956859481778404,0.016229290971273,0.0537381826569865,0.000256608012552891
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29360,-0.0161614338161324,0.00442250398395863,-0.0248295416246913,-0.00749332600757353,0.00025827081347785
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24173,0.00670908856301536,0.001837421266307,0.00310774288105365,0.0103104342449771,0.000261404677225241
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,24276,0.0103595800156122,0.00283849085179978,0.00479613794608465,0.0159230220851398,0.00026311921233935
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29213,-0.0056262798699166,0.0015434553219272,-0.00865145230089392,-0.00260110743893929,0.000267595907594584
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28792,0.0126858417135423,0.00348294513655069,0.00585926924590294,0.0195124141811816,0.000270714126705625
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,24376,-0.00780594024232224,0.00214453383942338,-0.0120092265675921,-0.00360265391705243,0.00027328258622142
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,29269,0.00691576891650355,0.0019023023515462,0.00318725630747301,0.0106442815255341,0.000277946697739528
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24800,0.0104779669181618,0.00288767292466525,0.00481812798581788,0.0161378058505057,0.000285628007558572
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELN,Elastin,24917,0.00842496774306394,0.00232391770282057,0.00387008904553563,0.0129798464405923,0.00028916830532825
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,28926,0.019674045737776,0.00542886869655016,0.00903346309253765,0.0303146283830143,0.000290614988059012
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29344,0.00934962300983763,0.00258039619960869,0.00429204645860459,0.0144071995610707,0.000291327229014568
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29561,-0.0108687146725117,0.00300249315394612,-0.0167536012542461,-0.00498382809077733,0.000295213076107645
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24800,0.019659115104328,0.00544607940531182,0.00898479946991682,0.0303334307387392,0.000307067974779011
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24788,0.00976155291201715,0.00270691615958777,0.00445599723922513,0.0150671085848092,0.000311380752281287
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24224,0.00893148754126919,0.00248182384594541,0.00406711280321618,0.0137958622793222,0.000320376239187066
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,28911,0.0127196985080609,0.00353654080592858,0.00578807852844086,0.0196513184876809,0.000322879487762142
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24863,0.00840109780048476,0.00233635271170521,0.00382184648554254,0.012980349115427,0.000324001009848056
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,28769,-0.00855902405917987,0.00238116463702505,-0.013226106747749,-0.00389194137061077,0.000325596380924874
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24863,0.008530894385395,0.00237695505419358,0.00387206247917559,0.0131897262916144,0.0003325859206434
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28911,0.00510481122648856,0.00142336092779878,0.00231502380800296,0.00789459864497417,0.000335764675291228
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29815,0.00645532921645089,0.00180401529900521,0.00291945923040069,0.00999119920250109,0.00034636921971674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,29438,0.00851610240166324,0.00238141064352918,0.00384853754034605,0.0131836672629804,0.000349350949800015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24840,0.016118642745371,0.00450822652937523,0.00728251874779558,0.0249547667429465,0.000350377506651183
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,28792,0.0228288890495948,0.00638671785480876,0.0103109220541696,0.03534685604502,0.000351563054549966
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29531,0.0180568469169709,0.00505464202864841,0.00814974854082004,0.0279639452931218,0.000354382827881105
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,24376,0.0165093191257285,0.00464174371612642,0.00741150144212076,0.0256071368093363,0.000376245907893205
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,24715,0.0066080397727037,0.00186280263217382,0.00295694661364302,0.0102591329317644,0.000389826771615471
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,24788,0.00929488751250809,0.00262128728311889,0.00415716443759506,0.0144326105874211,0.000391959396019818
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28769,0.0115964865275062,0.00327179879265033,0.00518376089391153,0.0180092121611008,0.000394167147845366
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24840,0.0109216899434095,0.00308870002132239,0.00486783790161762,0.0169755419852014,0.000406951244257099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,29815,0.0169879141664125,0.00480596720149212,0.00756821845148796,0.0264076098813371,0.000408772531196697
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,28759,0.0139063225983712,0.00394032920431832,0.0061832773579073,0.0216293678388351,0.000417423713282648
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,24268,0.00803658623936968,0.00227765324055101,0.0035723858878897,0.0125007865908497,0.000418773454294093
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29393,0.00569654671281244,0.00161780067761054,0.00252565738469577,0.0088674360409291,0.000430302420316129
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24840,0.00693939772767871,0.00197162831784079,0.00307500622471076,0.0108037892306467,0.000432926362795403
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24800,0.0164057926500558,0.00467061490826421,0.00725138742985799,0.0255601978702537,0.000444609514450346
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRNN,Cornulin,28575,0.0155456438463356,0.00443333449317312,0.00685630823971625,0.0242349794529549,0.000454677724640532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28769,0.0091107999175083,0.00260070664395663,0.0040134148953533,0.0142081849396633,0.000460399259476126
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24863,0.0087635121351356,0.00250746015522817,0.00384889023088838,0.0136781340393828,0.00047493088241408
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24863,0.00908852774734015,0.00260914546683164,0.00397460263235013,0.0142024528623302,0.000496060188845121
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,24840,0.0156616119676662,0.00449856308103044,0.00684442832884656,0.0244787956064859,0.000499526789836253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24106,0.0128687610004646,0.00369777323961789,0.00562112545081352,0.0201163965501156,0.000502041884150509
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28717,0.0123741087217248,0.00355958351723547,0.00539732502794331,0.0193508924155064,0.000509172776205403
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,29473,0.0161312885885937,0.00464494039903742,0.00702720540648037,0.0252353717707071,0.000515657568804489
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,28769,-0.0118152624566487,0.00341042324911984,-0.0184996920249236,-0.00513083288837384,0.000532078343781437
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24190,0.0238486195135221,0.0068850584298413,0.0103539049910331,0.037343334036011,0.000533480210090828
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29429,0.00861554844680756,0.00248811199733819,0.0037388489320247,0.0134922479615904,0.000535573975121761
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,29475,0.0120322520389065,0.00347525916986694,0.00522074406596729,0.0188437600118457,0.000536418524353507
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,24917,-0.0189348487959063,0.00548251411035332,-0.0296805764521988,-0.00818912113961384,0.000553912830303315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,29669,0.027013957281821,0.00784286588163496,0.0116419401538165,0.0423859744098255,0.000573122118841353
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAST,Gastrin,24840,-0.0296891901061967,0.00862370063033121,-0.0465916433416459,-0.0127867368707475,0.000576794192203252
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,28911,0.0101882715731689,0.00296348332005754,0.00437984426585608,0.0159966988804816,0.000586987860756166
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,29561,0.00627879941939441,0.0018291785155929,0.00269360952883232,0.00986398930995649,0.000598688989313706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24840,0.0124806506759234,0.00363632969048841,0.00535344448256616,0.0196078568692807,0.000599657272417519
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,24235,0.00913863442543551,0.00266314155785808,0.00391887697203367,0.0143583918788373,0.000601201623683034
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,24933,-0.00925583847652269,0.0027012175107232,-0.0145502247975402,-0.00396145215550521,0.000612302954055465
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28296,-0.00857583479895038,0.00250306785814312,-0.0134818478009109,-0.00366982179698986,0.000613118263436615
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,24106,0.0164162503146914,0.00479379747019727,0.00702040727310474,0.025812093356278,0.000617009236765862
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28792,0.0192365847766024,0.0056216096529472,0.00821822985682592,0.030254939696379,0.000622716771269981
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,24946,0.00592861236736119,0.00173610859810919,0.00252583951506718,0.00933138521965519,0.000639104018956132
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28911,0.0110251672199426,0.0032292186147043,0.00469589873512215,0.017354435704763,0.000640596726185729
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24863,0.0067670124695692,0.00199464341565438,0.00285751137488661,0.0106765135642518,0.000693424887425621
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,29164,0.0089996937554734,0.00265312005077682,0.00379957845595082,0.014199809054996,0.000694469417169628
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29576,-0.00636229406408603,0.00187701208923798,-0.0100412377589925,-0.00268335036917959,0.000700896666218647
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29720,0.0120875690067671,0.00356796007990641,0.00509436725015053,0.0190807707633837,0.000705445925821423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23970,0.00580662656568095,0.00171402773955214,0.00244713219615876,0.00916612093520313,0.00070592482922975
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,29390,0.00903970923340265,0.00266897599838471,0.00380851627656862,0.0142709021902367,0.000707648804335037
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29344,0.0058616941338346,0.00173161469861636,0.00246772932454653,0.00925565894312267,0.000712447696843206
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,29438,0.00987801062867004,0.00291992919414254,0.00415494940815066,0.0156010718491894,0.000718018855946073
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,29522,0.00872232769545758,0.00257831677204088,0.00366882682225745,0.0137758285686577,0.000718037439903765
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,28879,0.00925908850968316,0.0027371193898769,0.00389433450552443,0.0146238425138419,0.000718498681864289
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,29160,-0.0107739144005834,0.00318585926517903,-0.0170181985603342,-0.00452963024083246,0.00072109170984268
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29344,0.0121017651311995,0.00359239825709612,0.00506066454729113,0.0191428657151079,0.000756167089953006
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,28769,0.0114714856326022,0.00340977716764966,0.00478832238400884,0.0181546488811955,0.000768405728013815
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29522,0.0127644337852678,0.00379557838223375,0.00532510015608969,0.020203767414446,0.000772054516691711
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,24917,-0.00591124418036557,0.00175905959576057,-0.0093590009880563,-0.00246348737267484,0.000779305037489044
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,29449,-0.0121390914253251,0.00361539208291548,-0.0192252599078395,-0.00505292294281079,0.000787178663653152
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,24648,0.0060692791204085,0.00180829794051261,0.00252501515700378,0.00961354308381321,0.0007909818604681
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,24190,0.00927741062594303,0.00276945279753473,0.00384928314277496,0.0147055381091111,0.000809621727407008
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29344,0.00878907915824855,0.00262392599888349,0.0036461842004369,0.0139319741160602,0.000810329032273858
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23820,0.00712543916539502,0.00212779145240515,0.00295496791868093,0.0112959104121091,0.000813032471439821
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29213,-0.0254053772854971,0.00759873215163216,-0.0402988923026961,-0.0105118622682981,0.000828713261665612
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29404,-0.00390111558866178,0.00116997740541831,-0.00619427130328167,-0.00160795987404189,0.000856043223521777
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,24863,-0.00564055570814131,0.00169301286927604,-0.00895886093192236,-0.00232225048436027,0.000864532325829274
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29429,0.0233207839414758,0.00701971998291227,0.0095621327749677,0.0370794351079838,0.00089425408766877
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,29438,0.0121846814376806,0.00368478952193549,0.00496249397468709,0.0194068689006742,0.000944977615461257
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24440,0.0114657382876287,0.00347184096215461,0.00466093000180563,0.0182705465734517,0.000959662824641928
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,29781,0.00663173957105592,0.00200852552836494,0.00269502953546063,0.0105684496066512,0.000961813226185567
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,28645,0.00666698432135395,0.00202076040270743,0.00270629393204739,0.0106276747106605,0.000970634412666045
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,24863,-0.0150256223356548,0.00456510749713349,-0.0239732330300365,-0.00607801164127319,0.000998268501022705
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,24800,0.0093197309583388,0.00283786305975855,0.00375751936121204,0.0148819425554656,0.00102462571568993
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,24440,0.00637164812753977,0.00194040635479148,0.00256845167214847,0.0101748445829311,0.00102609970757896
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29678,0.0136722560958943,0.00416815120650177,0.00550267973115088,0.0218418324606378,0.00103863120863626
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24917,-0.0151659110439591,0.00462481302834011,-0.0242305445795057,-0.00610127750841247,0.00104226727247446
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,24800,-0.0211850538849355,0.00647266784802595,-0.0338714828670663,-0.0084986249028046,0.00106557407746684
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,24917,0.0197969455182146,0.00605151934964347,0.00793596759291338,0.0316579234435158,0.00107161612463082
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HLA_DRA,,29317,0.00780154552564597,0.00239367657641005,0.00310993943588227,0.0124931516154097,0.00111841874553029
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,24106,0.0151757992066989,0.00466148448805478,0.00603928961011157,0.0243123088032863,0.00113320347470662
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,29506,0.00795473846619089,0.00245302966177961,0.00314680032910286,0.0127626766032789,0.00118483676681681
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCT,Secretin,24190,-0.0100713127092915,0.00311805203270306,-0.0161826946933895,-0.00395993072519352,0.00123954977666349
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,29438,0.00881384422632838,0.00273250761464957,0.00345812930161521,0.0141695591510415,0.00125867506013927
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,28769,0.0137312251930334,0.00427224667179386,0.00535762171631741,0.0221048286697494,0.00131020086781297
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,29429,0.0118917310757454,0.0037105102414959,0.00461913100241342,0.0191643311490773,0.00135264101659048
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24106,0.0140612047077326,0.00439476440080856,0.00544746648214786,0.0226749429333174,0.00137827458625496
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24106,0.00548893185758777,0.00171953259322369,0.00211864797486933,0.00885921574030621,0.00141420360888182
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29296,0.0159830014395567,0.00501109665830899,0.00616125198927109,0.0258047508898423,0.00142658506566407
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,29473,0.0133942946927959,0.00420639440359143,0.00514976166175664,0.0216388277238351,0.00145270650791667
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,24106,-0.0107686486229395,0.00338814989437725,-0.0174094224159189,-0.00412787482996012,0.00148314684124744
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24566,0.0117573729765766,0.00371085596710751,0.00448409528104591,0.0190306506721073,0.00153482980428174
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24224,0.0181229638858462,0.00572140498059823,0.0069090101238737,0.0293369176478188,0.00153908353270958
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,27437,0.0085421231908008,0.00269849660085805,0.00325306985311902,0.0138311765284826,0.00154979600496649
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,29378,0.00606150764396726,0.00191530140235262,0.00230751689535613,0.00981549839257839,0.00155358590565756
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29213,0.00687288638400377,0.0021733467038795,0.00261312684439995,0.0111326459236076,0.00156660625023596
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28792,0.0116311189991943,0.00368331250318485,0.00441182649295201,0.0188504115054366,0.00159135441387341
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,24376,0.00811366178753607,0.00257179181915518,0.00307294982199191,0.0131543737530802,0.00160766370518035
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALB1,Calbindin,29344,0.00913810313874824,0.00289749815533518,0.00345900675429129,0.0148171995232052,0.00161327090659947
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24788,0.0127413371326945,0.00404827928436276,0.00480670973534352,0.0206759645300455,0.00164954920159273
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24863,0.0142211147833475,0.00451952584722541,0.00536284412278575,0.0230793854439093,0.00165378923363373
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,29438,-0.00538303018243523,0.00171090019991743,-0.00873639457427339,-0.00202966579059708,0.00165506859868784
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24224,0.00734698118864413,0.0023442499294223,0.00275225132697642,0.0119417110503118,0.00172621175983646
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,24917,0.00617478928177511,0.00197121026747839,0.00231121715751747,0.0100383614060327,0.00173533311503904
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28911,-0.00732112807591088,0.0023432930241567,-0.011913982403258,-0.00272827374856375,0.00178410665014185
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29344,0.00873129936180223,0.00280137089391071,0.00324061240973725,0.0142219863138672,0.00183005097526529
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24800,0.0103778264506813,0.00333806504432856,0.00383521896379732,0.0169204339375653,0.00187975776799728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,29164,-0.00950987514281063,0.00306290087481893,-0.0155131608574557,-0.00350658942816554,0.00190552189604803
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28769,0.0131278473344837,0.0042347959092442,0.00482764735236503,0.0214280473166023,0.00193710613228394
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,24096,0.0198674244305686,0.00641455991878209,0.00729488698975566,0.0324399618713814,0.00195556908913451
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,29781,0.0125227992915686,0.00404743465663091,0.00458982736457198,0.0204557712185652,0.00197654402989902
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,29561,0.0162711114980362,0.00526064513183401,0.00596024703964149,0.0265819759564308,0.00198336931805956
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24106,0.0105412874527155,0.00341359536703867,0.00385064053331975,0.0172319343721113,0.00201716602253692
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24788,0.0069676244920443,0.00225749797033266,0.00254292847019229,0.0113923205138963,0.00202794548625412
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24224,0.00892027636546384,0.00289045427278694,0.00325498599080143,0.0145855667401262,0.0020301869875827
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29589,0.00858341801828303,0.0027903209604766,0.00311438893574888,0.0140524471008172,0.00209890726805845
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,29815,0.00599659476629225,0.00195024154151993,0.00217412134491318,0.00981906818767132,0.00210837119554846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,24235,-0.0105842074184139,0.00344405824511343,-0.0173345615788363,-0.0038338532579916,0.00212026631073374
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,24011,-0.00847444376825707,0.00275779090465498,-0.0138797139413808,-0.0030691735951333,0.00212219822930815
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24011,-0.00622753117849322,0.00202973537586242,-0.0102058125151836,-0.00224924984180288,0.00215628972917505
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,28926,-0.0058132005960825,0.00189698967487473,-0.00953130035883696,-0.00209510083332804,0.00218282711880641
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24235,0.0127192463306294,0.0041520428057575,0.00458124243134467,0.0208572502299141,0.00219098983779442
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28792,0.0253607753082099,0.00829282276621568,0.00910684268642719,0.0416147079299926,0.00222905406892431
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29473,0.00520341921322932,0.00170659231404453,0.00185849827770204,0.00854834014875659,0.00229799524586408
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,24440,-0.00696008418373478,0.00228270851661657,-0.0114341928763033,-0.00248597549116631,0.00229814643355727
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,24235,-0.0123019682434318,0.00403956094100881,-0.020219507687809,-0.00438442879905449,0.00232641846748976
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,24541,0.00690025029118016,0.00226816868510226,0.00245463966837974,0.0113458609139806,0.00235094512690634
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29815,0.00821853258032713,0.00270375171074185,0.0029191792272731,0.0135178859333812,0.00237037145265115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,29152,-0.00565896968766525,0.00186611597903569,-0.00931655700657519,-0.0020013823687553,0.00242761974060617
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24106,0.00789100852917254,0.00261674046013119,0.00276219722731542,0.0130198198310297,0.00256749561134143
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,24840,0.00745985403436761,0.00247416804316371,0.00261048466976673,0.0123092233989685,0.00257157558011984
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24224,0.00890759458239102,0.00295544219665455,0.00311492787694809,0.0147002612878339,0.00258125737807235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24800,-0.00998411322467789,0.00331616675828904,-0.0164838000709244,-0.00348442637843137,0.00260874966484122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24106,0.00558002973298562,0.00185866056171459,0.00193705503202502,0.00922300443394622,0.00268330210075636
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,28472,-0.00799020515819609,0.00266299976886668,-0.0132096847051748,-0.0027707256112174,0.00269811950213914
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28926,0.00749153101436864,0.00249900546768898,0.00259348029769825,0.012389581731039,0.00272162659833025
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24106,0.00891684289102244,0.00297968573379093,0.00307665885279223,0.0147570269292527,0.00276942388303651
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,24190,0.0149695189358606,0.00501190495393457,0.00514618522614882,0.0247928526455723,0.00282203847736225
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28728,0.0056636654224733,0.00190113879743736,0.00193743337949606,0.00938989746545053,0.00289346659702461
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28792,0.0109982713532777,0.00369189729845544,0.00376215264830505,0.0182343900582504,0.00289404056548187
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29561,0.00532565188376771,0.00178837604727479,0.00182043483110912,0.0088308689364263,0.0029044132267129
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29576,0.00509192235115604,0.00171037126018953,0.00173959468118456,0.00844425002112753,0.00291238111542003
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,24235,-0.00471433049085363,0.00158904253682029,-0.0078288538630214,-0.00159980711868585,0.00301235668128607
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28926,0.00696399345719806,0.0023538479445813,0.00235045148581872,0.0115775354285774,0.0030933328466875
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29815,0.00680734620660179,0.00230380293084672,0.00229189246214222,0.0113227999510614,0.0031308592801097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,24961,0.00442902480225972,0.00149940296997678,0.00149019498110523,0.00736785462341421,0.00314120272411149
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,24096,0.00943021832892835,0.00319264508557962,0.0031726339611923,0.0156878026966644,0.00314259812729903
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,28926,0.00959235287541233,0.00325026997348978,0.00322182372737236,0.0159628820234523,0.0031674662319274
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29781,0.00716820336371129,0.00243398548566373,0.00239759181181038,0.0119388149156122,0.00323154629390663
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24096,0.0115159368894949,0.00391130848990416,0.0038497722492827,0.019182101529707,0.00324029703505409
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24096,-0.0106036157866074,0.00360630675256501,-0.0176719770216348,-0.00353525455157993,0.00328208607681942
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24840,0.00722098193532927,0.00245747404224393,0.00240433281253117,0.0120376310581274,0.00330240444588933
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24440,0.0134141477270455,0.00456808535119713,0.00446070043869913,0.0223675950153919,0.00332256607003073
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,24440,0.00660065947733785,0.00225065633591318,0.00218937305894801,0.0110119458957277,0.00336263561981306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24190,0.00758130991975955,0.00259149882859299,0.00250197221571729,0.0126606476238018,0.00344274035465626
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24106,0.00727531277194168,0.00249266380005834,0.00238969172382733,0.012160933820056,0.0035183077979447
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24190,0.0139722339764356,0.00480212429282434,0.0045600703624999,0.0233843975903713,0.00362227886347274
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28792,0.0187591088410313,0.00650593773834165,0.00600747087388168,0.031510746808181,0.00393720513378418
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29815,0.0044193372851178,0.00153371479720906,0.00141325628258803,0.00742541828764756,0.00396120429774406
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,28769,0.0128677965731883,0.00447541044315473,0.00409599210460506,0.0216396010417716,0.0040404037178349
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29668,0.00575410238874908,0.00201695348592702,0.00180087355633211,0.00970733122116605,0.0043356564004586
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,24863,-0.00854479503252517,0.00299589382024291,-0.0144167469202013,-0.00267284314484907,0.00434578444464393
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24235,0.0108039750694502,0.00378853836078104,0.00337843988231933,0.018229510256581,0.00435156645696647
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24863,0.00509108930281568,0.00178619042008506,0.00159015607944896,0.00859202252618241,0.00437208178318132
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,24235,0.0096545118684498,0.00338822487750844,0.00301359110853326,0.0162954326283663,0.00438344842589273
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,24915,-0.0069468067583238,0.00244040901388309,-0.0117300084255347,-0.00216360509111294,0.00442284653995548
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,29438,-0.00596239331172661,0.00209631614284397,-0.0100711729517008,-0.00185361367175243,0.00445503946438434
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24440,0.0142122050589386,0.00500605948797332,0.0044003284625109,0.0240240816553663,0.00452924388856104
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28911,0.0166063788396591,0.00585178692768162,0.00513687646140313,0.0280758812179151,0.00454529435617081
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,24096,0.00651294010801552,0.00230286833418845,0.00199931817300615,0.0110265620430249,0.0046851234869147
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,28447,-0.0112425547559723,0.00399235216731804,-0.0190675650039157,-0.00341754450802896,0.00486556838491153
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,24096,0.010746658184731,0.00382212938579568,0.00325528458857149,0.0182380317808906,0.00493211960151387
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24106,-0.0104696687314164,0.00372909242750665,-0.0177786898893294,-0.00316064757350334,0.00499577467762041
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,24106,0.00820923862321855,0.00292624607862408,0.00247379630911536,0.0139446809373217,0.00502972244087752
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24376,-0.0075184710254564,0.00268108179522307,-0.0127733913440936,-0.00226355070681918,0.00504709255838823
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,29574,0.0283164637724296,0.0100983384854961,0.00852372034085726,0.048109207204002,0.00504946050010091
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,24235,-0.00333378245677164,0.00119148958584992,-0.00566910204503749,-0.00099846286850579,0.0051461434176821
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,24933,0.00923034557365851,0.00330429542467945,0.00275392654128678,0.0157067646060302,0.00521907556041123
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,24800,0.00644214833563221,0.00230659863646626,0.00192121500815834,0.0109630816631061,0.00522744458673908
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,24096,0.00815451772496543,0.00292033708567309,0.00243065703704617,0.0138783784128847,0.00523727132727122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24235,-0.00456726329587096,0.00165040109749361,-0.00780204944695844,-0.00133247714478349,0.00565542164685565
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24440,0.012782841472588,0.00461922421168722,0.00372916201768102,0.0218365209274949,0.00565629027416541
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,24106,0.0119963928957055,0.00433511581968264,0.00349956588912748,0.0204932199022834,0.00565727599782036
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29344,0.00842450259388874,0.0030496957477218,0.002447098928354,0.0144019062594235,0.00574125293046184
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28769,0.00931777376139701,0.00337513602069611,0.00270250716083264,0.0159330403619614,0.00577123066442906
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28590,0.0157765209044823,0.00573064104433694,0.00454446445758194,0.0270085773513827,0.0059087090294063
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,29438,0.00740174220762271,0.00269447918216409,0.00212056301058109,0.0126829214046643,0.00601791789665448
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,24917,0.0100130057172755,0.00364806718036602,0.00286279404375809,0.0171632173907929,0.00606017537060609
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24440,0.0128424125038262,0.0046790640591798,0.00367144694783379,0.0220133780598186,0.00606189500998273
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29657,0.0074019557636038,0.0026993102271628,0.0021113077183647,0.0126926038088429,0.00610721716120257
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,24224,0.00513624469089086,0.00188023542946699,0.00145098324913555,0.00882150613264617,0.00630535729021226
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24168,0.00694687721850811,0.00255287134176066,0.00194324938865722,0.011950505048359,0.00650916981706027
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,24344,0.00663154475512791,0.00243796109333445,0.00185314101219239,0.0114099484980634,0.00653047278469333
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",24106,0.00715708033249069,0.00263579851667335,0.00199091523981094,0.0123232454251705,0.00662556069469801
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24796,0.00670842388340174,0.00247197292454348,0.00186335695129651,0.011553490815507,0.00665636149238289
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,28769,0.0147665343886181,0.00544712242794996,0.0040901744298362,0.0254428943474,0.00671432792960729
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24788,0.00864440389073365,0.0031919090508661,0.0023882621510361,0.0149005456304312,0.00676908368375853
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29438,0.00482959942116379,0.00178526785220938,0.00133047443083341,0.00832872441149416,0.006829188415327
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,24190,0.0124824659459976,0.00461654134121077,0.00343404491722447,0.0215308869747707,0.0068587789402464
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,28862,0.0106510298553327,0.00395982568958476,0.00288977150374656,0.0184122882069188,0.00715418955440011
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24800,0.00986975676234891,0.00368105360307058,0.00265489170033058,0.0170846218243672,0.00734003134325689
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29752,-0.0110144064203153,0.00411841628267656,-0.0190865023343614,-0.00294231050626923,0.00748978490210968
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,29074,0.0067453557647633,0.00252401198531499,0.00179829227354591,0.0116924192559807,0.00753362804522463
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,24224,0.00466392888467537,0.00174960818120377,0.00123469684951598,0.00809316091983476,0.00768794274215751
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,29623,0.00488437565926022,0.00184061377071407,0.00127677266866064,0.00849197864985981,0.00796649248071456
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,24788,0.00787574347953779,0.00296824916008213,0.00205797512577681,0.0136935118332988,0.00797528368547125
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,24788,0.00476614416088508,0.00179985500886567,0.00123842834350837,0.0082938599782618,0.00810037587091274
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,29213,0.0074001738525337,0.00279535570822579,0.00192127666441114,0.0128790710406562,0.0081178435050468
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,24788,0.00972377803361677,0.00367586212868257,0.00251908826139892,0.0169284678058346,0.00816687175671976
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,24440,-0.00539000739792881,0.0020377382489935,-0.00938397436595607,-0.00139604042990156,0.00817207000210905
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,24106,0.00839432426693658,0.003180951157644,0.00215965999795435,0.0146289885359188,0.00832203618451339
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28792,0.0135326577519328,0.0051294499163665,0.00347893591585444,0.0235863795880111,0.0083385403167779
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24788,0.00915867198085648,0.00347525547245647,0.00234717125484179,0.0159701727068712,0.00840916741516786
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,24800,-0.0147420855703363,0.0056026097922065,-0.0257232007630611,-0.00376097037761159,0.00851143122921495
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24096,0.00560852368148812,0.00213183399193527,0.001430129057295,0.00978691830568124,0.00852272269017078
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24096,0.00977101752045729,0.00372361233403568,0.00247273734574735,0.0170692976951672,0.00869408640724126
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,24106,0.00685167282323651,0.00261223416296783,0.00173169386381957,0.0119716517826535,0.00872354489487355
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,29344,0.0328891163635588,0.0125398881829227,0.00831093552503036,0.0574672972020873,0.00872657981337846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29429,0.0168864938984366,0.00644779830231335,0.00424880922590243,0.0295241785709707,0.00882448024148897
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24961,0.00324131976830149,0.00123767895534321,0.000815469015828789,0.00566717052077419,0.00882750108896586
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,29689,0.0222432582853078,0.00850130995613852,0.00558069077127626,0.0389058257993393,0.00888942097637264
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24190,-0.00655267569125991,0.00250508866246085,-0.0114626494696832,-0.00164270191283664,0.00890880702880054
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29815,-0.00547512574363204,0.00209843573835872,-0.00958805979081514,-0.00136219169644895,0.00908137761941464
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,24840,-0.00457781472348459,0.0017576747966966,-0.00802285732500993,-0.00113277212195925,0.00920707699138125
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24800,0.007365272035146,0.00283765288718847,0.0018034723762566,0.0129270716940354,0.00944951300398674
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,24788,0.0192101960206457,0.00740426207661569,0.00469784235047896,0.0337225496908125,0.00947904302873479
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,24224,0.0056925512524609,0.0021942056024158,0.00139190827172594,0.00999319423319587,0.00948253046254248
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,29756,0.0103093434368322,0.00397553981647968,0.00251728539653206,0.0181014014771324,0.00951358553427742
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,24224,0.0114054747577816,0.00440864844703788,0.00276452380158739,0.0200464257139759,0.00968541375191526
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29815,-0.00428152859944663,0.00165704392319538,-0.00752933468890957,-0.00103372250998369,0.00977555776466351
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29429,0.0074125076759601,0.00287153319948055,0.00178430260497823,0.013040712746942,0.00984551951662292
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,29429,0.0125719180933479,0.00487285303120371,0.00302112615218859,0.0221227100345071,0.0098850861927942
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29340,-0.0316658046059297,0.0122988914422653,-0.0557716318327696,-0.00755997737908972,0.0100379202176498
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24727,-0.00847890410420793,0.0032992877107944,-0.0149455080173649,-0.00201230019105091,0.0101780180637096
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,24106,0.0153741475640421,0.00600006262533748,0.00361402481838062,0.0271342703097035,0.0104032354794532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,24190,0.00830193379439932,0.00324185610093416,0.00194789583656836,0.0146559717522303,0.0104474119595754
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24696,0.00515280729769754,0.0020127296786532,0.00120785712753727,0.00909775746785781,0.0104698337645836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24788,0.0115959410617819,0.0045308530212034,0.00271546914022323,0.0204764129833405,0.0104933440521348
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRN1,Neuritin,24863,-0.0060548001058924,0.00236908232994128,-0.0106982014725773,-0.00141139873920749,0.010601588377745
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,29213,0.00706850884480188,0.00276896475081528,0.00164133793320394,0.0124956797563998,0.010692281325142
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,29720,0.00498025347092809,0.001952356858051,0.00115363402914814,0.00880687291270805,0.0107496990934153
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24440,0.00770132925754886,0.00302151526775336,0.00177915933275228,0.0136234991823454,0.0108145536525381
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,24011,-0.00693051903662253,0.0027210806715412,-0.0122638371528433,-0.00159720092040177,0.0108723703102049
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,29720,0.00674790454798997,0.00265590582366902,0.00154232913359869,0.0119534799623813,0.0110675922061009
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28926,-0.00726085701130157,0.00286197747974128,-0.0128703328715945,-0.00165138115100867,0.0111856811074764
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,29344,0.00254994690754867,0.00100575561939932,0.000578665893525991,0.00452122792157134,0.0112385110327426
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24224,0.0104060915006959,0.0041070097770404,0.00235635233769675,0.0184558306636951,0.0112915224306975
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28926,0.0117829080214835,0.00465081320439998,0.00266731414085954,0.0208985019021075,0.0112977069645602
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,29708,0.00356266734944987,0.00140666115581598,0.000805611484050556,0.00631972321484919,0.0113235010322824
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28792,0.00560410992217053,0.00221871320786295,0.00125543203475915,0.00995278780958191,0.0115475926725706
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28792,0.00864226888910151,0.00342260175521975,0.00193396944887081,0.0153505683293322,0.0115732368607826
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29525,-0.0082120727016359,0.00325936238919986,-0.0146004229844676,-0.00182372241880417,0.0117562816296373
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28792,0.00882140876053785,0.00350365303823967,0.00195424880558811,0.0156885687154876,0.0118152683248514
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28769,0.00706834062737679,0.00281349938183837,0.00155388183897359,0.01258279941578,0.0120003040779076
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28769,0.0113292813201472,0.00451065931160047,0.00248838906941027,0.0201701735708841,0.012021621506772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24863,0.012725472774334,0.00507153407515665,0.00278526598702693,0.022665679561641,0.0121069442877032
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,29561,-0.00624355683358984,0.00250093786193879,-0.0111453950429899,-0.0013417186241898,0.0125484585730971
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,28830,0.00639473996604092,0.00256181546926173,0.00137358164628792,0.0114158982857939,0.0125596045172439
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24800,0.0046742701032362,0.00187793494272077,0.00099351761550348,0.00835502259096891,0.0128150779842842
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,29473,0.00847307292288689,0.00340983366751464,0.00178979893455819,0.0151563469112156,0.0129645340215281
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29669,0.00693322987008684,0.00279027351228943,0.00146429378599956,0.0124021659541741,0.0129684409042814
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,24096,0.014875383118301,0.00599389171676158,0.00312735535344828,0.0266234108831537,0.0130804044887669
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,29429,0.0115336208358165,0.00465648171268309,0.00240691667895769,0.0206603249926754,0.0132586296705685
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,29689,-0.00607095349442736,0.00245127277041226,-0.0108754481244354,-0.00126645886441932,0.0132675857701693
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,29589,0.00495543524616571,0.00200219459021113,0.00103113384935191,0.00887973664297952,0.0133291117530069
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28926,-0.00518530017059009,0.00209820720225248,-0.00929778628700496,-0.00107281405417522,0.01346798872452
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29748,0.00857041786388069,0.00346920640079843,0.00177077331831577,0.0153700624094456,0.0135007888319592
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,24011,0.0152925146995399,0.00619796290435336,0.00314450740700729,0.0274405219920725,0.01361882928807
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24106,0.0162848131204595,0.00660031131395201,0.00334820294511352,0.0292214232958054,0.0136213028972306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24917,0.0120701454215869,0.00489253899371671,0.00248076899390216,0.0216595218492717,0.0136297559838101
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28926,0.00645872440518868,0.00261892053962864,0.00132564014751655,0.0115918086628608,0.0136621011038945
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,24106,0.00654346255755981,0.00265427556063933,0.00134108245870673,0.0117458426564129,0.0136985478740757
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24440,0.00580018089994032,0.00235380264357563,0.00118672771853209,0.0104136340813485,0.0137397511589508
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24800,0.0240502658912405,0.00976359004556332,0.00491362940193636,0.0431869023805446,0.0137747277148688
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,29429,0.00982316724969893,0.00399956960654147,0.00198401082087764,0.0176623236785202,0.0140528619073046
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,24096,0.00872590775852173,0.0035645548262147,0.00173938029914093,0.0157124352179025,0.0143736213285789
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,29473,0.00581258883862981,0.00239031201287156,0.00112757729340156,0.0104976003838581,0.0150329028594541
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24497,0.00685577799947845,0.00282525536707992,0.00131827748000181,0.0123932785189551,0.0152480212480725
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,24190,0.00504923074416946,0.00208147726289101,0.000969535308903086,0.00912892617943583,0.0152822938536829
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24096,0.00788591616131959,0.0032592935941226,0.0014977007168393,0.0142741316057999,0.0155484926678856
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24235,0.00947668061056379,0.00392088109840831,0.00179175365768351,0.0171616075634441,0.015657332115669
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,28649,0.011305125146577,0.00467918522117606,0.00213392211307197,0.0204763281800821,0.015696308841805
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,23796,0.00624930697355472,0.00259789035712537,0.00115744187358901,0.0113411720735204,0.0161565471998882
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,24106,0.0177335873217555,0.00737528331205476,0.00327803203012822,0.0321891426133829,0.016203795062847
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,24917,0.0168467395069446,0.00701324770209842,0.00310077401083166,0.0305927050030575,0.0163071470702351
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24840,0.0126602866926446,0.00527271890824529,0.00232575763248385,0.0229948157528054,0.0163535044450087
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,24096,0.00939390617560716,0.00391763589563492,0.00171533982016272,0.0170724725310516,0.0164991481249429
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24800,0.00739682987981981,0.00308729406676484,0.00134573350896072,0.0134479262506789,0.0165872444902904
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24788,0.00825494233268174,0.00345289072151265,0.00148727651851695,0.0150226081468465,0.0168221624119806
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,29213,-0.00572368818746759,0.0023989293224557,-0.0104255896594808,-0.00102178671545442,0.0170421193776642
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,24224,0.00907698780807288,0.00380536371136377,0.00161847493379988,0.0165355006823459,0.0170721881748923
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,28623,-0.0176827227401369,0.0074182238771747,-0.0322224415393993,-0.00314300394087451,0.0171466628889666
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,29482,0.00495818345454479,0.00209210948133601,0.000857648871126213,0.00905871803796337,0.0177971550751241
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29344,0.0103132705804406,0.00435916672839327,0.00176930379278977,0.0188572373680914,0.0179936795462671
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,24011,0.0137033584254164,0.00579614907872244,0.00234290623112042,0.0250638106197124,0.0180761069172736
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,24011,0.00960872973791413,0.00407248699644441,0.00162665522488309,0.0175908042509452,0.0183112178943971
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24011,-0.00410299264037862,0.0017395724989457,-0.00751255473831219,-0.000693430542445051,0.0183509379531725
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,24440,0.0263621650898419,0.0111845197836464,0.00444050631389492,0.048283823865789,0.0184299754141258
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,24096,0.0169163051363444,0.00718120177501245,0.00284114965732005,0.0309914606153688,0.0184989451413468
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,24096,0.00683819816243237,0.00290357307576624,0.00114719493393055,0.0125292013909342,0.0185258149740048
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,24788,0.00331689430509871,0.00140861751670673,0.000556003972353514,0.00607778463784392,0.0185446209188519
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24224,0.00486797548992964,0.00206862549565122,0.000813469518453243,0.00892248146140604,0.01861849221279
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,24224,0.00434177034022165,0.00185284598759033,0.000710192204544601,0.00797334847589871,0.0191221563250227
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24190,0.011112270025743,0.00474391112750555,0.00181420421583213,0.0204103358356539,0.0191668004173747
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTTG1,Securin,24440,0.00643658792620943,0.00274875164395886,0.00104903470405006,0.0118241411483688,0.0192071954351493
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,24096,0.00732969867741178,0.00315400552906554,0.00114784784044333,0.0135115495143802,0.0201373437607162
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,24224,-0.00704663642996315,0.00304259819055061,-0.0130101288834423,-0.00108314397648396,0.0205669556958792
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,24198,0.0106726586109087,0.00462445923771799,0.00160871850498147,0.019736598716836,0.0210146709690274
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24440,0.00628479679361605,0.00272711878874231,0.000939643967681122,0.011629949619551,0.0211998226610608
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28769,0.00783419110889213,0.00340169036969489,0.00116687798429014,0.0145015042334941,0.0212843208457819
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29473,0.0048626144780858,0.00211234348002733,0.000722421257232237,0.00900280769893936,0.0213421179835719
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,24106,-0.0067407773118768,0.00293137349433193,-0.0124862693607674,-0.000995285262986206,0.021483448955483
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24800,0.00746280657820689,0.00324712925168413,0.001098433244906,0.0138271799115078,0.0215542402998856
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,24235,0.0112060369146076,0.00487644565853387,0.00164820342388124,0.020763870405334,0.0215706795746084
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,29815,0.00461133232957755,0.00201241361050435,0.000667001652989022,0.00855566300616608,0.0219447118885845
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,24190,-0.0103961166356804,0.00453751775302425,-0.019289651431608,-0.0015025818397529,0.0219635193956565
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24961,-0.00294863354429159,0.00128830985151956,-0.00547372085326994,-0.000423546235313243,0.0221015522018487
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,24440,0.0113225455180561,0.00495223917150457,0.00161615674190712,0.021028934294205,0.0222423867909129
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29473,0.00410810750830669,0.00179840166788083,0.000583240239260271,0.00763297477735311,0.0223603787128937
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,24190,-0.00439186325997061,0.00192623682050518,-0.00816728742816076,-0.000616439091780458,0.0226150227473405
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,29429,0.0102576249939029,0.00450096930783758,0.00143572515054126,0.0190795248372646,0.0226753075746879
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,24840,-0.0106495257906041,0.00469187367022765,-0.0198455981842503,-0.00145345339695788,0.023229409173485
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,29473,0.0175811162054297,0.00774596286304846,0.0023990289938547,0.0327632034170047,0.0232321681762404
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AFM,Afamin,24961,0.00292476486306818,0.00128978139807519,0.000396793322840811,0.00545273640329554,0.0233594370401349
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28792,0.00885923704187333,0.00390756353684184,0.00120041250966333,0.0165180615740833,0.023385255008668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",24106,0.00944204095891548,0.00417049666699599,0.00126786749160335,0.0176162144262276,0.023582428144733
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,24863,0.00868149780668453,0.00383467756501014,0.00116552977926465,0.0161974658341044,0.0235861011429603
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,28769,0.00529281233557047,0.00234060990939845,0.000705216913149514,0.00988040775799142,0.0237483583035356
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24096,-0.00683787698296456,0.00302402049153277,-0.0127649571463688,-0.000910796819560329,0.0237565384789769
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,29456,0.0281065550616669,0.0124458616645026,0.00371266619924177,0.0525004439240921,0.0239339214743998
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,29689,-0.0207684451054803,0.00919795736772049,-0.0387964415462124,-0.00274044866474813,0.0239565711911629
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24096,0.0111017391871118,0.00494852990865764,0.0014026205661428,0.0208008578080807,0.0248773866409248
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",24788,0.00644841277038744,0.00287458745971495,0.000814221349346144,0.0120826041914287,0.0248896231383784
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24788,0.00991872046552796,0.00443093544417445,0.00123408699494604,0.0186033539361099,0.0251962616194729
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28911,0.00558968834503148,0.00249912427583729,0.000691404764390401,0.0104879719256726,0.0253162452321714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,29815,0.00651436085172332,0.00291501279889154,0.000800935765895911,0.0122277859375507,0.0254403365732463
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,24440,0.00782638610047157,0.00350733924843354,0.000952001173541829,0.0147007710274013,0.0256616198951734
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28911,-0.00455561167159022,0.00204560699561257,-0.00856500138299086,-0.000546221960189586,0.0259534810748521
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24440,0.010869170013789,0.00488070860199227,0.00130298115388414,0.0204353588736939,0.0259586541516802
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,24224,0.00857521547267846,0.00386288206973037,0.00100396661600694,0.01614646432935,0.0264347206502868
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLGN,Calmegin,24190,0.00663036219014337,0.00298719964325929,0.000775450889355168,0.0124852734909316,0.0264557694867507
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,28911,-0.00832355545632265,0.00376732876727982,-0.0157075198401911,-0.000939591072454209,0.027154288237992
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,24863,0.00401193852159001,0.00181879607360974,0.00044709821731492,0.00757677882586511,0.0274056556529279
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,23897,0.00641210631072642,0.00291114725933615,0.000706257682427566,0.0121179549390253,0.0276321478866711
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,29720,-0.00553961672967157,0.00252722930356483,-0.0104929861646586,-0.000586247294684494,0.0283892366680986
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24800,0.00574189012416762,0.00263006566211189,0.000586961426428325,0.0108968188219069,0.0290323699112195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,28769,0.00831468364170841,0.00381692729371997,0.000833506146017266,0.0157958611373996,0.0293865233950259
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24933,-0.00380293030208487,0.00175155041775187,-0.00723596912087854,-0.000369891483291207,0.0299270140444594
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24106,0.00700823101195352,0.00322976148762623,0.000677898496206115,0.0133385635277009,0.0300248295215248
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,29815,0.00872508026714624,0.00402517104828638,0.000835745012504937,0.0166144155217875,0.0301947638784856
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29344,-0.00301501558497099,0.00139148449362533,-0.00574232519247665,-0.000287705977465338,0.0302610381638731
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24190,-0.0073907955567902,0.00341328110333694,-0.0140808265193306,-0.000700764594249803,0.0303740634337798
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27981,0.0041863431596139,0.00193466314632249,0.000394403392821815,0.00797828292640598,0.0304834163082841
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,24106,0.0113724912684041,0.00526249917191272,0.00105799289145518,0.021686989645353,0.0307017767775996
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28769,0.0208022920836483,0.00962621775069667,0.00193490529228286,0.0396696788750138,0.0307032834129763
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,29720,-0.00855956585965737,0.00396414591122881,-0.0163292918456658,-0.000789839873648909,0.0308390724716847
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29720,0.00860267897721665,0.00398809059624542,0.000786021408575628,0.0164193365458577,0.0310064787356361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,29815,0.00388586418927788,0.00180606083066972,0.000345984961165224,0.00742574341739053,0.0314393393867443
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29561,0.0140226037843585,0.00652623412448534,0.00123118490036724,0.0268140226683498,0.0316701240099375
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,24106,-0.00482112346635205,0.00224519929829063,-0.00922171409100169,-0.00042053284170241,0.0317791045774099
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28926,0.00644062552847755,0.0030062086400067,0.000548456594064404,0.0123327944628907,0.0321663137079943
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28769,0.00806848696874366,0.00376645095625261,0.000686243094488549,0.0154507308429988,0.0321858557357119
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,28769,-0.0105019560954399,0.00491336756371412,-0.0201321565203196,-0.000871755670560253,0.0325718254686378
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",24440,0.0064897700493476,0.00303989199767532,0.000531581733903977,0.0124479583647912,0.0327816653078119
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28911,0.00385960566146969,0.00181068463357446,0.00031066377966374,0.00740854754327564,0.033050414408726
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,24863,0.00623893421180384,0.00293063463232089,0.000494890332454898,0.0119829780911528,0.0332749911825637
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,24224,0.00550705665891107,0.00258724991404398,0.00043604682738487,0.0105780664904373,0.0333026698358798
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24376,-0.00905282514067824,0.00425492898225904,-0.017392485945906,-0.000713164335450524,0.0333795297842487
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,29584,-0.00481747589934848,0.002266543562022,-0.0092599012809116,-0.000375050517785361,0.0335554757430483
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24235,-0.003676994671439,0.0017304607513382,-0.00706869774406188,-0.000285291598816123,0.0336080144697573
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24863,0.0124439290930645,0.00585718652138882,0.000963843511142407,0.0239240146749866,0.0336334034763839
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24788,0.00402478217284623,0.00189722424839384,0.000306222645994299,0.00774334169969816,0.0338975840137668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,29429,0.0082170303109367,0.00388200383571489,0.000608302792935509,0.0158257578289379,0.0342938476307812
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24946,0.0060228116206254,0.00286197773782814,0.000413335254482247,0.0116322879867685,0.0353515534928567
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALLD,Palladin,24224,0.00556732921889499,0.00264845368554239,0.000376359995231897,0.0107582984425581,0.0355543318658166
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29438,0.0041837721607385,0.00199256949569675,0.000278335949172877,0.00808920837230412,0.0357648823819605
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSPN,Persephin,29429,0.0130514948504885,0.00622594348188213,0.000848645625999563,0.0252543440749775,0.0360634021690562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29429,-0.00510746765326993,0.00243784198852366,-0.0098856379507763,-0.000329297355763547,0.0361726421499123
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,24224,0.00567380841517218,0.00270848488602863,0.000365178038556058,0.0109824387917883,0.0361967018934008
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,24917,0.00681477567700563,0.00326021450596852,0.000424755245307335,0.0132047961087039,0.0366023709373169
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29344,0.00758626040462753,0.00363204333430954,0.000467455469380822,0.0147050653398742,0.0367430517540901
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,24011,0.00569102632624341,0.0027289626548521,0.000342259522733288,0.0110397931297535,0.037041964518847
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29720,0.00795530816253983,0.00381801026082215,0.000472008051328412,0.0154386082737513,0.0372026621495586
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,29689,0.0049954808313709,0.00239810720993537,0.000295190699897582,0.00969577096284421,0.0372512681572756
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24321,0.00746839147890109,0.00360011841208356,0.000412159391217322,0.0145246235665849,0.0380447935338606
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24096,0.00397075408358051,0.00191673714971607,0.000213949270137008,0.00772755889702402,0.0383113652942887
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24788,0.0133163870510068,0.00644245649917017,0.000689172312633251,0.0259436017893803,0.0387470116398417
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28926,0.00796662281718194,0.00386433067009134,0.000392534703802927,0.015540710930561,0.0392567568115134
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24235,0.00654990629910626,0.00318240178822712,0.000312398794181101,0.0127874138040314,0.0395850219747687
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,24914,0.00763492419401898,0.00371294625585945,0.000357549532534448,0.0149122988555035,0.0397641932871662
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28769,0.00748903764570793,0.00365086436397768,0.000333343492311681,0.0146447317991042,0.040246258071412
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,24096,0.00648131541445173,0.00316603642110198,0.000275884029091843,0.0126867467998116,0.0406553048174832
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,24933,-0.00736661196088469,0.00360345250873892,-0.014429378878013,-0.000303845043756406,0.0409323791649478
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,24106,0.00518846176047624,0.00255347075228129,0.000183659086004912,0.0101932644349476,0.0421721708501434
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,24224,0.00865663259847915,0.00427167581248179,0.000284148006014848,0.0170291171909435,0.0427225580385172
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,29291,0.00415066652937515,0.00204850021636945,0.000135606105291022,0.00816572695345927,0.04275357283255
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24440,0.00717604081230875,0.00354753647910295,0.000222869313266969,0.0141292123113505,0.0431022016664136
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,28926,-0.00407081873607244,0.00201630522055357,-0.00802277696835743,-0.000118860503787442,0.0435016639176792
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24106,0.00651619603725903,0.00323661709239888,0.000172426536157236,0.0128599655383608,0.0440969449263563
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,24933,0.00444102241982799,0.00220782271487765,0.000113689898667802,0.00876835494098819,0.0442840359024096
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,28825,0.00649505828062115,0.00323222236234918,0.000159902450416746,0.0128302141108255,0.0444964760395734
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,24788,-0.00898545160871535,0.00448480003001851,-0.0177756596675516,-0.000195243549879072,0.0451308176907558
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,24011,0.00969386419194942,0.00484367352770266,0.000200264077652199,0.0191874643062466,0.045366409286164
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,28926,0.0108693362409413,0.00545500609527724,0.000177524294197894,0.0215611481876847,0.0463208570621551
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24096,0.00649536782209162,0.00326152283341964,0.000102783068589133,0.0128879525755941,0.0464357027736211
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24840,0.00485197574324425,0.00245029430228249,4.93989107705596e-05,0.00965455257571793,0.0476965310019937
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LXN,Latexin,29112,0.00880452754538381,0.0044536444613936,7.53844010523662e-05,0.0175336706897153,0.0480593691554597
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24172,0.00765954804943565,0.00387518809548418,6.41793822866591e-05,0.0152549167165846,0.048102559300168
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,24788,0.00629627546112351,0.00318942100391969,4.5010293440912e-05,0.0125475406288061,0.0483800575454044
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24106,0.0113124685658496,0.00573471378141106,7.24295542839249e-05,0.0225525075774153,0.0485491458221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24106,0.00671901260766457,0.0034083062827104,3.87322935521857e-05,0.013399292921777,0.0486936708585363
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,29473,-0.00405558433170222,0.0020590817361899,-0.00809138453463442,-1.97841287700182e-05,0.0488926422833791
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,24096,0.00367700487614095,0.00186685797536561,1.79632444243512e-05,0.00733604650785755,0.048893130701632
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24096,0.0119070286043864,0.00605725526688161,3.48082812984853e-05,0.0237792489274744,0.049339367483678
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24106,0.00425037657750509,0.00216242981497276,1.20141401584737e-05,0.0084887390148517,0.0493614066593683
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,29540,0.00361099893885119,0.00183826151552232,8.0063684274388e-06,0.00721399150927495,0.0494982561143657
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,24096,0.0110319939813903,0.00561804059749896,2.06344102923056e-05,0.0220433535524882,0.0495795265563727
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,24224,0.0034823760754421,0.00177374092023137,5.8438717886254e-06,0.00695890827909558,0.0496233751233581
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,24440,0.00300022336902159,0.00152875956325193,3.85462504781274e-06,0.00599659211299538,0.0497131448259518
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,28419,0.0119009898203197,0.00607117961252527,1.47777977020647e-06,0.0238005018608693,0.0499771075576045
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24788,0.00583291774506113,0.00297777058487463,-3.51260129313833e-06,0.0116693480914154,0.0501450259025077
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24096,0.00795920869255885,0.00407380182517078,-2.54428847758868e-05,0.0159438602698936,0.0507418166019722
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,28792,0.00460194411857037,0.0023558675420652,-1.55562638774259e-05,0.00921944450101817,0.0507822711529283
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29344,-0.0134081330536945,0.00686776655477334,-0.0268689555010502,5.26893936612597e-05,0.0509087736165942
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24440,0.00840190139503067,0.0043055330777487,-3.69434373567804e-05,0.0168407462274181,0.0510185727104613
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,24096,0.00634604400917496,0.00326861647262391,-6.04442771679039e-05,0.0127525322955178,0.0522083765196175
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24788,0.00513466150019992,0.00265023660491416,-5.98022454318271e-05,0.0103291252458317,0.0527035272823892
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29429,0.00452335513376098,0.00233648295352579,-5.6151455149556e-05,0.00910286172267153,0.0528812466945494
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,24235,0.0103372412384847,0.00534006848536884,-0.000129292992838244,0.0208037754698076,0.0529052762569256
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28769,0.00822167020075076,0.0042484522621449,-0.000105296233053248,0.0165486366345548,0.0529736629206246
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24224,0.00572155370925197,0.00296002020027725,-8.00858832914423e-05,0.0115231933017954,0.0532547264537707
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,28792,0.011136868357051,0.00576392921717704,-0.000160432908615997,0.022434169622718,0.053348816930308
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28769,0.00527354682593421,0.0027314931696284,-8.01797865374598e-05,0.0106272734384059,0.0535366438840115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,24822,0.00304972341313747,0.00158000858730635,-4.70934179829844e-05,0.00614654024425792,0.0535941650196999
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24317,-0.00624105206571776,0.00323736950423336,-0.0125862962940151,0.000104192162579632,0.0538896805409194
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,24946,-0.0061748093716328,0.00320544800412071,-0.0124574874597094,0.000107868716443785,0.0540722504396432
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24788,0.0044747561678648,0.00233078677450521,-9.35859101654016e-05,0.009043098245895,0.0548885808002524
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29561,-0.00304688043670224,0.00158854342605252,-0.00616042555176517,6.66646783607006e-05,0.0551163168535577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,28874,0.00543265472510007,0.00283415701883181,-0.00012229303181027,0.0109876024820104,0.0552668163050784
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28792,0.00757227146350001,0.00395900711410362,-0.000187382480143073,0.0153319254071431,0.0558003137792011
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28792,0.00501791052734744,0.00264172757507847,-0.000159875519806355,0.0101956965745012,0.0575112911474217
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERVV_1,,24106,0.00581938003549601,0.00306675785682073,-0.000191465363872619,0.0118302254348646,0.0577650230634188
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,28926,0.00490634737348627,0.00258584511231553,-0.000161909046652175,0.00997460379362472,0.0577869115772291
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIT,Vitrin,24917,-0.00472496943984758,0.00249265577540002,-0.00961057475963161,0.000160635879936454,0.0580303036254556
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,24190,0.00637598657405675,0.00337551719186765,-0.000240027122003842,0.0129920002701173,0.0589182933348341
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29576,0.00352934490655902,0.00187106796117732,-0.000137948297348531,0.00719663811046657,0.0592679737513751
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24011,0.00833798914716444,0.00442920307859624,-0.000343248886884187,0.0170192271812131,0.0597798083240619
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,29429,-0.00487286991835415,0.00260105346527283,-0.00997093471028888,0.000225194873580592,0.0610200881197576
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,24800,0.00756716606159009,0.00405202836227327,-0.000374809528465522,0.0155091416516457,0.0618434835262186
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,24106,0.00426422495714089,0.00228501402175498,-0.000214402525498878,0.00874285243978065,0.0620297051129949
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24096,0.00618595931426123,0.00331801599211008,-0.000317352030274534,0.012689270658797,0.0622840414002657
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,24190,0.00847670516593935,0.00455124228076759,-0.000443729704365126,0.0173971400362438,0.0625442582744253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24788,0.00687681593797223,0.00369541235218382,-0.000366192272308052,0.0141198241482525,0.0627692547214332
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24917,-0.00730951936180869,0.0039373192056212,-0.0150266650048262,0.000407626281208848,0.0633982386039531
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,24190,0.0033678910911974,0.001816987579529,-0.000193404564679438,0.00692918674707424,0.0638146555136365
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,24440,0.00435951488127281,0.00235233721586351,-0.000251066061819668,0.00897009582436529,0.0638557871136373
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,24376,-0.00494498844425128,0.00267261314917652,-0.0101833102166373,0.000293333328134701,0.0642903816817639
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,29745,0.00660333740195546,0.00357339011522763,-0.000400507223890702,0.0136071820278016,0.0646239094805336
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,28792,0.00748487439933681,0.00405989913587935,-0.000472527906986714,0.0154422767056603,0.0652501375799677
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,24106,0.00742890878390276,0.00403172034815605,-0.0004732630984831,0.0153310806662886,0.0653975069300376
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24840,0.00476561645311837,0.00259301631323844,-0.000316695520828975,0.00984792842706572,0.0660940988808027
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24096,-0.00462056312174467,0.00251573794387969,-0.00955140949174887,0.000310283248259531,0.0662719591800426
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,29314,0.00958614454752249,0.00523083482847113,-0.000666291716280926,0.0198385808113259,0.0668689019555918
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,28926,0.00572940646623229,0.00312869901699054,-0.000402843607069176,0.0118616565395337,0.0670746473184426
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,28769,0.00470690434561146,0.00257100837789899,-0.000332272075070557,0.00974608076629348,0.0671464229994274
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24106,-0.00494835167320219,0.00271076301518141,-0.0102614471829578,0.000364743836553375,0.0679461173582613
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29589,-0.00401887597661643,0.00220379697792564,-0.00833831805335068,0.000300566100117826,0.0682204707886736
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,24106,0.00405506313368434,0.00222387702678507,-0.000303735838814401,0.00841386210618309,0.068252100622396
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,24946,-0.00723909826018928,0.00397274362105233,-0.0150256757574519,0.000547479237073294,0.0684379609644437
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,24106,0.00611140194910347,0.00336170780724968,-0.000477545353105906,0.0127003492513129,0.0690848599718754
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,24011,0.00763396710118269,0.0042035894232174,-0.000605068168323416,0.0158730023706888,0.0693737694440444
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,29484,0.00330833782943069,0.00182254077800175,-0.000263842095452742,0.00688051775431412,0.0694981298897961
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,28926,0.0092257293804034,0.0050829784287283,-0.00073690833990407,0.0191883671007109,0.0695305316195643
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,24011,0.00639135320748242,0.00352368890097178,-0.000515077038422268,0.0132977834533871,0.0697172359792127
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,24190,0.00696676566764657,0.00384355447235104,-0.000566601098161474,0.0145001324334546,0.0699083926080851
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29033,0.020575287952104,0.0113777555878603,-0.00172511300010214,0.0428756889043102,0.0705579675175754
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24788,0.00444904364749371,0.00246851356465666,-0.000389242939233352,0.00928733023422077,0.0715077151777887
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24190,0.00626188062036215,0.00347619782709755,-0.000551467120749057,0.0130752283614734,0.0716587518719852
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28911,0.00374486233556206,0.00207946065987867,-0.000330880557800135,0.00782060522892426,0.0717319738328858
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29399,-0.00236639332432301,0.00131842014697515,-0.0049504968123943,0.000217710163748291,0.0726846208860553
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,29213,0.0062732877781562,0.00350221994197653,-0.000591063308117794,0.0131376388644302,0.0732664561790307
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,28926,0.00944577774236554,0.00527369145269687,-0.000890657504920329,0.0197822129896514,0.0732856069817117
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29429,-0.00607398071580905,0.00339637068203305,-0.0127308672525938,0.000582905820975719,0.0737259910227569
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,28621,0.00795510030522431,0.00445497575921597,-0.000776652182838993,0.0166868527932876,0.0741638864588669
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,28109,-0.00331613792763278,0.00186353523212735,-0.00696866698260238,0.000336391127336827,0.075170655345061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,29328,-0.00403406287114517,0.0022691511214858,-0.00848159906925735,0.000413473326967,0.0754495339354459
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,28926,0.00567692210500511,0.0031970635325836,-0.000589322418858747,0.011943166628869,0.0757982382457093
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,24946,-0.00308328663559313,0.00173723256576186,-0.00648826246448637,0.000321689193300114,0.0759387150685832
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,24224,0.00640495206031182,0.0036104489786081,-0.000671527937760057,0.0134814320583837,0.0760750030358094
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24011,0.00655667341803033,0.00369942132625872,-0.000694192381436773,0.0138075392174974,0.0763489805220284
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,29815,0.00292925259751645,0.00165339307759734,-0.000311397834574348,0.00616990302960724,0.0764610075917394
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24011,0.00695166171326686,0.00394053333184557,-0.000771783617150454,0.0146751070436842,0.0777207378434655
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28926,0.00498265182787234,0.00282506395652809,-0.00055447352692271,0.0105197771826674,0.0777879018953756
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24096,0.00381820251191247,0.00217506747685977,-0.000444929742732676,0.00808133476655761,0.0791966262108205
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24863,0.00881089434952016,0.00501982001896129,-0.00102795288764397,0.0186497415866843,0.079233806171477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,28769,0.00761393419974792,0.00434352890236291,-0.000899382448883391,0.0161272508483792,0.0796234109942792
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29344,0.00307707649900006,0.00176224954232826,-0.000376932603963333,0.00653108560196346,0.0808028065643523
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29815,0.0080887989739937,0.00464034634357968,-0.00100627985942247,0.0171838778074099,0.0813185109849509
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,24788,-0.00437124672137745,0.00251624901380715,-0.00930309478843947,0.000560601345684578,0.0823629753505927
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,24106,-0.0068001467338733,0.0039348622323331,-0.0145124767092462,0.000912183241499583,0.083968930161645
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,24190,-0.00384827978724732,0.00223039328404563,-0.00821985062397676,0.000523291049482124,0.0844714834699955
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24224,0.00410150219562203,0.00237820475124363,-0.000559779116815491,0.00876278350805955,0.0846085343552544
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29650,0.003494390383033,0.00202673982920211,-0.000478019682203133,0.00746680044826913,0.0846923618975285
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24106,0.00977793270738943,0.00568249651393904,-0.00135976045993108,0.0209156258747099,0.0853161688253176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24106,0.0111777056313313,0.00652186378018428,-0.0016051473778299,0.0239605586404925,0.0865632432328486
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29473,0.00200304288189274,0.0011689260031943,-0.000288052084368087,0.00429413784815356,0.0866172492357126
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24863,-0.00479449938734153,0.00280020676502384,-0.0102829046467883,0.000693905872105205,0.086873257136434
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,28911,-0.00596470876686686,0.00348929581557098,-0.012803728565386,0.000874311031652261,0.0873819678152165
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29164,0.00380573384459907,0.00222702421949362,-0.000559233625608412,0.00817070131480656,0.0874824357452717
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,24106,0.00837975425366104,0.00490640468144158,-0.00123679892196446,0.0179963074292865,0.0876637840704959
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,28792,0.00924030336672789,0.00541379537194094,-0.00137073556227635,0.0198513422957321,0.0878687351456376
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,24190,0.00681153518570975,0.00402049813141453,-0.00106864115186272,0.0146917115232822,0.0902398225036356
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,24788,-0.00443012183005604,0.00261626231500622,-0.00955799596746823,0.000697752307356158,0.0904105972440391
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GH1,Somatotropin,29428,0.0197203437615058,0.0117532219720815,-0.00331597130377382,0.0427566588267855,0.0933836820926401
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,28926,0.00484169977803355,0.00289121236849654,-0.000825076464219671,0.0105084760202868,0.0940184246137585
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,24190,0.0114899452846896,0.00686294555511126,-0.00196142800332843,0.0249413185727077,0.0941041820428985
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29731,-0.00513531261937621,0.00308057496013335,-0.0111732395412376,0.000902614302485162,0.0955253194780375
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,24106,0.00613661072890672,0.00368409314626426,-0.00108421183777123,0.0133574332955847,0.095785275742617
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24190,0.00934814747753593,0.00561404592314778,-0.00165538253183373,0.0203516774869056,0.0958986718193981
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24190,-0.00691054383948979,0.00415254686305978,-0.015049535691087,0.00122844801210737,0.0960914245379734
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29213,-0.00314849975501405,0.00189306750511031,-0.00685891206503024,0.000561912555002154,0.0962884377290339
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,24235,0.00660755583216077,0.0039805492843267,-0.00119432076511955,0.0144094324294411,0.0969352809623946
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSC1,Hamartin,24224,0.00826273670635359,0.00497782747749302,-0.00149380514953274,0.0180192785622399,0.0969458703600248
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,24106,-0.00393911508621889,0.00238093396147081,-0.00860574565070168,0.0007275154782639,0.098050940892668
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28911,0.00677823647856413,0.0041013031361405,-0.00126031766827124,0.0148167906253995,0.0984021632496781
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,29473,-0.00419922368232515,0.00254479510304297,-0.00918702208428937,0.000788574719639064,0.098928542439243
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,29815,0.00643535091194838,0.00390825274077877,-0.00122482445997801,0.0140955262838748,0.0996496795022254
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29561,-0.00315734165488997,0.00192131178382381,-0.00692311275118463,0.0006084294414047,0.10032613665733
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24011,0.0156624938981944,0.00953706573502617,-0.00303015494245688,0.0343551427388457,0.100545927183698
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24224,0.00477996263116321,0.00291503836271958,-0.000933512559767175,0.0104934378220936,0.101068118407328
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24096,0.00839833985972027,0.00512722836449003,-0.0016510277346802,0.0184477074541207,0.101437207603432
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29390,-0.00316886769699367,0.00193792486682052,-0.0069672004359619,0.000629465041974554,0.102020766946302
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,24840,0.00415389735179172,0.0025422172192556,-0.000828848397949247,0.00913664310153268,0.102278599451672
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24799,0.00919782783133127,0.00563723020558031,-0.00185114337160615,0.0202467990342687,0.102771882454894
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,24440,0.00777492405552291,0.00477024815293638,-0.00157476232423239,0.0171246104352782,0.103140110318505
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,28746,0.00936107975110474,0.00575662698385087,-0.00192190913724296,0.0206440686394524,0.103930904314005
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,24224,0.00281867390476281,0.0017371533828403,-0.000586146725604181,0.0062234945351298,0.10469179982542
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28911,0.00469085834456749,0.00289282455341876,-0.000979077780133279,0.0103607944692683,0.104910742840634
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,24011,-0.004766010366014,0.00294596499484714,-0.0105401017559144,0.00100808102388639,0.105716785954476
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28388,-0.00685202111175708,0.00424322780319961,-0.0151687476060283,0.00146470538251416,0.106362229543196
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29385,-0.00246230019559996,0.00152543550246388,-0.00545215378042917,0.000527553389229244,0.106503009497169
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,29322,0.00633638494840869,0.00392690361038911,-0.00136034612795398,0.0140331160247714,0.106628670390537
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,29438,-0.00210088968865045,0.00130367905795607,-0.00465610064224436,0.000454321264943451,0.107079694182172
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,24096,0.00457461165325536,0.00284282514897148,-0.000997325638728738,0.0101465489452395,0.107590535800201
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,29815,0.00320068604913574,0.00199325145153723,-0.000706086795877234,0.00710745889414871,0.108336961387399
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,24106,0.00474638158549463,0.00295995486394498,-0.00105512994783753,0.0105478931188268,0.108830415122001
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,29689,-0.00229960766469501,0.00143426902215399,-0.00511077494811684,0.000511559618726823,0.108872287764644
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24190,0.00894279782876132,0.00558606396113555,-0.00200588753506435,0.019891483192587,0.109409437480612
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,23965,0.00845832508859214,0.00530055948312649,-0.00193077149833579,0.0188474216755201,0.11055961364026
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,24440,0.00390261325189998,0.00244780905974196,-0.000895092505194253,0.00870031900899422,0.110875278075795
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24106,0.00392972022911191,0.00246714728012943,-0.00090588843994177,0.00876532889816558,0.111213814364376
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,24440,0.00412340114159155,0.00259120577222677,-0.000955362171972931,0.00920216445515602,0.111553681011301
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24096,0.00610383142776178,0.00383710962433485,-0.00141690343593453,0.0136245662914581,0.111681950783253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24011,0.00539045878779753,0.00339234983330552,-0.00125854688548128,0.0120394644610763,0.112072574805008
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24106,0.00390951473374485,0.00247757643780267,-0.00094653508434838,0.00876556455183807,0.114588093751456
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,29434,-0.00612274174192906,0.00391398448513747,-0.0137941513327985,0.00154866784894038,0.11775214172242
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24800,-0.00354562650148642,0.00226869429115565,-0.0079922673121515,0.000901014309178656,0.118100893141152
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29373,0.00674772947103037,0.00432693431909872,-0.00173306179440311,0.0152285207364639,0.118895673642713
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPGN,Epigen,24788,-0.00495163798366515,0.00318254321792559,-0.0111894226907993,0.00128614672346901,0.119750701015842
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,24917,0.00304957842422279,0.00196141038393685,-0.000794785928293437,0.00689394277673901,0.12000914246991
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24235,0.00417779127355377,0.00269122953804479,-0.00109701862101402,0.00945260116812156,0.120586136332178
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,29720,0.006466948329986,0.0041715002755011,-0.00170919220999616,0.0146430888699682,0.121087573267358
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,29720,0.0032611053750424,0.00210445518278899,-0.000863626783224024,0.00738583753330883,0.121243455661798
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24235,0.00623487335179,0.00402570956744175,-0.00165551740039583,0.0141252641039758,0.121451569547288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,24224,-0.00224837083292246,0.00145232572334255,-0.00509492925067385,0.00059818758482894,0.121607086296594
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24376,-0.00330689796897699,0.00213750192239772,-0.00749640173687653,0.000882605798922544,0.12185564872942
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,24011,-0.00651159363016376,0.00420993196986747,-0.014763060291104,0.00173987303077648,0.121943526504517
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,28926,0.0145873797509246,0.00943355663319197,-0.00390239125013169,0.0330771507519808,0.122036139229327
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,29428,0.00307444586973244,0.00198929800780361,-0.000824578225562631,0.0069734699650275,0.122237852489324
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24011,-0.00817546767540838,0.00529744234226857,-0.0185584546662548,0.00220751931543803,0.122774627557181
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,24106,0.0074390026380468,0.0048421214385677,-0.00205155538154589,0.0169295606576395,0.124475345677715
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28769,0.00484115606716471,0.00315250926972652,-0.00133776210149928,0.0110200742358287,0.124634841171389
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,24011,0.00607219036375968,0.00395436359105446,-0.00167836227470706,0.0138227430022264,0.124657788785714
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24011,0.00671785133818101,0.00437703647076453,-0.00186114014451747,0.0152968428208795,0.124847506847811
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,29274,0.00612024468279439,0.00399031416076457,-0.00170077107230417,0.0139412604378929,0.125095791312291
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,28769,-0.0043523444197788,0.00283814610137715,-0.009915110778478,0.0012104219389204,0.125159598760408
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24224,0.00296208766644898,0.00193307843580761,-0.000826746067733944,0.0067509214006319,0.125457458111501
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24224,0.0029999040658137,0.00195984843415406,-0.000841398865128259,0.00684120699675567,0.12586115276229
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,24190,-0.00419405500362057,0.00274009740928202,-0.00956464592581333,0.00117653591857218,0.125875778363262
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24224,0.00369931031014937,0.00242524554260289,-0.0010541709533523,0.00845279157365104,0.127188789199525
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24106,-0.00400876993550019,0.00264388183201657,-0.00919077832625267,0.00117323845525228,0.129470788759054
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24863,0.0116009143327708,0.00765697002300487,-0.00340674691231874,0.0266085755778603,0.129765123508916
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24106,0.00205225897416204,0.00135751792855162,-0.000608476165799147,0.00471299411412322,0.130604732186383
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,24106,0.00519635292471238,0.00344074175254091,-0.0015475009102678,0.0119402067596926,0.130994783774431
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24096,0.00628955280528145,0.00416898741483228,-0.00188166252778981,0.0144607681383527,0.1314007582356
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,24190,0.00601135504449085,0.00400454064615658,-0.00183754462197604,0.0138602547109577,0.133333777002923
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,24224,0.0105441878509627,0.00703338154134367,-0.00324123997007087,0.0243296156719963,0.133844298639275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24106,0.00373931903062385,0.00250149732732933,-0.00116361573094165,0.00864225379218934,0.134971308873403
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,28769,0.00512332040301641,0.00342843960656163,-0.00159642122584438,0.0118430620318772,0.135092722219586
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,28926,0.00559372906296001,0.00374395333276363,-0.0017444194692567,0.0129318775951767,0.135168187916645
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRTN,Neurturin,28926,0.00487919564888002,0.00328075894342506,-0.00155109188023309,0.0113094831779931,0.136968801029387
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24440,0.00550498797981565,0.00370288376381785,-0.00175266419726733,0.0127626401568986,0.137113343200234
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,24064,-0.00966143957454552,0.00651092668097448,-0.0224228558692555,0.00309997672016446,0.137853631514438
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29213,0.00685896009355517,0.00462613335859732,-0.00220826128929557,0.0159261814764059,0.138176869173878
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,29492,0.0048856847792076,0.00329585613657323,-0.00157419324847593,0.0113455628068911,0.138252035795469
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,29429,0.0034018477820399,0.00230006899790412,-0.00110628745385219,0.00790998301793198,0.139145708983101
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,29438,0.00636801189759916,0.00431271616151181,-0.00208491177896398,0.0148209355741623,0.139802598217001
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,24096,0.00891748305771353,0.00604129356221352,-0.00292345232422497,0.020758418439652,0.139933250263547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,24054,0.00835915240685768,0.00566417570559398,-0.00274263197610652,0.0194609367898219,0.140012494186814
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,24917,0.00792973263723719,0.00540218092381731,-0.00265854197344474,0.0185180072479191,0.142150492182163
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23965,0.00510145238625971,0.00347983838474758,-0.00171903084784555,0.011921935620365,0.142660685633163
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAYN,Layilin,29158,0.0033911681674854,0.00231467193637046,-0.00114558882780071,0.0079279251627715,0.14291122263489
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,28926,0.00633414968717704,0.00432647502086575,-0.00214574135371982,0.0148140407280739,0.143192805618984
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28769,0.00388091570615573,0.00265272248127015,-0.00131842035713377,0.00908025176944523,0.143480091625547
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,24224,0.00545786759633153,0.00373959684348942,-0.00187174221690773,0.0127874774095708,0.144445957499594
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24096,0.00742651522139873,0.00510960666441521,-0.00258831384085507,0.0174413442836525,0.146114195792848
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,24788,-0.00495331836110144,0.00340956731047606,-0.0116360702896345,0.00172943356743164,0.146300186737861
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,28769,0.00462357739898481,0.00318974988826743,-0.00162833238201936,0.010875487179989,0.147205849610222
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,29781,0.0036132313663686,0.0024931121987692,-0.00127326854321904,0.00849973127595624,0.147268402496044
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28769,0.00369013949424446,0.00254899521076621,-0.00130589111885731,0.00868617010734623,0.14771635857063
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24863,-0.00284056599881399,0.00196601922882293,-0.00669396368730694,0.00101283168967895,0.148517903439228
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TTN,Titin,24106,-0.00644298615917711,0.00446209397352828,-0.0151886903472925,0.00230271802893832,0.148769475741761
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29438,0.00409237038557183,0.00283465761177159,-0.00146355853350048,0.00964829930464414,0.148836490944891
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,29473,0.00340810718226602,0.00236307640381236,-0.00122352256920621,0.00803973693373825,0.14924723599337
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,29486,-0.0061699338560184,0.00428131911619158,-0.0145613193237539,0.0022214516117171,0.149558818719838
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29627,0.00678483966550257,0.00471734208847722,-0.00246115082791277,0.0160308301589179,0.150366341172178
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28926,0.00530226530864912,0.00369457231202563,-0.00193909642292111,0.0125436270402194,0.151255186587756
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,28769,0.00503864666017918,0.00351193578353021,-0.00184474747554003,0.0119220407958984,0.151377603334213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24224,0.00826500314358876,0.005765648641728,-0.00303566819419812,0.0195656744813756,0.151730596603317
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,24011,0.00351540203842852,0.00245683754626615,-0.00129999955225313,0.00833080362911017,0.152482026581782
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24224,0.00621590814315908,0.00435150909118064,-0.00231304967555498,0.0147448659618731,0.153175608535181
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,24224,0.00653860115472956,0.0045974705541931,-0.00247244113148892,0.015549643440948,0.154976124445518
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24440,0.00365887982239527,0.00257635917936319,-0.00139078416915659,0.00870854381394712,0.155569624678314
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,28792,0.0155479127958611,0.0109754531011652,-0.0059639752824227,0.0370598008741449,0.156608442451805
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,24224,0.00534736312493063,0.00377559078259302,-0.00205279480895169,0.0127475210588129,0.156701026452415
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24440,0.00498735834853477,0.00352556975034014,-0.00192275836213189,0.0118974750592014,0.157191284998221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,29390,0.00777703261790282,0.00549809362762099,-0.00299923089223432,0.01855329612804,0.157226857106662
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,24224,-0.0072013855270178,0.00509278793954593,-0.0171832498885278,0.00278047883449222,0.157364189258125
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,29720,-0.00429430975620875,0.00303906602227976,-0.0102508791598771,0.00166225964745958,0.157655610867381
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24224,0.00541129979244658,0.00383244976814643,-0.00210030175312042,0.0129229013380136,0.157971978215539
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,24096,-0.00351457316526956,0.00249406163525524,-0.00840293397036984,0.00137378763983071,0.158795882768453
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C7,Complement component C7,24369,-0.00301076530718336,0.00215423499661868,-0.00723306590055598,0.00121153528618926,0.162245045062576
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,24224,0.00406590554405672,0.00291306285843175,-0.0016436976584695,0.00977550874658295,0.162802792358739
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28911,0.00450598078874193,0.00324127604135598,-0.0018469202523158,0.0108588818297997,0.164482716454641
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,24224,0.00199968928588068,0.00143846947501543,-0.000819710885149553,0.00481908945691091,0.164495913716971
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,24863,-0.0057120529317986,0.00412882630958807,-0.0138045524985912,0.00238044663499402,0.166537265545025
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,24224,0.00572283570323903,0.00414519376512194,-0.00240174407639997,0.013847415482878,0.167416124803723
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29473,0.00611994956058758,0.0044340263604501,-0.00257074210589463,0.0148106412270698,0.16752816273934
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24106,0.00632687104916725,0.00460942835593021,-0.00270760852845596,0.0153613506267905,0.169891554552437
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24440,-0.00399398403935769,0.0029149744631589,-0.00970733398714913,0.00171936590843374,0.170649273080909
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,28926,-0.005400850923886,0.00394700680089874,-0.0131369842536475,0.00233528240587552,0.171216020248483
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCN,Decorin,28911,-0.00206958748883567,0.00151963769867773,-0.00504807737824401,0.000908902400572674,0.173241535929158
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24104,0.00370548737519227,0.0027365768900437,-0.00165820332929337,0.00906917807967792,0.175730162805434
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,24961,-0.00293634135060645,0.00216949853302017,-0.00718855847532599,0.00131587577411309,0.175919237118213
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28792,0.00434047167709495,0.00324817386260221,-0.00202594909360537,0.0107068924477953,0.181468144689758
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,29720,0.00407559470037809,0.0030525810144971,-0.00190746408803623,0.0100586534887924,0.181843796358331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24800,-0.0151674382071445,0.0114353960343403,-0.0375808144344514,0.0072459380201625,0.184733098458154
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24224,-0.00307994525905638,0.00232957490418121,-0.00764591207125155,0.00148602155313879,0.186145303987799
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24863,0.00319796350804126,0.00242222989661578,-0.00154960708932567,0.00794553410540818,0.186761727745018
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24096,0.0049294480914331,0.00373514725241436,-0.00239144052329905,0.0122503367061653,0.186932162986011
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28769,-0.005960543751291,0.00451912350600779,-0.0148180258230663,0.00289693832048427,0.187192943533473
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24106,0.00520646103590357,0.00395250988149756,-0.00254045833183165,0.0129533804036388,0.187765892006176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,29438,-0.00427519160676513,0.00324964371112838,-0.0106444932805768,0.0020941100670465,0.188322682555459
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,28926,0.00485831453737748,0.00369322419588526,-0.00238040488655763,0.0120970339613126,0.188363433972954
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24011,-0.00221521792828369,0.00168884330976178,-0.00552535081541679,0.00109491495884941,0.189641488522332
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24096,0.00298013734433457,0.00227692808623643,-0.00148264170468883,0.00744291639335797,0.190600628882635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24011,0.0066476860637415,0.00508668446914191,-0.00332221549577665,0.0166175876232596,0.191266001911478
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,29438,-0.00291287107384699,0.00223644958710519,-0.00729631226457316,0.00147057011687918,0.192771677364348
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24946,-0.0054332846455073,0.00418625364857274,-0.0136383417967099,0.00277177250569526,0.194338137381216
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29344,0.0037449242471298,0.0028937821520683,-0.00192688877092407,0.00941673726518367,0.19563143219746
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,24106,0.00292837864589135,0.00226697678766516,-0.00151489585793237,0.00737165314971507,0.196454388554043
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,29513,-0.00386457774621959,0.00299904702963737,-0.00974270992430883,0.00201355443186966,0.19754662323421
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,24885,0.00397904348622973,0.00309107622685826,-0.00207946591841246,0.0100375528908719,0.198012875175315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,24190,0.00308649431889422,0.00241296694461023,-0.00164292089254183,0.00781590953033026,0.200864154365575
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24106,-0.00427176288364943,0.00334622022810083,-0.0108303545307271,0.00228682876342819,0.201758114248265
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,29348,0.00414246281931996,0.00326329219610501,-0.00225358988504587,0.0105385155236858,0.20430416975153
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28926,0.00251945137987653,0.00198832819566082,-0.00137767188361868,0.00641657464337174,0.205122419648721
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28769,0.00399593799728172,0.00315674121124023,-0.00219127477674914,0.0101831507713126,0.205579639528967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,29429,0.00766736812155706,0.00606204638269085,-0.00421424278851699,0.0195489790316311,0.20594761861607
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,28926,-0.00589884125880147,0.00467222380895049,-0.0150563999243444,0.00325871740674149,0.206766894977231
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28769,0.00427297404529619,0.00338877529000356,-0.00236902552311078,0.0109149736137032,0.207347954428087
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29422,-0.00615728054650076,0.00488599047808002,-0.0157338218835376,0.00341926079053609,0.207610518427263
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,28926,0.00767240123833309,0.00609288432564367,-0.0042696520399285,0.0196144545165947,0.207953967218499
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,29689,-0.0024204479434199,0.001932031664617,-0.00620723000606923,0.00136633411922943,0.210288623445206
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,28769,0.00277491149704237,0.00222458154540066,-0.00158526833194293,0.00713509132602767,0.212266218627927
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,28769,0.00246898749670589,0.00198499012831172,-0.00142159315478507,0.00635956814819685,0.213572790753104
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,28926,-0.00273098356875401,0.00219654744577952,-0.00703621656248186,0.00157424942497384,0.213764681023017
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24416,0.00827947496882647,0.00667091438927068,-0.00479551723414406,0.021354467171797,0.214569493923294
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,28840,0.00362714925114882,0.00292378195494074,-0.00210346338053503,0.00935776188283267,0.214775612873941
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,24106,-0.00340060539152814,0.0027864269345595,-0.00886200218326475,0.00206079140020847,0.222318428732307
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,24011,0.0029525282919212,0.00242222464038893,-0.0017950320032411,0.00770008858708349,0.222881802003453
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29428,-0.00601764660482292,0.00493943878081489,-0.0156989466152201,0.00366365340557426,0.223125272982023
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,29720,-0.00347597173949958,0.00285558061096318,-0.00907290973698741,0.00212096625798824,0.223516618191459
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,28769,0.00381397925582141,0.00314435762631673,-0.00234896169175938,0.0099769202034022,0.225155172018546
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,24235,0.00689459298260801,0.00568774739497963,-0.00425339191155206,0.0180425778767681,0.225454007977363
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,24096,0.00370619674293722,0.00306163398238641,-0.00229460586254013,0.00970699934841458,0.226087847919275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,29132,0.00500691933580224,0.00414706763833975,-0.00312133323534367,0.0131351719069482,0.227311160421645
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,24863,-0.00397581861725189,0.00329725449071343,-0.0104384374190502,0.00248680018454642,0.227907365488161
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,23493,-0.00984694725845552,0.00818381200992467,-0.0258872187979079,0.00619332428099683,0.228902338014065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29438,0.00253113004038922,0.00210396795210953,-0.00159264714574546,0.0066549072265239,0.22897559127763
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24011,0.00431670279360292,0.00359112505537746,-0.0027219023149369,0.0113553079021427,0.229356997761239
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28926,-0.00296605686252918,0.0024709698663275,-0.00780915780053109,0.00187704407547272,0.23000884591559
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24376,-0.00327990702811198,0.00274510339150694,-0.00866030967546557,0.00210049561924162,0.232168626918921
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,28717,0.00285776678462407,0.00239868345878271,-0.00184365279459003,0.00755918636383818,0.233510482798501
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,24106,0.00361388770093053,0.00303502817537968,-0.00233476752281363,0.0095625429246747,0.233772803289581
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,28769,0.0035208100261181,0.00295989408006886,-0.00228058237081686,0.00932220242305305,0.234250664437318
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,24235,-0.00493108312471088,0.00414873442853966,-0.0130626026046486,0.00320043635522686,0.234618499213549
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NENF,Neudesin,24788,0.00866083538830236,0.0072895343150745,-0.00562665186924365,0.0229483226458484,0.234797856551707
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29429,0.00674279804785711,0.00568090924856289,-0.00439178407932615,0.0178773801750404,0.235267843514054
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24011,0.00238290497436898,0.00200870009092795,-0.0015541472038498,0.00631995715258775,0.235518724957267
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24106,-0.00286892440148509,0.00242188669817958,-0.00761582232991707,0.00187797352694689,0.236194277650452
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29512,0.00384813859104013,0.00325514755305384,-0.0025319506129454,0.0102282277950257,0.237147684420545
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,24788,0.00453375662951415,0.00383796571069458,-0.00298865616344724,0.0120561694224755,0.237498245557854
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24096,0.00548421489691178,0.0046552974244597,-0.00364016805502923,0.0146085978488528,0.238784738063858
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24440,0.00557808805468988,0.00475023011536379,-0.00373236297142315,0.0148885390808029,0.240295365320799
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,24190,0.00334385624404347,0.00286777540479777,-0.00227698354936016,0.00896469603744709,0.243621701439999
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,28769,0.00460928178060538,0.003956539448919,-0.00314553553927586,0.0123640991004866,0.244037524876272
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24106,-0.00242862958454656,0.00209431563440228,-0.00653348822797502,0.0016762290588819,0.246211295424155
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,24224,0.00316735112990293,0.00273173892979654,-0.00218685717249829,0.00852155943230415,0.246278808439179
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24106,0.00544153916504384,0.00469754762161526,-0.00376565417332207,0.0146487325034098,0.246721004900101
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,29222,0.00555688446868389,0.00480101099991242,-0.00385309709114445,0.0149668660285122,0.247101909249447
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,24235,0.00223375107468289,0.00193164080856521,-0.00155226491010492,0.0060197670594707,0.247528639257001
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,24096,-0.00336165745768948,0.002910026843863,-0.00906531007166096,0.00234199515628199,0.248020777636574
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24224,0.00369621835933091,0.0032066951451173,-0.00258890412509899,0.00998134084376081,0.249062737863612
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",28769,0.00412813431368106,0.00359329726311546,-0.00291472832202524,0.0111709969493874,0.250630291770649
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,24933,0.00695469970477652,0.0060578373295119,-0.00491866146106681,0.0188280608706199,0.250958974429202
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28911,0.00593528925594457,0.00518641908723805,-0.00423009215504201,0.0161006706669312,0.252471163301825
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,29164,-0.00243665229269261,0.002129838865072,-0.00661113646823373,0.00173783188284851,0.252610321954781
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29603,0.00778507509170292,0.0068200587297391,-0.0055822400185857,0.0211523902019916,0.253672488312376
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,28926,0.00472734792329829,0.00414237131491901,-0.00339169985394297,0.0128463957005396,0.253788746595065
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,28664,0.00676346769351736,0.00596120798814471,-0.00492049996324627,0.018447435350281,0.256560805799352
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,24224,0.00347907898419275,0.0030739679403843,-0.00254589817896048,0.00950405614734598,0.257734926672567
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,POSTN,Periostin,24933,0.00283393425326896,0.00250863017537963,-0.00208298089047512,0.00775084939701305,0.258624495967733
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24106,0.0046840277364304,0.00415892024567319,-0.00346745594508905,0.0128355114179498,0.260066475950288
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24096,0.00426585742007627,0.00380395260275144,-0.00318988968131654,0.0117216045214691,0.262117077267766
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,24376,0.00255262578257339,0.00227647143042991,-0.00190925822106923,0.00701450978621601,0.262167804700386
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29781,0.0025161172164627,0.00225001413120228,-0.00189391048069377,0.00692614491361916,0.263461875025643
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24106,0.00388085048040922,0.00348872825148009,-0.00295705689249175,0.0107187578533102,0.265978637927439
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,24106,-0.00353652823350106,0.00317933182116861,-0.00976801860299153,0.00269496213598941,0.26599899802573
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29335,0.00253680628956088,0.0022818708801289,-0.00193566063549177,0.00700927321461353,0.266266769476721
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24788,0.00640187285260598,0.00576207494168883,-0.00489179403310412,0.0176955397383161,0.266563624621747
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,24376,0.00564469350707738,0.00508667376911642,-0.00432518708039081,0.0156145740945456,0.26713829116496
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24129,0.00290478603904495,0.00262138370209779,-0.00223312601706672,0.00804269809515662,0.267824615836957
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24011,-0.00362154561352795,0.00328236712548889,-0.0100549851794862,0.00281189395243028,0.26989342722473
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,24106,0.00292919134947711,0.00266059452085146,-0.00228557391139176,0.00814395661034598,0.270927813385934
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24106,0.00317085709152965,0.0028807664236293,-0.00247544509878379,0.00881715928184309,0.271038622973185
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24190,-0.00352233841761058,0.00321301473694428,-0.00981984730202136,0.0027751704668002,0.272970634524315
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,24224,0.00737640751184226,0.00675418042616689,-0.00586178612344484,0.0206146011471294,0.274789146225116
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,24011,0.00339932178469671,0.00313683446420138,-0.00274887376513799,0.00954751733453142,0.27851801653982
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24440,0.00454043726383878,0.00419104751305807,-0.00367401586175504,0.0127548903894326,0.278656812789291
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24863,0.00171011058543168,0.00157940768360818,-0.00138552847444035,0.00480574964530372,0.278927966448523
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,24235,0.00217737116822583,0.00201237596519658,-0.00176688572355947,0.00612162806001114,0.279267633434913
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,24096,0.00430882636552128,0.0039845668380054,-0.0035009246369693,0.0121185773680119,0.279539447530423
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,29669,0.00220431943388789,0.00205013920797993,-0.00181395341375277,0.00622259228152855,0.282291812778983
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,24946,-0.00174429866507053,0.00162766329940722,-0.00493451873190869,0.00144592140176762,0.283883970966027
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,24190,0.00336990060834308,0.0031573249485507,-0.0028184562908163,0.00955825750750246,0.285834508420876
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24224,0.00253564963419428,0.00239453222795471,-0.00215763353259695,0.00722893280098552,0.289640775505499
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29449,0.00240190362465004,0.0022702960579648,-0.00204787664896096,0.00685168389826105,0.290078102220789
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,28911,0.0075120979483513,0.00712352145242826,-0.00645000409840808,0.0214741999951107,0.291640743558345
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24840,0.00439469214043295,0.0041697721861965,-0.00377806134451218,0.0125674456253781,0.291920376930337
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24096,0.0039437756012122,0.00374869946647732,-0.00340367535308334,0.0112912265555077,0.292792511065951
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,24235,-0.00276240588999666,0.00262868186977882,-0.00791462235476315,0.00238981057476984,0.293328265341996
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24011,0.00440141869747353,0.00420860345083501,-0.0038474440661631,0.0126502814611102,0.295657199073819
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,24096,0.0044991361964343,0.00430333366410467,-0.00393539778521085,0.0129336701780794,0.295802343098917
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,24011,0.00330262507643523,0.00316780845084934,-0.00290627948722947,0.00951152964009993,0.29716340145287
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24440,0.00540646703362011,0.005190654942787,-0.00476721665424241,0.0155801507214826,0.297618125129558
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,28926,0.00450996000203355,0.00433320295155638,-0.00398311778301696,0.0130030377870841,0.297981114497122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,28329,0.0032970853724647,0.00317147119659661,-0.00291899817286465,0.00951316891779406,0.298531148922371
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,24440,0.00234109130635633,0.00225502908817435,-0.00207876570646539,0.00676094831917805,0.299203720451369
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,24011,0.00280465370214719,0.00270892749166844,-0.00250484418152295,0.00811415158581734,0.300521844434412
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29781,0.00240025483327776,0.0023189145001092,-0.00214481758693627,0.00694532725349179,0.300641407953648
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,24096,0.00508466810950258,0.00491719263770474,-0.00455302946039872,0.0147223656794039,0.301118888955523
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,28792,0.00625217026565968,0.00605952986141566,-0.00562450826271502,0.0181288487940344,0.302178561127008
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24440,0.00431699401189406,0.00418463872311936,-0.0038848978854199,0.012518885909208,0.302256236702497
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,24863,0.00353558228135989,0.00343058637232212,-0.00318836700839146,0.0102595315711112,0.302735736538859
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24224,-0.00230125302389856,0.00223561798383065,-0.00668306427220664,0.00208055822440951,0.303321389864803
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24840,-0.00583375623955508,0.00572000366020033,-0.0170449634135477,0.00537745093443757,0.307792088058884
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24733,0.00183510628258911,0.00179935668924371,-0.00169163282832856,0.00536184539350677,0.307801055734716
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,27580,0.00330011292721564,0.0032429601658039,-0.00305608899776001,0.00965631485219128,0.3088657796934
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24106,-0.00263462913195079,0.00260304005068508,-0.00773658763129356,0.00246732936739197,0.311483455725869
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,24106,0.00311676763478829,0.00310273260089285,-0.0029645882629617,0.00919812353253828,0.315136466241379
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24096,0.00485985053749378,0.00489075372003835,-0.00472602675378139,0.014445727828769,0.320388031252144
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24440,0.00569071314869269,0.00574149401354606,-0.00556261511785758,0.016944041415243,0.321619492939925
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24011,0.0030631897014695,0.00310964159738043,-0.00303170782939614,0.00915808723233514,0.324603560049286
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24933,-0.00213484164887908,0.00217589866024116,-0.00639960302295175,0.00212991972519359,0.326537665638932
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,24933,-0.00241711862301712,0.00246607689587186,-0.00725062933892597,0.00241639209289173,0.327022926996609
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24788,0.00337345769772588,0.00344186545391724,-0.0033725985919519,0.0101195139874037,0.327034088642424
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24746,0.0026175353800107,0.00267559043730895,-0.00262662187711484,0.00786169263713623,0.327934567869137
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,21651,-0.0068366920353055,0.00699313254818992,-0.0205432318297578,0.00686984775914674,0.328268577101421
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,24440,0.00268129426552814,0.00276376471229264,-0.00273568457056544,0.00809827310162171,0.331976299111101
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24190,0.00406089959236154,0.00419297574254462,-0.00415733286302591,0.012279132047749,0.332804099768355
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24788,0.00400203827296223,0.00413514095093097,-0.00410283799086248,0.0121069145367869,0.333147809360542
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,24011,0.00462058369517492,0.00479885928941661,-0.00478518051208163,0.0140263479024315,0.335632294485632
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,24863,0.00189372960232197,0.00196785810595428,-0.00196327228534842,0.00575073148999236,0.335893046580086
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,24096,0.00487066637543844,0.0050767263715914,-0.00507971731288069,0.0148210500637576,0.337361442143908
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24106,-0.00255316452846532,0.00266682715073363,-0.00778014574390323,0.00267381668697259,0.338385559661606
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,24190,0.0022381571439671,0.00234735865277186,-0.00236266581546573,0.00683898010339994,0.340356972098072
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,24224,0.0029596950043166,0.00310546503707628,-0.00312701646835291,0.00904640647698611,0.34056910555241
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,28926,0.00202329369205252,0.00212396824932365,-0.00213968407662183,0.00618627146072688,0.340800373915324
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,24011,-0.00458339080175153,0.00487094205373022,-0.0141304372270628,0.0049636556235597,0.346731761135813
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24190,0.00486426426265016,0.00517245078009046,-0.00527373926632715,0.0150022677916275,0.347012742885768
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,24106,0.00304596805497007,0.00324885373222965,-0.00332178526020004,0.00941372137014018,0.34848428639061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29213,0.00377784377766508,0.0040381288470708,-0.00413688876259369,0.0116925763179239,0.349516194238347
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,24011,0.00332580022375617,0.00355564462273328,-0.00364326323680106,0.0102948636843134,0.349613307034755
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24190,0.00477355428195286,0.00511823261403082,-0.00525818164154754,0.0148052902054533,0.351006527517225
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MME,Neprilysin,29344,-0.00495731018898389,0.00531849058830293,-0.0153815517420576,0.00546693136408985,0.351297853413335
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,24106,-0.00314721719756232,0.00337736112100885,-0.00976684499473967,0.00347241059961503,0.351419832306541
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24190,0.00255530955452135,0.00275826374763698,-0.00285088739084713,0.00796150649988983,0.354237218029439
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,29408,0.00784298073196394,0.00848607561299278,-0.00878972746950191,0.0244756889334298,0.355380602704086
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,24011,-0.00226243380475161,0.00245416038423448,-0.0070725881578512,0.00254772054834797,0.356602049607745
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24800,-0.00489780424438528,0.00531644406185098,-0.0153180346056132,0.00552242611684265,0.356925925238239
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24391,0.00308346563390298,0.00335130777545455,-0.00348509760598794,0.00965202887379389,0.357540936357248
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28769,0.0047907025064437,0.0052101523184579,-0.00542119603773379,0.0150026010506212,0.357845084975347
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24440,0.00425278998219252,0.00462614312306474,-0.00481445053901436,0.0133200305033994,0.357950399726972
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24096,0.00306305532943685,0.00333307561222019,-0.00346977287051472,0.00959588352938842,0.358111235431204
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAG,S-arrestin,24096,-0.0032196718016872,0.00350458758694049,-0.0100886634720906,0.00364931986871616,0.358260638353813
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VIM,Vimentin,28911,0.00709061044938123,0.00773830262099448,-0.00807646268776794,0.0222576835865304,0.359516959993828
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24190,0.00220779622984623,0.00241304263111095,-0.00252176732713124,0.00693735978682369,0.360230730705562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,24011,0.00253085855119353,0.00276842709415236,-0.00289525855334508,0.00795697565573215,0.360628065337757
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,29688,-0.00342266713804615,0.00376381736892775,-0.0107997491811445,0.00395441490505223,0.363167209491061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,24190,0.00187692228677207,0.00207787860609348,-0.00219571978117116,0.0059495643547153,0.366382197290982
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,24011,0.00413836835146486,0.00459465626790556,-0.00486715793363003,0.0131438946365598,0.367761349631223
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,29438,0.00170302859823341,0.00189290396147816,-0.00200706316626379,0.00541312036273061,0.368292093884577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,24946,0.00379981183199986,0.00422821156155018,-0.00448748282863849,0.0120871064926382,0.368831475838757
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24933,0.00176095493302492,0.00197339012470175,-0.00210688971139051,0.00562879957744035,0.372213909572008
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24440,0.00259440105265932,0.00291481957284118,-0.0031186453101094,0.00830744741542804,0.373435667513992
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24863,0.00247148991959366,0.0027793687625826,-0.00297607285506823,0.00791905269425556,0.373889669523494
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,24224,0.00282071375796905,0.00317430391911207,-0.0034009219234906,0.00904234943942871,0.374222296676846
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,24914,-0.00643319822017325,0.0072477919641777,-0.0206388704699615,0.00777247402961505,0.374760215486364
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,29720,0.00155725970386875,0.00176070340607925,-0.00189371897204659,0.00500823837978408,0.376458791466091
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24096,0.00176035196128419,0.00199657098823754,-0.0021529271756614,0.00567363109822977,0.377954546962534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24840,-0.00164140091784384,0.00186314727550887,-0.00529316957784123,0.00201036774215355,0.378335595926116
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24106,-0.00208329537749732,0.00237999383235774,-0.00674808328891849,0.00258149253392385,0.381399587573628
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28769,0.00313039488662361,0.00357814396998399,-0.00388276729454502,0.0101435570677922,0.381654373521531
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24863,0.00195897798351025,0.00224316708182863,-0.00243762949687386,0.00635558546389436,0.382503119631646
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29561,0.00244149328616492,0.00280606836700164,-0.00305840071315829,0.00794138728548813,0.384265834428734
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,24224,-0.00522848687027246,0.00601253751962476,-0.017013060408737,0.00655608666819206,0.384529091625073
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24376,-0.00223782286048247,0.00257831870645603,-0.00729132752513629,0.00281568180417134,0.385436382679451
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELE,E-selectin,29815,-0.00287920749358417,0.00333314739432691,-0.0094121763864649,0.00365376139929657,0.387698987904654
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEB,Nebulin,24106,0.00217484996212147,0.00251916764760371,-0.00276271862718179,0.00711241855142473,0.387969676284028
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29429,-0.00320505583171133,0.00371976772019462,-0.0104958005632928,0.00408568889987012,0.388899309555591
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24400,0.00302242388692046,0.0035123652734594,-0.00386181204905997,0.0099066598229009,0.389516677346238
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24917,-0.00169280192205452,0.00196860159280366,-0.00555126104394969,0.00216565719984065,0.389852050789739
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,24011,0.00344230602325265,0.00402177649529269,-0.00444037590752102,0.0113249879540263,0.392052353884199
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,28792,0.00266079965667322,0.0031192472491988,-0.00345292495175643,0.00877452426510286,0.393651869485872
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,29194,-0.00721183155534755,0.008461783403254,-0.0237969270257254,0.00937326391503028,0.394064203762615
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,24011,-0.0014727402285088,0.00172845353261034,-0.00486050915242506,0.00191502869540746,0.394191185349515
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,29209,-0.00189927624800713,0.00223110622295183,-0.00627224444499273,0.00247369194897846,0.394625757075569
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,24011,0.00188971487279322,0.00222143141846873,-0.00246429070740549,0.00624372045299193,0.39495872702046
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28792,0.00179882505250954,0.00211512539859247,-0.00234682072873171,0.00594447083375078,0.395077646603548
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,24011,-0.00381742812698124,0.00448930009052278,-0.0126164563044059,0.00498160005044341,0.395144977911833
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,29720,0.00119150455663818,0.00140421048799107,-0.00156074799982432,0.00394375711310069,0.396153740676426
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,24106,0.00471378511359819,0.00555898712405591,-0.00618182964955139,0.0156093998767478,0.396470035179002
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,23965,0.00229720646680949,0.00271114032265635,-0.00301662856559696,0.00761104149921593,0.396824621870953
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,24096,-0.00344943015881156,0.00409100698491436,-0.0114678038492437,0.00456894353162059,0.399139588911487
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,24440,0.00336641509657743,0.0039935090295859,-0.00446086260141094,0.0111936927945658,0.399252525608577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24106,0.00335504982270959,0.00405295032290031,-0.00458873281017503,0.0112988324555942,0.407789522301209
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,24800,-0.0141758255869596,0.0171973379914785,-0.0478826080502574,0.0195309568763382,0.409775072676831
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24788,0.00245313154232864,0.00298287437693515,-0.00339330223646425,0.00829956532112153,0.410854208626089
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24863,0.00314072495919526,0.00383284025703767,-0.00437164194459858,0.0106530918629891,0.41255186030832
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24933,-0.00178919456989941,0.00218660478205547,-0.00607493994272813,0.00249655080292932,0.413220914809021
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,24440,0.00237343611924714,0.00290336762442895,-0.00331716442463359,0.00806403666312788,0.413663888328479
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,24933,-0.0047285321077007,0.00581312477367275,-0.0161222566640993,0.0066651924486979,0.415983081141705
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,24749,0.00278641726133478,0.00343177966701069,-0.00393987088600617,0.00951270540867574,0.416830851337042
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24106,0.00257082313164737,0.00317766555564502,-0.00365740135741686,0.0087990476207116,0.41850653733589
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,24020,-0.00336016878417633,0.00415733861176003,-0.011508552463226,0.00478821489487333,0.418954709374105
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,24235,0.00171657290836615,0.00213826161231417,-0.00247441985176963,0.00590756566850193,0.422104576381266
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24190,0.00351156903308122,0.00437896908107151,-0.00507121036581893,0.0120943484319814,0.422608948187864
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,28926,0.00259349109230951,0.00323477602921831,-0.00374666992495837,0.0089336521095774,0.422702492777917
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24096,0.00287430687961635,0.00360397846957113,-0.00418949092074306,0.00993810467997576,0.425146973401221
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,24376,0.00113758889296915,0.00143035831746533,-0.0016659134092629,0.0039410911952012,0.426436628744023
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,24946,-0.00374720535742301,0.00471693373810186,-0.0129923954841027,0.00549798476925665,0.426961134798209
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,24840,0.00363550386001981,0.00458406513750418,-0.00534926380948839,0.012620271529528,0.427742163873506
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,24106,0.0024910986892418,0.00314925387473196,-0.00368143890523283,0.00866363628371643,0.428944575025253
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24190,-0.00198387127088614,0.00251490606387933,-0.00691308715608962,0.00294534461431734,0.430210294368534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24011,-0.00166886535479383,0.00211801640569918,-0.00582017750996422,0.00248244680037655,0.430740825929958
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,24224,0.00168122542262891,0.0021455195392221,-0.00252399287424641,0.00588644371950423,0.433283530527991
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24106,0.00206033052046437,0.00264572852986465,-0.00312529739807035,0.00724595843899908,0.436141453010515
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,28769,0.00167970270714572,0.00215954405803486,-0.00255300364660262,0.00591240906089405,0.436690777505793
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24190,-0.00252115486572815,0.0032788454166663,-0.00894769188239409,0.00390538215093779,0.441951022354743
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24224,0.00149717384157518,0.00195091334405005,-0.00232661631276292,0.00532096399591329,0.442838129939907
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,24440,0.00285996580768947,0.00377165340922654,-0.00453247487439455,0.0102524064897735,0.448291255389354
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,24190,0.00253471690773045,0.00334362751197511,-0.00401879301574078,0.00908822683120167,0.448414104291553
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,28926,-0.00158260976457204,0.00209559358858389,-0.00568997319819647,0.00252475366905239,0.450130134623201
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TF,Serotransferrin,24961,-0.0010700401746958,0.00143146622596383,-0.00387571397758491,0.00173563362819331,0.45476076752472
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24440,0.00320520207994588,0.00428789138342001,-0.00519906503155734,0.0116094691914491,0.454768538370862
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYOC,Myocilin,29438,0.00226246206822315,0.00302707651411159,-0.00367060789943556,0.00819553203588185,0.454823118091541
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,24106,-0.0022811104652645,0.00306540688255769,-0.00828930795507757,0.00372708702454857,0.456795371929876
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24096,0.00361081416382683,0.00486498142798212,-0.00592454943501814,0.0131461777626718,0.457970300801809
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,28926,0.0030165789252337,0.00408696727236815,-0.00499387692860786,0.0110270347790753,0.460461401916921
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,29211,0.00252557543786336,0.00342867379472771,-0.00419462519980295,0.00924577607552968,0.46136901260833
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,24235,-0.00207336659603261,0.00281813551765689,-0.00759691221064012,0.00345017901857489,0.461906526475192
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,24096,0.00411617990391143,0.0056218174327365,-0.00690258226425211,0.015134942072075,0.46406609405342
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24933,0.00297087649612462,0.00406042293318998,-0.00498755245292773,0.010929305445177,0.464378869333028
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,24416,0.00478681329373743,0.00654861052669238,-0.00804846333857964,0.0176220899260545,0.46480678503488
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24054,0.00165715514732465,0.00228348152270059,-0.00281846863716851,0.00613277893181782,0.46802101084558
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24106,-0.0019733984384787,0.00274355155232574,-0.00735075948103715,0.00340396260407975,0.471971648226052
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,24224,0.00165496512626036,0.0023183777675028,-0.00288905529804513,0.00619898555056585,0.475329178429946
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,24224,0.00355598623152909,0.00499739607527468,-0.00623891007600928,0.0133508825390675,0.476739295986663
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,24106,0.00130106582157926,0.00183188507452773,-0.00228942892449508,0.0048915605676536,0.477566335040235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,29473,0.00289705313244709,0.00408217860951961,-0.00510401694221135,0.0108981232071055,0.477906297252989
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,24106,0.00181147126094087,0.00255449943300748,-0.00319534762775379,0.00681829014963553,0.478250893670214
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24235,0.00154132066968513,0.00219453852651114,-0.0027599748422767,0.00584261618164697,0.482471493405726
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24096,0.00191483069516493,0.00273722344946757,-0.0034501272657915,0.00727978865612136,0.484213757605465
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,24190,0.00275285500921581,0.00394005077919741,-0.00496964451801111,0.0104753545364427,0.484755530902127
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,24788,0.00238310935134939,0.00341349654676999,-0.00430734388031978,0.00907356258301857,0.485094205877331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,28885,-0.00255776987882505,0.00367941224007823,-0.00976941786937839,0.00465387811172828,0.486962391405618
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,24106,0.00166473580985259,0.00239533098255169,-0.00303011291594873,0.0063595845356539,0.487067033492154
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,24096,0.00433496169670161,0.00625171426148567,-0.0079183982558103,0.0165883216492135,0.488062938819019
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24440,-0.00200349374262601,0.00289969000612747,-0.00768688615463585,0.00367989866938383,0.489613729847225
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24440,0.00302325663183728,0.00440047082398824,-0.00560166618317967,0.0116481794468542,0.492070179885782
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28926,-0.00286843871280107,0.00418498247897509,-0.0110710043715922,0.00533412694599011,0.49308924273246
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28792,-0.00559551107903593,0.00818026093762621,-0.0216288225167833,0.0104378003587114,0.493964262683338
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,24011,0.0028819852760109,0.00422147390468927,-0.00539210357718007,0.0111560741292019,0.49480525946654
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,29344,-0.00426885770122062,0.00625372781642642,-0.0165261642214164,0.00798844881897517,0.494858648331952
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,24224,-0.002154449676519,0.00316109265535208,-0.00835019128100908,0.00404129192797107,0.495528663594214
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29492,0.00120308802053899,0.00177038999549924,-0.00226687637063953,0.0046730524117175,0.496787798109088
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,29391,-0.00116614537475735,0.0017192443944195,-0.00453586438781957,0.00220357363830487,0.497593514410363
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,23965,-0.0015964070895844,0.00235794151080853,-0.00621797245076912,0.00302515827160031,0.498390782185944
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29429,-0.00293344635262173,0.00434165338170718,-0.0114430869807678,0.00557619427552435,0.499266993645015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,24106,0.00179841882260194,0.00266496849675598,-0.00342491943103978,0.00702175707624366,0.49978593064987
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,28911,0.00318131973340474,0.00473940176274935,-0.00610790772158399,0.0124705471883935,0.502067143833759
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,24224,0.00133339651061816,0.00199168680951591,-0.00257030963603303,0.00523710265726935,0.503195070520951
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,24096,0.00418392652655508,0.0063412001851791,-0.00824482583639595,0.0166126788895061,0.509388225530782
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,24224,0.00251428751066999,0.00382070627655054,-0.00497429679136908,0.010002871812709,0.510500194366477
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24106,0.00154008880456416,0.00234610968786567,-0.00305828618365255,0.00613846379278087,0.511544983253345
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,24440,-0.00258913109380628,0.00394464480228388,-0.0103206349062827,0.00514237271867013,0.511594784978815
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24096,0.00137480854535341,0.00212046203215184,-0.00278129703766419,0.00553091412837101,0.516762652822361
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24235,0.00170882997568366,0.00266475808725394,-0.00351409587533406,0.00693175582670139,0.521353208841029
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,29344,0.000810436904990174,0.00126764387022819,-0.00167414508065708,0.00329501889063742,0.522616270997909
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,24840,0.000942686373205584,0.00149560821313796,-0.00198870572454482,0.00387407847095599,0.528502149035694
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,24321,0.00475055096847652,0.00753825394006929,-0.0100244267540593,0.0195255286910123,0.528574580832996
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24235,-0.0015401229946229,0.00246255679020273,-0.00636673430342025,0.00328648831417446,0.531703802270796
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,24235,0.00173393352633958,0.0027784725534339,-0.00371187267839086,0.00717973973107002,0.532594072386562
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,29815,0.00113415298464089,0.00182044438695217,-0.00243391801378536,0.00470222398306713,0.533283466203512
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,24235,-0.00122367491030382,0.00196877319139797,-0.00508247036544385,0.00263512054483621,0.534249024566938
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28911,0.00235257650432144,0.00379741878331192,-0.00509036431096992,0.00979551731961279,0.535578800928066
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,24863,-0.00649024978225798,0.0105058180526001,-0.0270816531653541,0.0141011536008382,0.536728194859771
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,24011,0.00147704407305911,0.00239092464210208,-0.00320916822546097,0.00616325637157918,0.536732118879623
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24440,0.00274400811135468,0.00445254470825727,-0.00598297951682957,0.0114709957395389,0.537716389727009
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24106,-0.00240060965290849,0.00389602962349506,-0.0100368277149588,0.00523560840914184,0.537789319769117
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,24106,-0.00206335153997222,0.00335038984326588,-0.00863011563277334,0.0045034125528289,0.537996592728455
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,24096,0.001391314869115,0.00226477191817341,-0.00304763809050488,0.00583026782873488,0.539003804260596
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24011,-0.00119355855388499,0.0019475837447612,-0.00501082269361695,0.00262370558584697,0.539987494769413
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23489,-0.00201517226184163,0.00332488928297897,-0.00853195525648041,0.00450161073279716,0.544462825131385
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,24224,-0.00172308438111561,0.00285178751601856,-0.00731258791251198,0.00386641915028076,0.545708332338196
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24224,0.00163460841936358,0.00270826750412761,-0.00367359588872653,0.00694281272745369,0.546140275773514
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,29815,-0.00160278286993899,0.00271382900735686,-0.00692188772435843,0.00371632198448045,0.554794065138018
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,24011,-0.00307766508377684,0.00521157482411724,-0.0132923517390466,0.00713702157149295,0.55483144921119
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,24946,0.000902034573338065,0.0015316507119389,-0.00210000082206219,0.00390406996873832,0.555913778136438
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24224,-0.0016494005241205,0.00280139821632102,-0.00714014102810969,0.00384133997986869,0.556015965844622
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,24224,0.00355802261252283,0.00613679719480202,-0.00847009988928912,0.0155861451143348,0.562065047811094
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24224,0.00187882748116451,0.0032459052689315,-0.00448314684594123,0.00824080180827024,0.56270924339146
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28911,0.00323394079878166,0.00559266428570725,-0.00772768120120455,0.0141955627987679,0.563101943366926
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,29720,0.00169555955314333,0.00295884505827546,-0.00410377676107657,0.00749489586736322,0.566616689616179
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24096,0.00448105104520103,0.00785763321345443,-0.0109199100531697,0.0198820121435717,0.568493126031826
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,24106,0.00172702869055802,0.0030470003296315,-0.00424509195551972,0.00769914933663576,0.570857825374207
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,24011,0.00300237033920502,0.00532911580492527,-0.00744269663844851,0.0134474373168585,0.573174636581034
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,24011,0.00130242778788593,0.00232896020261312,-0.00326233420923578,0.00586718978500765,0.576008991805303
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24917,0.00112430571014933,0.00201134188382682,-0.00281792438215124,0.0050665358024499,0.576178420014154
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,24440,0.00105015155455499,0.00189888941985201,-0.00267167170835496,0.00477197481746494,0.58024477776505
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,24224,0.00180780114083192,0.00327597081035446,-0.00461310164746282,0.00822870392912665,0.581065288018857
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29473,-0.00103889438965469,0.00188934836894858,-0.0047420171927939,0.00266422841348451,0.582413290946937
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NEO1,Neogenin,24863,0.000795396586626146,0.00145340280126472,-0.00205327290385271,0.003644066077105,0.584201552064577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,24096,0.00278314071995203,0.00512307155896175,-0.007258079535613,0.0128243609755171,0.586958400308493
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24011,0.0033141215669725,0.0061444656494129,-0.00872903110587678,0.0153572742398218,0.589638699826407
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,24011,0.00284277118300743,0.00527434332341406,-0.00749494173088414,0.013180484096899,0.589904919751498
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,24011,-0.00222623193084586,0.00413191180121361,-0.0103247790612245,0.00587231519953281,0.590036900792854
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,24788,-0.00158060201840025,0.00294538026906584,-0.00735354734576929,0.00419234330896879,0.591522733817551
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24788,0.0016695115111636,0.00314526044902321,-0.00449519896892189,0.00783422199124909,0.595560537432725
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,24190,0.000804651977435427,0.0015214210786355,-0.00217733333669015,0.00378663729156101,0.596892276690177
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,24106,0.00110630678672752,0.00209761758709677,-0.00300502368398215,0.00521763725743718,0.597912997648264
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,24800,0.00387407810698804,0.00734953051697336,-0.0105310017062797,0.0182791579202558,0.598115582974487
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23970,0.00169313791728444,0.00321728599788262,-0.0046127426385655,0.00799901847313439,0.598710502134638
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,28529,0.0026550388603036,0.00506710040918013,-0.00727647794168945,0.0125865556622967,0.600299324884168
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24399,0.00188818634183273,0.00360940636728132,-0.00518625013803865,0.00896262282170411,0.600889008018337
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,24096,0.00259119236215335,0.00497330952279167,-0.00715649430251833,0.012338879026825,0.602357820904775
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24190,-0.00131381550392125,0.0025306621375196,-0.00627391329345966,0.00364628228561716,0.603654763443965
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,24011,-0.00142541483210318,0.0027919674389654,-0.00689767101247537,0.00404684134826901,0.609676947676947
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,28792,0.00345704924044371,0.00686198437858968,-0.00999244014159207,0.0169065386224795,0.614407677831889
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24190,0.0011891587090858,0.00237374105874515,-0.0034633737660547,0.0058416911842263,0.616401051667426
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24011,0.00278035865328645,0.0055738622337697,-0.00814441132490216,0.0137051286314751,0.617910175574797
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24106,0.00156377227546784,0.00318152564644754,-0.00467201799156933,0.00779956254250501,0.623065679339586
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24106,-0.00152495908907985,0.00311381522652469,-0.00762803693306825,0.00457811875490855,0.624322529441592
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,29164,0.0016927557125439,0.00347296439218957,-0.00511425449614765,0.00849976592123545,0.625971853509318
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24096,-0.00192495098903668,0.00395182544236612,-0.00967052885607428,0.00582062687800091,0.626188884544864
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29438,-0.00141086664562302,0.00290508984282869,-0.00710484273756725,0.00428310944632121,0.627216572606122
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24011,-0.00142642875055584,0.00293913018839737,-0.00718712391981468,0.004334266418703,0.62745136696388
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,29441,-0.00139454695037076,0.00287532600586914,-0.00703018592187428,0.00424109202113277,0.627676542081941
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,28792,0.00201091443868886,0.00417282291630818,-0.00616781847727517,0.0101896473546529,0.629875360364755
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24946,0.00101995864580133,0.0021322163519617,-0.00315918540404359,0.00519910269564625,0.632400985665955
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28792,-0.00147060749384524,0.00307480009890697,-0.00749721568770291,0.00455600070001243,0.632456390362772
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,24011,0.000973410435018498,0.00204421576536977,-0.00303325246510625,0.00498007333514325,0.633951955325033
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28911,-0.00105148496386634,0.00221670392455089,-0.00539622465598609,0.00329325472825341,0.635256673830154
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24096,0.00222749996801854,0.00469946492258709,-0.00698345128025216,0.0114384512162892,0.635511246048132
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,29429,0.00155012897578938,0.00327447277868067,-0.00486783767042473,0.00796809562200349,0.635932745335677
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,24190,0.00157995697319921,0.00334013899063165,-0.00496671544843882,0.00812662939483724,0.636202235175905
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,24788,0.00131089113132417,0.00279238222249325,-0.0041621780247626,0.00678396028741094,0.638750280292001
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,28911,0.0018791921443897,0.00401695540917395,-0.00599404045759124,0.00975242474637063,0.639920394183952
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24106,0.00351991171871911,0.00753100092280605,-0.0112408500899807,0.018280673527419,0.640225369267015
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29513,0.00109339317279141,0.002359649487613,-0.00353151982293007,0.00571830616851289,0.64310187125651
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24096,0.00191960552762949,0.00415246146309213,-0.00621921894003109,0.0100584299952901,0.643883742146382
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",24096,0.00256429831381837,0.00557279439791249,-0.00835837870609012,0.0134869753337269,0.645415677419394
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24224,0.00275971713289876,0.00601800346273111,-0.00903556965405422,0.0145550039198517,0.646542173098224
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,24224,-0.0011491568473345,0.00250876806402145,-0.00606634225281654,0.00376802855814754,0.646916153319567
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,24096,0.00106472177370719,0.00233166142636927,-0.00350533462197657,0.00563477816939096,0.647936439241185
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,24096,0.00148786048569335,0.00327651891474128,-0.00493411658719957,0.00790983755858626,0.649762429159439
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24440,0.00120303561377975,0.00266712838524324,-0.004024536021297,0.0064306072488565,0.651950125045034
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24190,-0.0014665214762843,0.00326008463654442,-0.00785628736391137,0.00492324441134276,0.652828739800816
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29438,-0.00100825198192887,0.00224724019586429,-0.00541284276582288,0.00339633880196513,0.653678579790179
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,29727,-0.00105706558840864,0.00237218676660774,-0.0057065516509598,0.00359242047414253,0.655883620207463
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24011,0.00167868235221159,0.00377322276109317,-0.00571683425953102,0.0090741989639542,0.656400719084539
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,24224,0.00134850482072253,0.00303159844680255,-0.00459342813501047,0.00729043777645553,0.65645639109917
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28792,-0.00103618943532675,0.00235006537769774,-0.00564231757561431,0.00356993870496082,0.659274654783728
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,28926,-0.00146535939594882,0.00334698846453431,-0.00802545678643606,0.00509473799453842,0.661524177946571
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24011,-0.000988105916710646,0.0022597035364011,-0.00541712484805679,0.0034409130146355,0.661917767047163
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,24800,-0.00164419525594043,0.00376197026725367,-0.00901765697975761,0.00572926646787676,0.66207385371528
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24096,-0.0015277741439692,0.00353559806501574,-0.00845754635140005,0.00540199806346166,0.665663924926044
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,23598,-0.00200634176828561,0.00465056860816001,-0.0111214562402792,0.00710877270370801,0.666167976062236
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,24800,-0.00126856112457526,0.00295748451304194,-0.00706523077013746,0.00452810852098693,0.667976100574052
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24106,-0.00140550980695746,0.00329965612429984,-0.00787283581058515,0.00506181619667024,0.67014338571569
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29344,-0.000944280302973449,0.00222493736382134,-0.00530515753606327,0.00341659693011637,0.671271699719384
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24106,-0.000946707810312817,0.00223713379789989,-0.0053314900541966,0.00343807443357096,0.672168520576913
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28926,-0.00161640421172983,0.00394835154108993,-0.0093551732322661,0.00612236480880643,0.682258633142465
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,29306,-0.000940330959810233,0.002312335193621,-0.00547250793930739,0.00359184601968692,0.684261732709661
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ESPL1,Separin,24011,0.00149590211729037,0.00368347848069108,-0.00572371570486414,0.00871551993944489,0.684664467836532
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,24933,-0.00157499532734967,0.00391673125111598,-0.00925178857953698,0.00610179792483764,0.687599284231843
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CGN,Cingulin,24190,0.00106762912954944,0.00265564389844323,-0.00413743291139928,0.00627269117049816,0.687670874457241
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,29438,0.000640265074371148,0.00159523810931067,-0.00248640161987777,0.00376693176862007,0.688157867849155
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,24011,0.00134783499377767,0.00340285595435667,-0.00532176267676141,0.00801743266431675,0.692042638259446
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,24096,0.00165670765499636,0.00420392032248556,-0.00658297617707533,0.00989639148706805,0.693520770852019
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,24106,-0.00105346261857493,0.00267766052344203,-0.0063016772445213,0.00419475200737145,0.694007978770569
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24224,-0.0011556636439368,0.00294270272828213,-0.00692336099136978,0.00461203370349617,0.694528392147753
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24096,-0.00188612781618806,0.00482584189804198,-0.0113447779363503,0.00757252230397422,0.695919611757993
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24235,-0.0021873576404643,0.0056258730281855,-0.0132140687757079,0.00883935349477928,0.697425124255523
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,24440,-0.00138998001134197,0.00360043590753391,-0.00844683439010843,0.00566687436742449,0.699456474859473
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,29158,-0.0012344115070243,0.00321513250366056,-0.00753607121419901,0.0050672482001504,0.701027210100685
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,24190,0.0015357825934834,0.0040074813011263,-0.00631888075672415,0.00939044594369095,0.701553431783777
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,24011,-0.00103921146314733,0.00271627915990175,-0.00636311861655475,0.0042846956902601,0.702029844596675
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24235,0.000526611495958019,0.00138977729778223,-0.00219735200769515,0.00325057499961118,0.704752152338523
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,24190,-0.00104268356655048,0.00278246540484763,-0.00649631576005183,0.00441094862695087,0.707861810743804
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,29576,0.00190360588826386,0.00510350961963001,-0.00809927296621096,0.0119064847427387,0.709151584930819
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28792,-0.000793638419284896,0.00213305359198621,-0.00497442345957787,0.00338714662100807,0.709845855734757
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,24933,-0.00107969109118861,0.00291202732832469,-0.00678726465470499,0.00462788247232778,0.710812327186364
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29429,0.00361970525971017,0.00993940402409406,-0.0158615266275142,0.0231009371469345,0.715728239049369
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,24106,0.00129258311725384,0.00359194567247537,-0.00574763040079788,0.00833279663530555,0.718957994503236
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24190,0.0018640937937449,0.00520329495414633,-0.0083343643163819,0.0120625519038717,0.720157436573469
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCIN,Adseverin,24096,0.00174484226988922,0.0048762031058353,-0.00781251581754796,0.0113022003573264,0.720475130515064
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24440,-0.00196068067966951,0.00554004200095204,-0.0128191630015355,0.00889780164219649,0.723408789985158
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD248,Endosialin,24933,-0.00094114987825222,0.00266283026214751,-0.00616029719206134,0.0042779974355569,0.72376183174794
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24933,0.000586677492393176,0.00168279374152489,-0.00271159824099562,0.00388495322578197,0.727367767643743
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,24376,-0.000653266044659719,0.00189398108432553,-0.00436546896993776,0.00305893688061832,0.730159838324968
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,24011,0.00138129853476543,0.00401307242094429,-0.00648432341028538,0.00924692047981624,0.730699084282628
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24840,-0.000577741606997824,0.00170281169991945,-0.00391525253883995,0.0027597693248443,0.734396522594626
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24788,-0.00102173719359825,0.00301276563052887,-0.00692675782943483,0.00488328344223833,0.734510176951388
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,24800,-0.000687344765987385,0.00204142040377281,-0.00468852875738209,0.00331383922540732,0.736346461998342
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24106,-0.00149072823182935,0.0044528124026821,-0.0102182405410863,0.00723678407742757,0.737791303838384
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,24235,-0.00119201180272633,0.00356954176655821,-0.00818831366518042,0.00580429005972776,0.738427932151406
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,24224,0.00191452793320179,0.0057978618465607,-0.00944928128605718,0.0132783371524608,0.741242067068
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29449,0.00645731164903553,0.0195795541001723,-0.0319186143873021,0.0448332376853732,0.74155441038603
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24106,-0.00143652916564839,0.00437378452937128,-0.0100091468432161,0.00713608851191932,0.742581274370887
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,24190,-0.00112851882470903,0.0034374471280262,-0.00786591519564038,0.00560887754622232,0.742686602570208
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24096,0.00141322627155468,0.00431429732961117,-0.00704279649448321,0.00986924903759257,0.743241075993275
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,29781,0.00104509546900692,0.00325677033470177,-0.00533817438700856,0.0074283653250224,0.748288922675923
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,24190,0.00133820736884296,0.00418509001633771,-0.00686456906317895,0.00954098380086488,0.749156117422605
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29429,-0.000825708258850478,0.0025920823863798,-0.00590618973615489,0.00425477321845393,0.750069914073798
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24224,0.00098817873745368,0.00312763033278037,-0.00514197671479584,0.0071183341897032,0.752042228681917
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29576,0.000892041220271123,0.00282347948156144,-0.00464197856358931,0.00642606100413155,0.752052669699536
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BSND,Barttin,24011,-0.000696070658985928,0.00225091478651864,-0.00510786364056247,0.00371572232259061,0.757142406680474
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,23908,0.000708928456266909,0.00229812617705483,-0.00379539885076055,0.00521325576329437,0.757718980269263
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24190,-0.000969743715054455,0.00315007294410268,-0.0071438866854957,0.00520439925538679,0.758200632974163
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,29531,0.00117238481393865,0.00382257602784244,-0.00631986420063253,0.00866463382850983,0.759073744586478
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24788,0.000903435071694689,0.00295900472006568,-0.00489621417963404,0.00670308432302342,0.760127133109142
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,24106,-0.00123636847451631,0.00415451578667489,-0.0093792194163991,0.00690648246736648,0.766013874393049
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24224,0.000455178612536852,0.00154778622620554,-0.00257848239082601,0.00348883961589972,0.768696510393331
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24224,0.000806679739563611,0.00276292982460556,-0.00460866271666328,0.00622202219579051,0.77031562794324
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24106,-0.000869731305154429,0.00304365688003835,-0.00683529879002959,0.00509583617972073,0.775070464373862
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24106,0.000964203538788927,0.00337565282763231,-0.0056520760033704,0.00758048308094826,0.775160389026817
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,24011,0.000878831504881214,0.00308556928414253,-0.00516888429203815,0.00692654730180057,0.77578459070618
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24106,0.00115237323557528,0.00405244505681644,-0.00679041907578495,0.0090951655469355,0.776133179496769
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29429,-0.000519976569792426,0.00183781850463668,-0.00412210083888032,0.00308214769929547,0.777231411721645
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,24440,0.000774156547959363,0.00275656139284384,-0.00462870378201456,0.00617701687793329,0.77883443053554
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24840,0.0011115679778632,0.0039738791478888,-0.00667723515199885,0.00890037110772524,0.779695724596836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,28792,-0.00140199013590728,0.00505192153638334,-0.0113037563472186,0.00849977607540407,0.781385751381856
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24788,-0.00139514180785109,0.00508391311370714,-0.0113596115107171,0.00856932789501491,0.78376199098802
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29373,0.00122677727722394,0.00449262687667959,-0.00757877140106804,0.0100323259555159,0.784805493025733
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24190,-0.00100998141516963,0.00370169040789251,-0.00826529461463896,0.00624533178429969,0.784976005993786
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28792,0.000786186076547451,0.00290384721904428,-0.00490535447277934,0.00647772662587424,0.78659335394194
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29588,-0.000429241680212801,0.00160657598248221,-0.00357813060587793,0.00271964724545233,0.78933401429587
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28926,0.00208571932315069,0.00782974167471069,-0.0132605743592823,0.0174320130055836,0.789945246643032
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24011,0.00152259481104812,0.00574289731558192,-0.00973348392749245,0.0127786735495887,0.790914217577097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,29815,0.000975859709257468,0.00373508693738795,-0.00634491068802291,0.00829663010653785,0.79388743789927
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24190,-0.000623537510254843,0.00245641387287069,-0.0054381087010814,0.00419103368057172,0.799620884052727
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29344,0.000754742650139554,0.00298092445697187,-0.0050878692855253,0.00659735458580441,0.800122549444819
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24106,0.00163347297114273,0.00654649228179569,-0.0111976519011768,0.0144645978434623,0.802961619055235
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29213,-0.00115845874803226,0.00471033276487422,-0.0103907109671857,0.00807379347112121,0.805730488614744
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23965,0.00143210019821622,0.00582684010366527,-0.00998850640496771,0.0128527068014001,0.805857377794564
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,24106,-0.000760935410922277,0.00316144247967801,-0.00695736267109118,0.00543549184924662,0.809795520696764
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24096,-0.000680922332119832,0.00285340185774667,-0.0062735899733033,0.00491174530906363,0.811390441575115
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,29213,0.00017891094637796,0.000805984772714916,-0.00140081920814328,0.0017586411008992,0.824332505485097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24011,0.000803453071455254,0.00365511739378841,-0.00636057702037004,0.00796748316328055,0.82601637343543
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,24190,0.00073824670009998,0.00336980270371195,-0.00586656659917544,0.0073430599993754,0.826591816180967
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,24933,0.00125345787713427,0.00588842171847729,-0.0102878486910812,0.0127947644453498,0.83143148868171
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24190,-0.00109942006440027,0.0051656477036725,-0.0112240895635984,0.00902524943479782,0.831459052810424
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29815,-0.000426241246486431,0.00211038073444808,-0.00456258748600467,0.0037101049930318,0.839938722294203
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,REN,Renin,29473,0.0010171855338452,0.00504264032579431,-0.00886638950471165,0.0109007605724021,0.840139479974291
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24224,-0.00081217800721184,0.00402786260760214,-0.00870678871811204,0.00708243270368836,0.840199906651671
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NCLN,Nicalin,28926,-0.000698293274900739,0.00347228915439886,-0.0075039800175225,0.00610739346772102,0.840618210365234
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24011,0.00076744519169969,0.0038319541840462,-0.00674318500903087,0.00827807539243025,0.841267094880217
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,24224,0.000435429740061852,0.0022133927352724,-0.00390282002107205,0.00477367950119575,0.844044377348524
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,24190,0.000428718251380942,0.00223160315532784,-0.00394522393306163,0.00480266043582352,0.847655911260585
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,24190,0.00105476442150559,0.00550255092280472,-0.00973023538719165,0.0118397642302028,0.84798943470785
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,24190,-0.00083748464857654,0.00444768162140838,-0.00955494062653696,0.00787997132938388,0.8506454980176
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NPHS2,Podocin,24224,0.00128733529848231,0.00685333799294187,-0.0121452071676838,0.0147198777646484,0.851003161909307
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,24551,0.000760308312731861,0.00408788243464778,-0.00725194125917779,0.00877255788464151,0.852453554044753
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24011,0.00060170990710973,0.00325540052452426,-0.00577887512095782,0.00698229493517728,0.853360510422868
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29429,-0.000642757319026577,0.00348589156406009,-0.00747510478458436,0.00618959014653121,0.853710186416577
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,28911,-0.000595500351540634,0.00323106511270698,-0.00692838797244632,0.00573738726936505,0.853775753013705
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,24863,0.000417759205403384,0.002352125618431,-0.00419240700672137,0.00502792541752814,0.859031327846354
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,24011,-0.000491305213232394,0.00280638065132688,-0.00599181128983308,0.0050092008633683,0.86102830489185
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29618,-0.000949041888274602,0.00544488111777174,-0.0116210088791072,0.00972292510255801,0.861631019637027
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24190,-0.000483378959377779,0.00277652337794493,-0.00592536478014984,0.00495860686139428,0.861792225809009
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28911,-0.000699904941001652,0.00405561433374697,-0.00864890903514572,0.00724909915314242,0.862985298315126
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29657,-0.000728719219815328,0.00422433648146483,-0.0090084187234864,0.00755098028385574,0.863041698295229
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24106,-0.000648983834529625,0.00376888927521774,-0.00803600681395641,0.00673803914489715,0.863285686263428
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23033,-0.00059825435516384,0.0035259934834729,-0.00750920158277072,0.00631269287244304,0.86527137339604
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,24224,0.000305706027141438,0.00180668909145569,-0.00323540459211172,0.00384681664639459,0.865634547158653
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,24440,-0.000500116437168183,0.00296846830590789,-0.00631831431674765,0.00531808144241128,0.866210013677635
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,24224,-0.000321166077965797,0.00194710018189481,-0.00413748243447962,0.00349515027854803,0.868987987373739
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24190,-0.000321439749553597,0.00197742797413079,-0.00419719857884995,0.00355431907974276,0.870870598993114
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24096,0.000357569958490825,0.00220215652648985,-0.00395865683342927,0.00467379675041092,0.871013781054836
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24917,0.000284897461338809,0.00176054855376633,-0.00316577770404321,0.00373557262672082,0.871446458050844
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24011,0.000986605250824071,0.00621223470433713,-0.0111893747696767,0.0131625852713248,0.873814800635986
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24863,-0.000337537101641697,0.00213190657470817,-0.00451607398806971,0.00384099978478632,0.874200889719781
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,28792,-0.00144665046754234,0.00919119245201891,-0.0194613876734994,0.0165680867384147,0.874934423785437
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29344,-0.000353040753584913,0.00228126628656717,-0.00482432267525657,0.00411824116808674,0.877014362021454
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,24440,0.000617020078760713,0.00398767098169153,-0.00719881504535469,0.00843285520287612,0.877033924888659
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,24106,-0.000486322435285019,0.00334525016800128,-0.00704301276456752,0.00607036789399748,0.884414438865909
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,24190,-0.000407533135632123,0.00282344121903924,-0.00594147792494904,0.00512641165368479,0.885233859474118
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,24144,0.000640772205709356,0.0045077807169065,-0.00819447799942738,0.00947602241084609,0.886964257621196
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,28911,-0.000256360581344415,0.00182263075375616,-0.00382871685870648,0.00331599569601765,0.888144147440142
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28926,0.000553236655129706,0.00395883031641136,-0.00720607076503657,0.00831254407529598,0.888860465376721
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24224,0.000503832313233775,0.00361165054504526,-0.00657500275505494,0.00758266738152249,0.889054671268984
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,24011,0.000372045149078047,0.00268834696768429,-0.00489711490758315,0.00564120520573925,0.889931946403012
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,24224,-0.000498788173431436,0.00365120643502563,-0.00765515278608168,0.0066575764392188,0.891340886949405
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24224,0.000253261344042769,0.00186263880246814,-0.00339751070879478,0.00390403339688032,0.891846829651518
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24440,0.000443998439424395,0.00327673655296252,-0.00597840520438215,0.00686640208323094,0.892217527241051
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29449,0.000350646547633449,0.00262621654498953,-0.00479673788054604,0.00549803097581293,0.89378483315177
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,24190,-0.000426778266009881,0.00321554501568009,-0.00672924649674286,0.0058756899647231,0.89441319178148
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,24096,0.000544617078055578,0.00410918816811446,-0.00750939173144875,0.00859862588755991,0.894561127502819
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,24235,0.000366056028334582,0.00282472906297912,-0.00517041293510449,0.00590252499177366,0.896892062571695
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,24376,0.000245011346605175,0.00190017798422737,-0.00347933750248046,0.00396936019569081,0.897405191517239
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,24946,0.000437248861096013,0.00341911016865391,-0.00626420706946564,0.00713870479165767,0.898241948993097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24190,-0.000573141880345693,0.00462611014224352,-0.009640317759143,0.00849403399845161,0.90140115950277
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24011,-0.000455433084433527,0.00381265541063657,-0.00792823768928121,0.00701737152041416,0.904917482643502
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24224,0.00052134087595911,0.00461592968545174,-0.00852588130752631,0.00956856305944453,0.910076006870061
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,24224,0.000433760145878793,0.00406984146696148,-0.00754312912936571,0.00841064942112329,0.915123762474819
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,24440,0.000377061902880335,0.0035576968638704,-0.00659602395030566,0.00735014775606633,0.915595257378445
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,24011,-0.00039334275411072,0.00371787899498372,-0.00768038558427882,0.00689370007605738,0.915743808393555
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,24190,0.000644134844113875,0.006106532643482,-0.0113246691371108,0.0126129388253386,0.915993503877349
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,24190,-0.000458105330607187,0.00435396101647531,-0.00899186892289879,0.00807565826168441,0.916205475922838
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24440,0.000187089720385824,0.00187574716922499,-0.00348937473129516,0.00386355417206681,0.920550420156311
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,24190,-0.000444844529668108,0.00461597862191994,-0.0094921626286312,0.00860247356929498,0.92322705717271
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28911,-0.000215605132832246,0.00227607173517527,-0.00467670573377577,0.00424549546811127,0.924532438030763
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,28439,0.000213908593308421,0.00239034626264487,-0.00447117008147553,0.00489898726809237,0.928694292549565
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,24863,-0.000216700804673627,0.00248015774029207,-0.00507780997564609,0.00464440836629883,0.930375098869057
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24933,0.000228805828289843,0.00262856506463132,-0.00492318169838754,0.00538079335496723,0.930635722023473
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24011,-0.000281194694087007,0.00324370964260125,-0.00663886559358546,0.00607647620541144,0.930919259989195
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,24190,0.000197212883619879,0.00230113103208521,-0.00431300393926714,0.0047074297065069,0.93170355486667
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28911,-0.000296993250409545,0.00353982029181284,-0.0072350410223627,0.00664105452154361,0.933135997862306
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29689,0.000260638508632059,0.00311443419789279,-0.0058436525192378,0.00636492953650192,0.933305639874534
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,24302,0.00046152896795433,0.00556875711426585,-0.0104532349760067,0.0113762929119154,0.93394901384246
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24190,-0.000168946599567415,0.00211069199851244,-0.00430590291665179,0.00396800971751696,0.936203538286975
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28769,0.000325548416353406,0.00419208677556304,-0.00789094166375015,0.00854203849645696,0.938100769577639
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24440,0.000295506007696532,0.00386610438792095,-0.00728205859262853,0.0078730706080216,0.939073585471838
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24840,-0.000347538223821093,0.00464818369297143,-0.00945797826204509,0.00876290181440291,0.940399421594082
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24788,0.00029154610886827,0.00393120261393138,-0.00741361101443723,0.00799670323217377,0.940882028167536
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29082,0.000284556338217865,0.00393790453589188,-0.00743373655213023,0.00800284922856596,0.942394815677724
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28792,-0.000214558368334476,0.00348628086267106,-0.00704766885916975,0.0066185521225008,0.950926698455837
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,28926,0.000167316859094718,0.00273132455759601,-0.00518607927379347,0.0055207129919829,0.951153760337866
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ENG,Endoglin,29815,-6.55295947211689e-05,0.00114093099069445,-0.00230175433648229,0.00217069514703995,0.954198912226854
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28792,-0.000108548594736949,0.00202916358883103,-0.00408570922884577,0.00386861203937187,0.957338479149971
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,29671,0.000152588164574857,0.00287613480590789,-0.00548463605500462,0.00578981238415433,0.957689874594994
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24252,9.86415184267634e-05,0.001865408621708,-0.00355755938012091,0.00375484241697444,0.957828506348134
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24788,-0.000197923578273629,0.00394345808443331,-0.00792710142376291,0.00753125426721565,0.959971098630683
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,24011,-9.26033678757862e-05,0.00206615840667874,-0.00414227384496611,0.00395706710921454,0.964251870770558
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24190,-0.000105792486109989,0.00243807320012843,-0.00488441595836172,0.00467283098614174,0.965389539389193
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,24011,0.000113942411913318,0.00291220744580391,-0.00559398418186234,0.00582186900568898,0.968790426117185
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24840,-0.000140384592086346,0.0037101509798551,-0.00741228051260234,0.00713151132842965,0.969817172308682
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24011,-5.8627687980763e-05,0.00176139973920858,-0.00351097117682957,0.00339371580086805,0.973447819649041
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,28717,-0.000130652040552459,0.00471412607054366,-0.00937033913881804,0.00910903505771312,0.97788964653097
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24440,0.000155850542082875,0.00565469219470612,-0.0109273461595411,0.0112390472437069,0.978012290974387
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24917,6.10335259190976e-05,0.00234831173453614,-0.00454165747377174,0.00466372452560993,0.979265215825515
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,24440,-0.000144266330143847,0.00568684023527722,-0.0112904731912872,0.0110019405309995,0.979761282372075
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24440,-0.000123449625608734,0.0052860997842527,-0.010484205202744,0.0102373059515266,0.981368382499025
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,24190,-5.77711709538093e-05,0.00250704711285405,-0.00497158351214774,0.00485604117024012,0.981615754542289
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24235,-0.000397035787265599,0.017472261508614,-0.0346426683441491,0.0338485967696179,0.981870796019688
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29421,0.0001422683239284,0.00645304134967107,-0.0125056927214269,0.0127902293692837,0.982410845874744
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24011,-7.93627995838267e-05,0.00423834396981438,-0.00838651698042001,0.00822779138125236,0.985060676305564
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,24840,-5.51128621327798e-05,0.00341491191292107,-0.00674834021145808,0.00663811448719252,0.987123723482622
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29395,6.64823129041557e-05,0.00559404057346898,-0.010897837211095,0.0110308018369034,0.990517853726236
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24096,2.8455778238155e-05,0.00266537352890615,-0.00519567633841789,0.0052525878948942,0.991481959707673
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,28769,-2.26232902606075e-05,0.00217331529350681,-0.00428232126553395,0.00423707468501273,0.991694582404048
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24440,3.68754977137778e-05,0.003588175652619,-0.00699594878141946,0.00706969977684701,0.991800409430588
NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,24011,-6.70824897342523e-05,0.00774960533317756,-0.0152563089427623,0.0151221439632938,0.993093473215282
